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Scope and summary
Proteins are involved in nearly all aspects 
of life. These biomolecules are essential for 
metabolism, the generation and transduction 
of action potentials in the nervous system, 
the immune response to infection, and also 
for vision, smell, taste, hearing, and sensing 
heat, cold, or pressure. Most enzymes in 
the body are proteins, and so are receptors 
and some hormones. Proteins are also 
involved in transport, signalling, rigidity, and 
compartmentalisation.
The molecular function of a protein is 
determined by its amino-acid sequence and its 
three-dimensional shape. Our understanding 
of protein function, therefore, is largely based 
on the investigation of protein structure at the 
atomic level of detail. The field of structural 
biology strives to analyse the relation between 
molecular structure and biological function of 
macromolecules. Macromolecular structures 
are also a valuable source of information for 
various related fields. For example, in rational 
drug design, structure models of protein-drug 
complexes guide the development of lead 
compounds. In protein engineering, protein 
structures (and multiple sequence alignments 
based on protein structures and sequences) 
aid the selection of mutations that stabilize 
enzymes or that make enzymes convert their 
substrate more efficiently. In chemical biology, 
protein structures may help selecting amino 
acids at the surface that are most suitable for 
bio-conjugation to fluorescent probes. In 
molecular dynamics, the motion of protein 
structures is simulated at timescales ranging 
from femtoseconds to milliseconds. 
Many diseases can be treated with medicines 
that address a protein. Pharmaceutical drugs 
are often small molecules that specifically 
interact with a protein in a certain biological 
process. Imatinib, for example, prevents 
tumour cell proliferation by inhibiting 
constitutively active tyrosine kinases. Statins 
compete with the natural substrate of 
HMG-CoA reductase, thereby reducing the 
rate of cholesterol production. Sometimes 
drugs influence how reality is perceived. 
Most painkillers, for example, inhibit cyclo-
oxygenases, the enzymes involved in signalling 
pain. Some drugs activate proteins. One 
example is the muscle-relaxant Baclofen that 
activates the GABAB receptor. Recently new 
classes of biopharmaceuticals were introduced, 
such as monoclonal antibodies that are used 
to treat e.g. cancer, multiple sclerosis, arthritis, 
psoriasis, or Crohn’s disease.
The Protein Data Bank (PDB) (Berman et al., 2003) 
is the public repository for macromolecular 
structures. It holds over a hundred thousand 
structure models of either individual proteins 
or proteins in complex with other proteins, 
nucleic acids, lipids, carbohydrates, ions, 
metabolites, or drug molecules. The PDB is 
a rich source of information on biomolecular 
structure and interactions, and much of what 
we know about proteins has been learned from 
studying protein structures deposited in the 
PDB over the past four decades. 
The advance of sequencing technologies 
has led to a rapid increase in the amount of 
genome sequence information, but structure 
information is only available for a tiny fraction 
of all gene products. Structure prediction is one 
of the challenges in the field of bioinformatics 
that attempts to answer biological questions 
using computers. Homology modelling 
techniques are based on the collective structure 
data in the PDB and will, therefore, be better if 
the quality of the archive is higher.
Most aforementioned applications, such as 
protein engineering, molecular dynamics, drug 
design, or homology modelling, require high-
quality protein structure models for which the 
devil is often in the details.
Protein structures can be experimentally 
determined with atomistic detail by electron 
microscopy, nuclear magnetic resonance, 
or X-ray crystallography. These techniques 
are briefly introduced in Chapter 1a. They 
10 |
all have advantages and disadvantages, but 
share that the raw experimental data relate 
to structure only indirectly. Unambiguous 
interpretation of these data is virtually 
impossible and expert knowledge is often 
required to prevent incorrect interpretation. 
Consequently, many structure models contain 
errors. Although all structure models present a 
suboptimal interpretation of the experimental 
data, some can be made more useful1.
World-wide PDB validation task forces 
(Read et al., 2011; Henderson et al., 2012; Montelione et al., 2013) 
have been set up to discuss the detection 
of improbable or incorrect model features; 
preferably before the coordinates are 
deposited in the PDB. The WHAT_CHECK 
validation project (Hooft et al., 1996d) made clear that 
hundreds of classes of errors are observable in 
experimentally determined protein structures. 
The PDB_REDO project (Joosten & Vriend, 2007; Joosten et 
al., 2009a) aims at an optimal interpretation of the 
original experimental data by careful structure 
re-building and re-refinement with state-of-
the-art software and by exploiting today's 
knowledge of all details that govern protein 
sequence-structure relations. Combined 
with the ever growing computing power, 
the pipeline will continue to produce better 
coordinates faster. PDB_REDO addresses a 
limited number of the problems associated 
with crystallographic structure models, and 
this thesis has added several new aspects.
Chapter 1b introduces the problems by 
describing why accurate structure models are 
important for interpreting biological function. 
In ten examples it is shown that an optimised 
structure model can change the perspective 
on the biological role of a protein. Finally, 
this chapter introduces the PDB_REDO 
project and validation-driven optimisation of 
structure models.
The work for this thesis required the 
manual optimisation of more than a thousand 
proteins structure models, a daunting task 
that would not have been possible without 
1. free after George Box (1979)
an extensive software and data infrastructure. 
Re-refinement was performed with Coot (Emsley 
et al., 2010) and REFMAC (Murshudov et al., 2011). WHAT 
IF (Vriend, 1990a), YASARA (Krieger & Vriend, 2014), and a 
large number of R (R Core Team, 2016) and Python 
(Python Software Foundation) scripts were essential tools 
for protein structure analysis. Chapter 2 
discusses the data infrastructure and several 
protein structure bioinformatics facilities 
that are maintained for the (computational) 
structural biology community.
Almost all studies described in this thesis 
relied on a good description of the atomic 
displacement. The displacement of atoms in 
crystal structures can be modelled in many 
different ways and this has resulted in many 
different B-factor representations in PDB files. 
For example, residual B-factors may have been 
deposited when the motion of groups of atoms 
was refined using the TLS formalism (Schomaker & 
Trueblood, 1968). Although mathematically correct, 
this is very inconvenient for bioinformatics 
applications that use isotropic, full B-factors. 
Chapter 3 therefore discusses the BDB, a 
parallel PDB in which uncommon B-factor 
representations have been converted into full 
B-factors.
While analysing B-factors in PDB entries we 
observed that the fraudulent structure models 
deposited by H.K.M. Murthy in the period 
1998-2007 (Janssen et al., 2007; Borrell, 2009; University of Alabama 
at Birmingham, 2009) have odd B-factor distributions. 
Despite that a theoretical underpinning is 
lacking, we found that these odd distributions 
could have been detected using a Benford 
analysis of the B-factors (Newcomb, 1881; Benford, 1938). 
Chapter 4 describes the implementation of 
this validation method.
Chapter 1a briefly explains why it is 
important both for refinement and validation 
that the expectation values of geometric 
parameters are as detailed and as correct as 
possible. In this thesis several parameters are 
investigated. Chapter 5 describes a PDB-
wide study of the backbone angle τ (N—
Cα—C) as an example to explain the concept 
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that bond lengths, bond angles, and other 
geometric parameters depend on the local 
physicochemical environment in a protein. 
The implications for context-dependent 
refinement and validation targets are discussed.
Chapter 6 presents an investigation of 
the geometrical parameters of tetrahedral zinc 
complexes consisting of a zinc ion and four 
cysteine or histidine ligands. This chapter 
shows that incorrect restraints may lead to 
locally distorted protein structure models, 
and describes methods to detect and correct 
complexes with a distorted geometry. It is also 
demonstrated that the ion–ligand distance 
and ligand–ion–ligand angles depend on the 
ligand type. New refinement and validation 
targets are proposed based on optimised 
high-resolution protein structure models. 
The geometry problems associated with zinc 
complexes have also been the topic of an April 
Fools' Day article. This article is the Chapter 
6 appendix.
Chapter 7 discusses a method to detect 
protein backbones that are distorted due 
to incorrect peptide plane conformations. 
The method detects systematic deviations 
in geometrical parameters of the four amino 
acids and their B-factors around a central 
trans-peptide bond. Based on these patterns 
the method predicts whether the peptide plane 
should be flipped while maintaining the trans 
conformation or whether the trans-peptide 
should be flipped to the cis conformation. 
The work on cis-peptide validation will be an 
integral part of the X-ray VTF pipeline.
The research described in chapter 6 and 
much more so in chapter 7 has relied on the 
use of the Random Forest (RF) (Breiman, 2001) 
machine-learning algorithm to select the most 
significant variables from among very many 
variables that can describe a system. The RF 
applications required a deep understanding 
of the RF method. The Chapter 7 appendix 
is the abstract of a review that highlights the 
poential of data mining with RF in the Life 
Sciences.
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Several experimental techniques exist to probe 
the location of atoms in a structure. The vast 
majority of structures are determined by 
single-crystal X-ray diffraction, cryo-electron 
microscopy (cryo-EM) and solution Nuclear 
Magnetic Resonance (NMR) spectroscopy. 
These three methods each generate a different 
type of data, but have in common that a three-
dimensional model of the protein structure is 
the end result.
Cryo-EM
Electron radiation is scattered by the specimen 
and focused by the electromagnetic lenses of 
an electron microscope to form a real-space 
image that contains both amplitude and phase 
information. Hence, EM does not suffer from 
the so-called phase problem. Single-particle 
cryo-EM images contain 2D projections 
of macromolecular complexes immobilized 
on a grid under cryogenic conditions. The 
images usually contain a lot of noise, but 3D 
reconstruction of many noisy 2D projections 
may generate an interpretable electron 
density map (Sigworth et al., 2010; Scheres, 2012). Distinct 
conformations might be extracted from 
structurally heterogeneous data using clustering 
algorithms (Scheres, 2010). At low resolution a 
crystallographic structure model is needed 
to interpret cryo-EM electron density maps. 
Recent improvements in detector quality have 
yielded high-resolution images that allowed de 
novo tracing of macromolecular structures in 
the electron density (Bai et al., 2015; Nogales, 2016; Glaeser, 
2016). Cryo-EM is a powerful technique to 
study large macromolecular complexes.
NMR
NMR spectroscopy exploits the intrinsic 
angular momentum of atomic nuclei called 
spin. Spin magnitude is quantized and is 
characterized by the spin quantum number. 
Nuclei with spin quantum number ½ are 
most convenient for NMR experiments. The 
most common atoms in proteins are hydrogen 
(H), carbon (C), nitrogen (N), and oxygen 
(O). In nature the most abundant isotopes 
of these elements are 1H, 12C, 14N, and 16O. 
Of these, only 1H isotopes have spin-½. For 
protein structure determination the spin-
½ isotopes 13C and 15N can be incorporated 
into the protein. Spin-½ nuclei can adopt 
two orientations when placed in a strong 
magnetic field. The two orientations relative 
to the external magnetic field are associated 
with two energy levels. Nuclei that populate 
the lower energy level may be promoted to 
the upper energy level when a radio-frequency 
electromagnetic pulse is applied that matches 
the energy difference between the two energy 
levels; that is, when the resonance condition is 
satisfied (Ernst et al., 1990; Wüthrich, 1986; Cavanagh et al., 2007). 
The resonance frequency of a nucleus provides 
structure information because it is very sensitive 
to the local chemical environment. NMR 
experiments measure this so-called chemical 
shift. Backbone torsion angles are commonly 
predicted from backbone atom chemical 
shifts (Shen & Bax, 2013), but might also be derived 
from so-called 3J-coupling constants (Karplus, 
1959). The most important type of information 
for structure determination, however, can 
be extracted from experiments that measure 
the Nuclear Overhauser Effect, i.e. through-
space spin-spin polarization transfer via cross-
relaxation between pairs of atoms that are 
in close spatial proximity in a protein (Ernst et 
al., 1990; Wüthrich, 1986). These experiments allow 
measuring the distance between atoms. Other 
experiments measure the Residual Dipolar 
Coupling that provides information about the 
relative orientation of certain types of bonds 
(Cavanagh et al., 2007). The various types of geometry 
information can be converted to dihedral angle 
restraints, distance restraints, and orientation 
restraints. A structure calculation (Breukels et al., 2011) 
seeks to find structure models that satisfy these 
geometry restraints. The models in a well-
refined structure ensemble ideally represent 
the conformations a protein can adopt in 
15Introduction: Prior knowledge
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solution. Atomic structure elucidation is 
restricted to small proteins due to many 
limitations associated with e.g. the tumbling 
properties of large proteins in solution, spectral 
resonance overlap, and protein solubility. 
NMR is a very powerful technique, though, 
to probe disordered protein structure (Konrat, 
2014) and interactions between small molecules 
and proteins. Furthermore, in addition to 
information on average atomic positions, 
NMR may also provide unique data about 
dynamics (Cavanagh et al., 2007).
X-ray diffraction
Macromolecular structure determination 
by crystallographic diffraction requires 
crystallisation of the molecule of interest. 
Molecules are periodically stacked in a 
crystal in a highly ordered microscopic 
arrangement. Electrons scatter X-rays and 
the X-ray wavelength is of the same order of 
magnitude as typical interatomic distances. 
As a consequence, scattered X-ray waves 
interfere destructively in certain directions 
and constructively in other directions, giving 
rise to a diffraction pattern. The directions 
in which the waves add constructively 
are given by Bragg’s law (Bragg & Bragg, 1913) 
2d sin θ = nλ, where d is the distance between 
the lattice planes in the crystal, θ is the incident 
angle, n is a positive integer and λ is the X-ray 
wavelength. Reflection intensities are obtained 
from the regularly spaced spots in a diffraction 
image. Reflections provide wave amplitude 
information, but not wave phase information. 
This is the so-called phase problem. An electron 
density map can be calculated by Fourier 
transformation of the diffraction images once 
the phases have been recovered by molecular 
replacement, heavy-atom phasing or ab initio 
methods. The peaks in the electron density 
map provide information about the time- 
and space-averaged atom positions. Neutron 
diffraction also provides information about 
atom location in a crystal since atomic nuclei 
scatter neutron radiation. The diffraction data 
also contain information about atom disorder 
and domain motion within a crystal.
While being the oldest, X-ray crystallo-
graphy remains the principal technique to 
characterize protein structure and the vast 
majority of existing PDB entries have been 
solved by this technique. Furthermore, 
the PDB_REDO project has its focus on 
crystallographic structure models. The focus 
of this thesis is therefore on protein structure 
X-ray crystallography.
Model building, refinement 
and validation
The goal of structure determination is to find 
a structure model that optimally describes 
the experimental data and at the same time 
satisfies the rules that are dictated by protein 
chemistry.
The experimental data of an X-ray 
diffraction experiment do not directly provide 
a picture of a macromolecule; the reflections 
are indirectly related to structure. Obviously, 
correct interpretation of these data is 
necessary to obtain a correct structure model. 
The computational part of the structure 
determination process involves many steps. 
The last steps are iterations of model building, 
refinement and validation. In the building stage 
the electron density map is inspected (visually 
or automatically) and when necessary the 
model is modified by adding missing atoms, 
by removing spurious atoms, by changing 
the chemical identity of atoms, or by moving 
atoms. The agreement between the structure 
model, the measured reflections, and prior 
knowledge reflecting our understanding of 
(or our assumptions about) protein chemistry, 
is further improved in cycles of automated 
refinement (in reciprocal space or real space). 
Refinement fine-tunes the parameters of the 
structure model – the most important of 
which are the x, y and z coordinates, and the 
(anisotropic) atomic displacement parameters 
16
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(ADPs) (Trueblood et al., 1996) that describe atom 
movement in a simplistic way. Displacement 
parameters are further introduced in chapter 3. 
The resulting structure model is subjected to a 
series of validation checks. The fit of the model 
to the electron density map is checked, or it 
is tested whether certain chemical properties 
of the structure model have the expected 
value. Thus, prior chemical knowledge is not 
only used during refinement but also during 
validation.
Refinement: likelihood times 
prior
From a mathematical point of view, refinement 
is the minimization of a target function that 
has two components: the X-ray residual and 
the chemistry residual (Bricogne, 1997). The X-ray 
residual measures the difference between 
structure factor amplitudes calculated from the 
structure model and the measured structure 
factor amplitudes. The chemistry residual 
measures the difference between actual and 
expected values of either geometric variables 
that depend on the atom positions or ADPs. In 
most modern refinement software, the X-ray 
term defines the likelihood: the conditional 
probability distribution P(D|θ) of the data 
D given the model parameters θ. The prior 
probability distribution P(θ) quantifies how 
likely the parameters of the structure model 
are, given the prior chemical knowledge. 
According to Bayes’ theorem (Bayes & Price, 1763), 
the posterior P(θ|D) is proportional to the 
product likelihood times prior. The goal of 
refinement is to estimate the model from the 
data: the posterior must be maximized. For 
computational reasons, in practice the negative 
logarithm of the product P(D|θ)P(θ) is 
minimized instead. When many observations 
are available, the relative contribution of the 
prior to the posterior is minimal because 
the prior is outweighed by the likelihood. 
However, the number of reflections per atom is 
small in macromolecular crystallography. Prior 
chemical information has to be incorporated 
in refinement to complement the likelihood 
because of this small data-to-parameter ratio.
Restraints
The refinement prior may include information 
about ideal bond lengths, bond angles, 
torsion angles, ring- and other planarities, 
atom chiralities, disulfide bond geometries, 
coordination distances in ion complexes, 
sugar linkages, ring puckers, and other 
geometric variables in the structure model. 
This information is used in the form of so-
called restraints. Restraints have a target value 
and their residual – the difference between the 
actual value in the structure model and the 
‘ideal’ value – is weighted and added to the 
geometry component of the refinement target 
function. ADP restraints reflect assumptions 
about (correlated) atom movements.
Restraint sources
Engh & Huber (1991, 2001) derived average 
bond lengths and angles from peptide-like 
small molecule fragments in the Cambridge 
Structural Database (CSD). These average 
values are used as restraint targets in protein 
structure refinement. Parkinson et al. (1996) 
derived restraints for nucleic acids from 
the CSD and high-resolution samples of 
the Nucleic Acid Database. Inherent to the 
use of CSD restraints for protein structure 
refinement is the assumption that they are 
applicable to protein structures. The expected 
effects of the local stereochemical environment 
on protein geometry (Engh & Huber, 2001) may be 
taken into account by deriving restraints from 
high-resolution protein structures that have 
been refined without restraints. Recently, a 
conformation-dependent library was construc-
ted in which restraints have been made a 
function of the φ and ψ backbone torsion 
angles (Berkholz et al., 2009) and this library indeed 
improves refinement (Tronrud et al., 2010; Tronrud & Karplus, 
17Introduction: Prior knowledge
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2011). Chapter 5 and chapter 6 discuss other 
aspects that need to be taken into account.
Validation
The expected values of geometric parameters in 
protein structures are not only useful to restrain 
a structure model to plausible geometry, but 
also to validate the refined structure model. 
The refinement target function has many local 
minima and in practice it is very difficult, if 
not impossible, to find the model associated 
with the global minimum. Consequently, 
after refinement the model virtually never 
satisfies all geometric restraints perfectly. Many 
validation methods quantify the geometric 
quality of the model and detect local geometry 
outliers. At lower resolution there are fewer 
reflections and the contribution of the prior to 
the target function is relatively large. Although 
this means that restraints have a large impact 
on geometry at low resolution, the model may 
still contain errors in the local geometry after 
refinement. Certain geometrical properties of 
a protein structure model are not commonly 
restrained and are therefore relatively 
independent from the refinement protocol. 
An example of an ‘independent’ validation 
check is the Ramachandran plot (Ramachandran 
et al., 1963) normality of backbone φ/ψ dihedral 
angles relative to the distribution of φ/ψ angles 
observed in high-quality, high-resolution 
protein structure models. Model quality may 
also be assessed by checking model aspects 
that are not directly related to geometry, 
such as B-factors. B-factors are proportional 
to isotropic ADPs. ADPs normally reflect 
disorder of atoms in the crystal but may be 
artificially inflated when atoms are modelled 
at incorrect positions. Structure validation is 
further introduced and reviewed in the next 
chapter.
18
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Structure validation is a key component of all steps in the structure determination process, from structure building, refinement, deposition, and evaluation all the way to post-deposition optimisation of structures in the 
Protein Data Bank (PDB) by re-refinement and re-building. Today, many aspects 
of protein structures are understood better than ten years ago, and combined 
with improved software and more computing power, the automated PDB_REDO 
procedure can significantly improve about 85% of all X-ray structures ever 
deposited in the PDB. We review structure validation, structure improvement, and 
a series of validation resources and facilities that give access to improved PDB files 
and to reports on the quality of the original and the improved structures. Post-
deposition optimisation generally leads to improved protein structures and a 
series of examples will illustrate how that, in turn, leads to improved or even novel 
biological insights.
Introduction
In 1951, Pauling and Corey predicted the 
α-helix (Pauling & Corey, 1951a) and the β-sheet (Pauling 
& Corey, 1951b). In 1958, the first picture of a 
protein was obtained when Kendrew and 
colleagues solved the structure of myoglobin 
at 6 Å using X-ray crystallography (Kendrew et 
al., 1958). In 1960 the structure of myoglobin 
was obtained at 2 Å (Kendrew et al., 1960) and the 
structure of haemoglobin was solved (Perutz et 
al., 1960). The similarity between the tertiary 
structures of haemoglobin and myoglobin 
showed the evolutionary conservation of the 
globin folds (Perutz, 1965; Perutz et al., 1965), and these 
structures “laid the foundation” (Rossmann, 1994) for 
understanding the mechanism of cooperativity 
in haemoglobin and hinted already at the 
possibility to perform homology modelling, 
which was performed for the first time when 
α-lactalbumin was modelled based on the 
crystal structure of hen egg-white lysozyme 
four years later (Browne et al., 1969). Myoglobin and 
haemoglobin illustrate the impact of protein 
atom coordinates on science in general and 
on biology in particular. Kendrew and Perutz 
received for their work a Nobel Prize, an honour 
later also bestowed on scientists1 for (structure) 
work on G protein-coupled receptors, the 
ribosome, insulin, the photosynthetic reaction 
centre, ATPase, GFP, ubiquitin, ion and 
water channels, protein structure NMR in 
general, and for computational techniques 
on protein structures. The last of this list was 
awarded for "the development of multiscale 
models for complex chemical systems", which 
is a computational technique that critically 
depends on the accuracy of the protein 
structure coordinates.
Novotný, Bruccoleri, and Karplus were the 
first to ask whether correctly folded protein 
models could be distinguished from incorrectly 
folded protein models (Novotný et al., 1984, 1988). They 
modelled the sequence of the α-helical sea 
worm hemerythrin on the mainly β-stranded 
mouse immunoglobulin VL domain and 
vice versa. The incorrect side chains could 
be incorporated reasonably well and the 
empirical potential energy of these mis-folded 
models was comparable to the correct models. 
The mis-folded models, however, had higher 
non-covalent energy terms, a larger solvent-
accessible surface area, and more exposed non-
polar side-chain atoms (Novotný et al., 1984). Others 
reported that, compared to the correct models, 
1. http://www.nobelprize.org/nobel_prizes/chemistry/laureates/
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the incorrect models have a lower solvation 
free energy (Eisenberg & McLachlan, 1986), are less 
compact (Zehfus & Rose, 1986), and make only about 
half as many hydrophobic contacts (Bryant & Amzel, 
1987). These deliberately mis-folded proteins 
have long served to validate protein structure 
analysis and validation methods (Eisenberg & 
McLachlan, 1986; Zehfus & Rose, 1986; Bryant & Amzel, 1987; Baumann 
et al., 1989; Hendlich et al., 1990; Toma, 1991; Holm & Sander, 1992; Lüthy 
et al., 1992; Bryant & Lawrence, 1993; Vriend & Sander, 1993; Colovos & 
Yeates, 1993; Sippl, 1993; Delarue & Koehl, 1995).
(a) (b)
(c)
(d)
(e)
Figure 1.1. Threading errors in protein structures. (a) The best superposition possible for ferredoxin I in the correctly traced Protein 
Data Bank (PDB) entry 5fd1 (Stout, 1993) (orange) and the mis-threaded (Stout et al., 1988) PDB entry 2fd1 (Ghosh et al., 1982) (grey). (b) β-strands 
β1 (yellow) and β3 (orange) in the correct PDB entry 5p21 (Pai et al., 1990). These two β-strands were traced in each other’s density (Pai et 
al., 1989) in the structure of human p21 reported in (de Vos et al., 1988). (c) The small subunits of spinach RuBisCo are coloured in the correct 
structure model 1rcx (Taylor & Andersson, 1997). The small RuBisCo subunit was threaded incorrectly (Knight et al., 1989) in the structure reported by 
Chapman et al. (1988). (d) Residues 143-203 of the enolase structures 1enl (Lebioda & Stec, 1988) (grey) and 2enl (Lebioda et al., 1989) (orange). 
The first β-strand is followed by a loop and an anti-parallel second β-strand in the correct structure model 2enl. The 1enl structure 
model is traced backwards. (e) In the Cα-only PDB entry 2hvp (Navia et al., 1989) five Cα atoms (ball-and-sticks) are incorrectly assigned to the 
C-terminus of the HIV-1 protease rather than correctly to the N-terminus (spheres), resulting in an erroneous dimer interface (Wlodawer 
et al., 1989). The problem can be resolved [PDB 3hvp (Wlodawer et al., 1989)] by breaking the C-terminal connection (scissors) with the stretch of 
five Cα atoms and connecting (glue) the stretch to the N-terminus instead. The symmetry-related copy is shown in purple. Figures were 
prepared with CCP4mg (McNicholas et al., 2011).
22
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Validation 
It is generally believed that the field of protein 
structure validation came into existence in 
1989 when serious errors were discovered in 
a series of deposited crystal structures (see 
Fig. 1.1). These discoveries led to the CCP4 
study weekend “Accuracy and reliability of 
macromolecular crystal structures” and Brändén 
and Jones (1990) subsequently published their 
seminal commentary on errors and checks 
to detect them. Soon after this commentary 
was published, the crystallographic model-
building program O could compare rotamers 
and the position of backbone oxygen atoms 
to database penta-peptides (Jones et al., 1991). The 
protein structure bioinformatics community 
also took up the challenge and, in 1993, the 
first three structure validation methods were 
published in rapid succession: Directional 
Atomic Contact Analysis (DACA) (Vriend & Sander, 
1993), PROCHECK (Laskowski et al., 1993a), and Protein 
Structure Analysis (ProSA) (Sippl, 1993) were 
published. These three methods determined 
rules from protein structures solved at high 
resolution -that are therefore presumed 
'correct'- to find errors in protein structures in 
general.
Vriend and Sander determined a contact 
quality index that measures the agreement 
between the atom distributions of all possible 
close contacts in the structure model and 
equivalent database distributions (Vriend & 
Sander, 1993). This detailed evaluation of atomic 
packing also allows for the detection of local 
errors in the protein packing. This method 
was implemented in WHAT IF (Vriend, 1990a). 
The quality index resulting from this analysis 
is now known as packing quality or DACA in 
WHAT_CHECK (Hooft et al., 1996d).
Thornton and co-workers described the 
stereochemical quality of protein structures in 
terms of the parameters derived by Morris et 
al. (Cα chirality, disulfide bond length, proline 
φ, main-chain hydrogen-bond energy, peptide 
bond planarity, side-chain torsion angles χ1 
and χ2 etc.) (Morris et al., 1992), bond lengths and 
bond angles (Engh & Huber, 1991), and position in the 
Ramachandran plot (Ramachandran et al., 1963). These 
stereochemical checks were implemented in 
PROCHECK (Laskowski et al., 1993a).
Sippl applied the concept of potentials of 
mean force (Sippl, 1990) to Cα–Cα (Sippl, 1993) and 
Cβ–Cβ (Hendlich et al., 1990; Sippl, 1993) distances. In the 
ProSA method the pseudo-energy of proteins 
is derived using a combination of mean force 
potentials, and the mean field energy of a 
protein structure is transformed into a Z score 
by evaluating the energy for a large number of 
structure decoys (alternative conformations) as 
well (Sippl, 1993). 
More methods that give a score to a whole 
molecule have been published; often, like 
ProSA, in threading projects. Eisenberg and 
colleagues, for example, calculated amino 
acid preferences as a function of three-residue 
environment parameters (the area of the 
residue that is buried, the fraction of side-
chain area that is covered by polar atoms, and 
the local secondary structure) (Bowie et al., 1991) 
and measured the compatibility of a protein 
model with its sequence using this so-called 
3D profile (Lüthy et al., 1992).
Initially, protein structure validation was 
met with some resistance from the protein 
structure determination field [see (Petsko, 
1992)], but some high-profile cases of structure 
models with very unusual features (see Fig. 
1.2) led the protein structure communities 
-structure determination and bioinformatics 
alike- to start Validation Task Forces (VTFs) 
for X-ray crystallography (Read et al., 2011), NMR 
(Montelione et al., 2013), and electron microscopy 
(Henderson et al., 2012). The X-ray and NMR VTFs 
have written their recommendations, and the 
wwPDB consortium (Berman et al., 2007) is presently 
implementing these recommendations in 
software that depositors of structures must 
use. It will take time to implement all VTF 
recommendations; thus, depositors who want 
to very extensively validate their structure 
before deposition will still need, for a while, to 
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use tools such as WHAT_CHECK, Molprobity 
(Chen et al., 2010) and CING (Doreleijers et al., 2012) in 
addition to the PDB (Berman et al., 2007; Gutmanas et al., 
2014) validation server (Read et al., 2011; Gore et al., 2012).
Validation tools can be categorised in many 
ways; for example, by their level of detail. Most 
of the older tools give one score for the whole 
structure and capture the overall quality of a 
structure in one number. Although ProSA, 
PROCHECK, DACA, and QMEAN (Benkert et 
al., 2008; Haas et al., 2013), for example, score aspects 
of individual residues, their strength lies in 
whole protein quality evaluation. Validation 
tools also can be categorised by the certainty 
with which they can call things right or wrong. 
Most validation options do not determine 
the quality but merely the normality of 
a protein structure, that is, how similar a 
protein structure model is to a collection of 
good, high-resolution structures in terms of 
the validation parameters. Other validation 
options (noticeably, all nomenclature checks, 
many administrative validation options, and 
routines that calculate the agreement of a 
model with the experimental data) provide 
answers about quality rather than normality. 
The Cambridge Structural Database (CSD) 
(Groom & Allen, 2014) holds more than 700 000 
structures of small molecules that have been 
solved at much higher resolution than most 
PDB entries. Geometric parameters that can 
be determined from an analysis of CSD files 
are therefore so accurate that they can be used 
for all practical purposes as a gold standard 
when solving or validating PDB entries. The 
prime example of CSD-derived parameters are 
the famous Engh and Huber bond length and 
bond angle data (Engh & Huber, 1991, 2001) that are still 
used today in most refinement and validation 
software. Similarly, Hooft et al. (1996b) used 
the CSD to determine the normal deviation 
from planarity in planar groups in proteins.
Global scores can detect bad structure 
models but they are not very useful when 
validation is used to actually improve model 
quality. Many tools, fortunately, detect 
Figure 1.2. Protein structures with improbable features. Left: In 2006 Gros and colleagues (Janssen et al., 2007) identified several unusual and 
improbable features in a structure of the complement protein C3b (PDB 2hr0). The absence of crystal contacts in the c-direction of the 
unit cell (grey) was the most improbable feature. This triggered an investigation by the University of Alabama as to whether structures 
solved by H.K.M. Murthy were fabricated (Borrell, 2009). Right: another instance of unusual features was discovered by Rupp (2012). The 
figure shows residues Val134 and Lys135 (red: atoms modelled at zero occupancy; white: full occupancy) of PDB entry 3k78 (Zaborsky et al., 
2010) and the 2mFo-DFc map (calculated using a grid size of 0.1 Å) contoured at +1.0σ (green) and at the noise level +0.4σ (blue). One of 
the highly improbably model features noticed by Rupp was the complete absence of any 2mFo-DFc density for unoccupied atoms down 
to near-noise levels while normal main-chain B-factors had been reported. This suggested that the data were indeed calculated from a 
model with zero-occupancy atoms (Rupp, 2012).
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erroneous molecular details that can be used 
directly to improve the quality of structures.
Hooft et al. (1996c) used the CSD to arrive 
at a force field for hydrogen bond energies and 
used this force field to optimise the flipping 
of Asn, Gln, and His side chains. Hydrogen 
bond network optimisation is part of 
WHAT_CHECK (Hooft et al., 1996d) and Molprobity 
(Davis et al., 2007). Nielsen showed the importance of 
this validation-based structure improvement 
for electrostatic calculations (Nielsen et al., 1999; Nielsen 
& Vriend, 2001), and the realisation that a series 
of measured pKa values commonly used for 
the calibration of electrostatic computation 
methods were flawed by crystal packing 
artefacts dramatically improved the entire 
field of protein electrostatics (Nielsen & Vriend, 
2001). Nielsen also showed that electrostatic 
calculations for most enzymes in the PDB 
would give significantly better results if the 
hydrogen bonding network would be improved 
prior to the calculations (Nielsen et al., 1999).
Wrong cell dimensions lead to systematic 
deviations in bond lengths and angles. Hooft 
et al. wrote software that projects the protein’s 
bond lengths and angles on the axis system of 
the crystal cell to correct the cell’s dimensions 
(Vriend & Hooft, 1998). Lamzin and co-workers later 
improved this method (EU 3-D Validation Network, 1998).
The growth of the PDB has allowed 
validation of the Ramachandran plot (Hooft 
et al., 1997; Chen et al., 2010) and bond lengths and 
angles (Berkholz et al., 2009; Touw & Vriend, 2010) to become 
specific for secondary structure and residue 
type. Rotamer libraries constructed using 
high-resolution protein structures (Jones et al., 1991; 
De Filippis et al., 1994; Dunbrack & Cohen, 1997; Lovell et al., 2000; 
Berntsen & Vriend, 2014) are used in several programs 
to perform a knowledge-based validation of 
side-chain conformation. Misfit side chains 
may also be detected by Cβ position deviations 
(Lovell et al., 2003) and steric clashes (Hooft et al., 1996d; Chen 
et al., 2010). The RosettaHoles software provides a 
validation score for under-packing (Sheffler & Baker, 
2009).
Several groups have developed tools such 
as VHELIBS (Cereto-Massagué et al., 2013), ValLigURL 
(Kleywegt & Harris, 2007), Mogul (Bruno et al., 2004), and 
Twilight (Weichenberger et al., 2013) to visualise and 
validate ligands; tools such as pdb-care (Lütteke & 
von der Lieth, 2004), CARP (Lütteke et al., 2005), and Privateer 
(Agirre et al., 2015a,b) to check carbohydrates (Lütteke, 
2009; Emsley et al., 2015); and programs like ERRASER 
(Chou et al., 2013) to re-build and Molprobity (Chen et al., 
2010) to validate nucleic acids.
CH4, NH3, NH4
+, H2O, OH
-, Ne, Na+, 
Mg2+ and Al3+ all contain 10 electrons and thus 
will scatter X-rays roughly equally much. This 
makes it hard to see the difference between 
them in any electron density determined 
at worse than atomic resolution. The same 
problem exists for K+ and Ca2+ that both 
have 18 electrons. Moreover, K+ and Ca2+ at 
half-occupancy scatter X-rays roughly equally 
much as H2O, Na
+, Mg2+, etc. Consequently, 
many ions in the PDB are of the wrong type 
or actually should be water, while many waters 
should be ions (Nayal & Di Cera, 1996). Brown has 
determined empirical bond valence parameters 
(Brown, 1977, 1992) that can be used to determine the 
ion type from the distances between the ion 
and its coordinating atoms. This method works 
reasonably well but only at high resolution 
when all surrounding atoms can be seen very 
well in the density and when there is no bias 
caused by refining ion X as ion Y forcing ion X 
to get the ligand–atom distances of ion Y. The 
Brown parameters have been implemented 
in SHELX (Müller et al., 2003) and WHAT_CHECK 
(unpublished) and, later, in CheckMyMetal 
(Zheng et al., 2014) and Phenix (Echols et al., 2014).
Alkali and alkaline earth metals are 
preferentially coordinated by oxygen atoms 
and not by nitrogen atoms. Dauter et al. (2014) 
recently reported that calcium ions in the so-
called strong calcium site of several savinase 
structure models seem to be coordinated by 
the nitrogen atom instead of the oxygen atom 
of an asparagine. A pseudo-octahedral calcium 
site is normally coordinated by oxygen atoms 
only. The B-factors of the Asn suggested that 
the side chain should be flipped. An inspection 
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of the PDBREPORT database (Hooft et al., 1996d) 
reveals that the chemically highly implausible 
coordination of sodium, potassium, calcium, 
or magnesium ions by the nitrogen atom 
instead of the oxygen atom in asparagine 
or glutamine side chains occurs in 327 sites 
in 269 PDB entries, including the savinase 
example and several structures solved at atomic 
resolution (Fig. 1.3).
Several authors have noted an under-
representation of cis peptides in the PDB that 
is partly the result of the a priori assumption 
in structure determination that all peptides 
have a trans conformation (Huber & Steigemann, 
1974; Stewart et al., 1990; Weiss et al., 1998; Jabs et al., 1999). Trans 
peptide planes have also been observed rotated 
by 180°; this is called a peptide-plane flip. 
Peptide-plane flips typically are the result of 
mistakes in the early stages of model building 
when the electron density maps are not yet 
very clear. An incorrectly built peptide plane 
tends to lead to locally distorted geometry. 
We recently designed a Random-Forest-based 
method to detect these problems (Touw et al., 2015b) 
and found almost 5000 trans-cis errors and 
many thousands of peptide-plane flips.
Improving PDB files by re-
refinement and re-building
Over the years, 3299 PDB entries have been 
made obsolete. Most times, these entries 
were made obsolete because a better version 
became available, for example, based on higher 
resolution data, but sometimes, the entries 
were highly improbable and made obsolete 
without putting a replacement file in the 
PDB. We also see more and more cases of 
PDB files that were improved and deposited 
by others than the original authors. In 2007, 
Joosten and Vriend took a more systematic 
approach and re-refined some 1200 structure 
models for which data were available to 2.00 
Å resolution (Joosten & Vriend, 2007). More than 
three-quarters of the re-refined models had an 
improved Rfree value and improved geometric 
characteristics. After this successful small-scale 
proof of concept, Joosten et al. re-refined all 
high- and medium-resolution X-ray structures 
in the PDB (15 000 at the time) for which 
the reflection data (including the Rfree set) 
were deposited and useful (Joosten et al., 2009a). They 
showed that, despite the complication of using 
many more low-resolution models, two-thirds 
of the re-refined models were improved in 
terms of Rfree (Joosten et al., 2009a). The Ramachandran 
Z score of the structure models also improved 
over the entire resolution range. In addition, 
they showed that the possibility of improving 
published structure models was not limited 
to old structure models but that more than 
60% of recently deposited structure models 
could also be improved. The addition of side-
chain re-building and peptide-flipping tools 
Figure 1.3. Asn side-chain flips at atomic resolution. Sodium-
binding site of glycinamide ribonucleotide transformylase [PDB 
1kjq, determined at 1.05 Å resolution (Thoden et al., 2002)]. The side 
chain of Asn100 has a highly unlikely conformation because the 
nitrogen rather than the oxygen coordinates the ion. PDB_REDO 
flips the side chain so that the ion is coordinated by the side-chain 
oxygen. The PDB files of several hundred incorrect sites similar to 
this site contain LINK records specifying the N-metal coordination. 
Incorrect LINK records between the nitrogen of Asn and Gln 
side chains and Na+, Mg2+, K+ and Ca2+ are removed, allowing 
structure correction by side-chain re-building (since PDB_REDO 
version 5.37). Future versions of PDB_REDO will also flip metal 
coordinating side chains based on results from WHAT_CHECK.
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(Joosten et al., 2011b) plus more advanced refinement 
parameterisation algorithms improved the 
success rate of PDB_REDO and extended the 
scope to active correction of modelling errors 
or, more poetically, ‘constructive validation’ 
(Joosten et al., 2012). The specific PDB_REDO steps 
that are applied based on validation algorithms 
are described in Table 1.1. Analyses of Rfree and 
six WHAT_CHECK model-quality metrics of 
12 000 randomly chosen PDB entries show 
that 85% of the PDB entries can be improved 
in terms of overall quality (Joosten et al., 2012).
The re-refined structure models (plus 
electron density maps and a multitude of 
metadata) are stored in the PDB_REDO 
databank (Joosten et al., 2011a,Touw et al., 2015a). This 
repository now holds 99% of all crystallographic 
PDB entries for which experimental data are 
deposited (currently more than 90 000). New 
entries are added automatically with every new 
PDB release. Older PDB_REDO entries are 
replaced gradually or whenever a PDB entry 
is re-released, typically because of changes in 
the entry’s annotation. It should be noted that 
many changes in annotation of PDB entries are 
the result of the PDB_REDO project. Over the 
course of the project nearly 7500 annotation 
problems that somehow hampered the 
optimisation or interpretation of PDB entries 
were reported and the PDB staff corrected the 
majority of these.
In an automated procedure, there is always 
a risk of introducing errors. A particularly 
difficult step is the restraint generation for 
ligands. This relies on reasonable input 
coordinates of a ligand, correct annotation 
of the chemistry by the PDB and/or proper 
interpretation of the coordinates by the tools 
in PDB_REDO. Although ligands generally 
improve slightly in PDB_REDO (Cereto-
Massagué et al., 2013), sometimes ligands are refined 
incorrectly. It is therefore highly recommended 
to critically inspect ligands and their electron 
density manually, which is, by the way, not 
different for original PDB entries (Kleywegt, 2006; 
Kleywegt & Harris, 2007; Weichenberger et al., 2013; Pozharski et al., 2013).
Taken together, the PDB_REDO procedure 
typically leads to structure models that better 
fit their experimental data, have more plausible 
molecular geometry, and are more informative 
for biological interpretation.
Better biology through 
better structure models
Four decades after Browne’s first attempt at 
homology modelling on α-lactalbumin, the 
technique has become a research field in itself, 
PDB_REDO step Programs involved
Removal of improbable (metal coordination) LINKs Stripper (Joosten et al., 2012)
Correction of carbohydrate LINK topology Stripper
Correction of carbohydrate names pdb-care (Lütteke & von der Lieth, 2004) and Stripper
Removal of superfluous carbohydrate oxygens pdb-care and Stripper
Removal of improbable ligand occupancy models REFMAC (Murshudov et al., 2011)
Removal of overly detailed B-factor models REFMAC and Bselect (Joosten et al., 2012)
Correction of atomic chirality problems REFMAC, WHAT_CHECK (Hooft et al., 1996d) and Chiron (Joosten et al., 2012)
Addition of missing side-chain atoms SideAide (Joosten et al., 2011b) and DSSP (Kabsch & Sander, 1983,Touw et al., 2015a)
His, Asn, and Glu flips to improve hydrogen bonding WHAT_CHECK and SideAide
Peptide flipping Pepflip (Joosten et al., 2011b) and DSSP
Removal of waters not supported by the electron density Centrifuge (Joosten et al., 2011b)
Table 1.1. Validation-driven PDB_REDO steps. 
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and much effort is directed towards selecting 
good models from a large set of candidates 
(see (Krieger et al., 2009) and references therein). 
Using both PDB templates and PDB_REDO 
templates, we built homology models with 
YASARA for 33 CASP11 targets for which 
the alignment is essentially certain while 
small structural details are important (best 
GDT_TS > 60%) (Krieger et al., 2009). We found 
that the average Cα root-mean-square (r.m.s.) 
error was reduced from 2.28 Å (using PDB 
templates) to 2.15 Å (using PDB_REDO 
templates). The average Cα r.m.s. deviation 
between PDB and PDB_REDO structure 
models is 0.15 Å. These results suggest that the 
use of PDB_REDO templates certainly does 
not harm the homology modelling process 
and that the changes made by PDB_REDO are 
improvements in the right direction.
Better template structures thus lead to 
better homology models, and both better 
structure models and better homology models 
obviously must lead to better answers to 
biological questions. Sometimes corrections 
in PDB files do not influence the biology; 
a bond length correction by 0.18 Å, for 
example, is crystallographically significant 
but will not change the answer to a question 
related to mutability, antigen selection, or 
intermolecular interactions. Other corrections 
though, for example replacing a calcium ion 
near the active site by a zinc or flipping the 
side chain of asparagine in the ligand binding 
pocket, are likely to lead to radically different 
and more reliable answers to questions related 
to understanding an enzyme’s mechanism or 
drug design.
The next ten sections review examples of 
‘better biology through better structures’. In 
each example, improvement of the PDB file 
led to a different view on the biological role 
of a molecule or to a different answer to a 
biological question.
Example 1 – Peptide-plane flip in 
Plk1 Polo Box Domain substrate
García-Álvarez et al. reported the structure of 
the Polo Box Domain (PBD) of the human 
serine/threonine kinase Plk1 in complex with 
Figure 1.4. Peptide-plane flip in Plk1 PBD substrate. Left: the electron density around the peptide plane between Leu1 and Leu2 of the 
substrate (white carbons) suggests the peptide should be flipped to allow a hydrogen bond to the carbonyl of Asp416 in the enzyme 
(pink carbons) in PDB entry 2ojs (García-Alvarez et al., 2007). Right: the peptide substrate extends the Plk1 β-sheet in the superseding entry 
3bzi due to the flipped peptide plane. Unless mentioned otherwise, the 2mFo-DFc and mFo-DFc maps have been sampled with a grid 
size equal to a third of the resolution and are shown at a contour level of +1.2σ (blue) and +3σ (green) and -3σ (red), respectively, and 
the entire model has been used for the calculated structure factors. The 2mFo-DFc and mFo-DFc maps are shown up to 2 Å from the 
displayed peptide atoms.
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a 9-mer phosphopeptide substrate derived 
from Cdc25C [PDB 2ojs (García-Alvarez et al., 2007)]. 
Plk1 is essential for regulating cell cycle 
progression and is an important drug target 
for cancer therapy (Strebhardt & Ullrich, 2006). They 
discuss the molecular mechanisms of substrate 
recognition of Plk1 and the implications for 
the centrosomal localisation and activity.
The PDB_REDO program Pepflip detected 
that the peptide plane between Leu1 and Leu2 
of the Cdc25C phosphopeptide should be 
flipped to better fit the electron density and 
improve the Ramachandran plot. In the correct 
conformation there is an additional hydrogen 
bond between the peptide and Asp416 in Plk1 
(Fig. 1.4). Furthermore, after the peptide-
plane flip, the Cdc25C peptide forms an 
additional β-strand, thereby extending the 
β-sheet in Plk1. The substrate conformation 
was corrected by the depositors who obsoleted 
PDB entry 2ojs and superseded it by PDB 
entry 3bzi. Free energy calculations using the 
corrected phosphopeptide showed that the 
phosphothreonine residue and the main-chain 
atoms of the peptide account for the majority 
of the binding enthalpy (Huggins et al., 2010).
The extension of the β-sheet is an integral 
Figure 1.5. The phosphothreonine fragment of a Polo Box Domain inhibitor in the structure of the human Plk1 is di-anionic rather 
than mono-anionic. Left: although a disordered phosphoester moiety is modelled in PDB entry 4mlu (Qian et al., 2013), the electron density 
suggests that this group is absent. Right: water molecules and a di-anionic inhibitor are modelled in the superseding PDB entry 4o6w 
(Qian et al., 2013). The 2mFo-DFc and mFo-DFc maps are shown up to 1.5 Å from the displayed inhibitor fragment and water molecules.
part of the substrate recognition mechanism 
and is only visible in the corrected  
structure.
Example 2 - Wishfully modelling 
a Plk1 PDB inhibitor
The Plk1 PBD binds to pThr/pSer-containing 
motifs (Elia et al., 2003). Qian et al. reported a Plk1 
PBD structure in complex with an inhibitor in 
the PBD pocket [PDB 4mlu (Qian et al., 2013)]. Qian 
et al. designed the inhibitory peptide to mimic 
a natural substrate but wanted to improve 
the cellular uptake efficiency by making the 
inhibitory peptide mono-anionic rather than 
di-anionic by masking the phosphothreonine. 
The mono-anionic phosphoester was fitted in 
the reported structure model 4mlu.
Dauter et al. (2014) discovered that the 
electron density does not justify modelling 
the phosphoester moiety (Fig. 1.5). Thus, 
the inhibitor is still di-anionic. Qian et al. 
then retracted their paper and replaced 
the phosphoester moiety by water in PDB 
structure 4o6w that supersedes 4mlu (Fig. 
1.5).
In summary, the design of PBD inhibitors 
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that both mimic the natural substrate and have 
drug-like physicochemical properties is still an 
open challenge.
Example 3 –  
hPHMT ligand identification
Human phenylethanolamine N-methyltransfe-
rase (hPNMT) catalyses the conversion of 
R-noradrenaline into R-adrenaline. In this 
reaction, a methyl group is transferred from 
the co-factor S-adenosyl-L-methionine to 
noradrenaline. Central nervous system-
specific PNMT inhibitors potentially are 
important drug targets for Alzheimer’s and 
Parkinson’s diseases. In a fragment-based 
drug design screen, Drinkwater et al. (2010) 
soaked hPNMT crystals with 96 mixtures of 
four chemically diverse small molecules and 
modelled 12 hits in the electron density, 9 of 
which were confirmed by Isothermal Titration 
Calorimetry (ITC) to bind to hPNMT.
Nair et al. (2012) showed that molecular 
dynamics (MD) simulations reproduced the 
crystal structure binding mode modelled 
Figure 1.6. Ligand identification in the hPNMT active site. The binding pocket is occupied by 6-chlorooxindole in PDB entry 3kpy 
(Drinkwater et al., 2010) (left) and with benzene-1,3-diol (in two alternative conformations) and imidazole in PDB entry 4dm3 (Nair et al., 2012) 
(right). The binding modes of these two ligands were predicted by MD simulations (Nair et al., 2012). The figure shows the possible hydrogen 
bonds over time. The 2mFo-DFc map is shown up to 1.5 Å from the ligands.
for these nine compounds. For one of the 
other cocktails, Drinkwater et al. proposed 
6-chlorooxindole as the most likely candidate 
for explaining the electron density observed 
in the noradrenaline pocket (PDB 3kpy, Fig. 
1.6), but they could not confirm binding 
by ITC. The MD simulations predicted 
that 6-chlorooxindole cannot stably bind 
to hPNMT. In contrast, the simulations 
suggested that the pocket was occupied by two 
other fragments in the cocktail, benzene-1,3-
diol and imidazole. Free energy calculations 
predicted the binding to be cooperative and 
re-refinement showed that these two fragments 
together could also account for the electron 
density (PDB 4dm3, Fig. 1.6).
The combined pharmacophores of benzene-
1,3-diol and imidazole provide a better basis for 
rational design and thus for the development 
of hPNMT inhibitors. 
Example 4 –  
Herceptin-HER2 interface
When over-expressed, the human epidermal 
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growth factor receptor 2 (HER2, also known 
as ErbB2 and Neu) can promote malignant cell 
transformation (Di Fiore et al., 1987). The monoclonal 
antibody Trastuzumab, commercially known 
as Herceptin, is known to have an anti-
proliferative effect on cells transformed by 
over-expression of HER2 and is therefore 
used to treat HER2-positive metastatic breast 
cancers (Slamon et al., 2001). The structure of the 
Fab fragment of Herceptin bound to the 
extracellular domain of HER2, PDB entry 
1n8z (Cho et al., 2003), shows the binding interface 
of the two proteins. This indicates where 
Herceptin binds, but as a result of poor side-
chain fitting, the structure model does not 
properly show how and why Herceptin binds 
(Fig. 1.7).
Automated re-building of 1n8z reveals 
numerous additional receptor-antibody 
interactions, resulting in a much more faithful 
description of the binding mode of Herceptin.
The better understanding of the binding 
mode of Herceptin contributes to the 
development of other monoclonal antibodies 
in cancer immunotherapy.
Figure 1.7. Improving the binding interface between Herceptin and HER2. Left: detail of PDB entry 1n8z showing the Fab light chain of 
Herceptin (pink) with a single hydrogen bond to HER2 (Cho et al., 2003). Right: the PDB_REDO optimised version of 1n8z. Flipping Asn30 and 
re-fitting Thr31 together with small adjustments to the local HER2 side chains reveal a hydrogen bonding network between the proteins 
containing four hydrogen bonds and one hydrogen bond that correctly positions the Thr31 and Asn30 side chains. The 2mFo-DFc map is 
shown up to 1.5 Å from the protein fragments.
Example 5 – Ion identity in 
myosin heavy chain kinase 
regulatory sites
Myosin II plays a central role in cytokinesis, cell 
migration, and adhesion (Vicente-Manzanares et al., 2009). 
The α-kinase domain of myosin heavy chain 
kinase (A-CAT) is involved in regulating the 
formation of myosin II filaments and the active 
site of A-CAT undergoes a conformational 
switch that is said to be influenced by the 
magnesium-binding sites (Ye et al., 2010).
Minor and co-workers recently 
implemented Brown’s bond valence method 
in the CheckMyMetal web server (Zheng et al., 2014) 
for the validation of metals in macromolecular 
structures. They reported several examples 
of mis-identified ions, among which the 
magnesium ions in A-CAT [PDB 3lkm (Ye et 
al., 2010)]. The validation results, the reported 
crystallisation conditions, the sample 
preparation, and manual re-refinement all 
suggest that one magnesium ion should be 
replaced with water, while the other two should 
be replaced by potassium and coordinated also 
by ethylene glycol (Fig. 1.8) (Zheng et al., 2014).
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Figure 1.8. Water and potassium rather than 
magnesium in the α-kinase domain of myosin 
heavy chain kinase. Left: Mg901 should be replaced 
by a water molecule in PDB entry 3lkm (Ye et al., 2010) 
according to metal validation software (Zheng et al., 
2014). The contact distance is shown in ångströms. 
Right: the site occupied by Mg902 in 3lkm should be 
occupied by a potassium ion instead (Zheng et al., 2014). 
The two water molecules (bottom right) should be 
replaced by ethylene glycol (Zheng et al., 2014). The 2mFo-
DFc maps are shown at a contour level of +1.5σ.
The presence of potassium rather than 
magnesium in the regulatory sites casts serious 
doubt on the role of magnesium and suggests 
that the role of potassium in regulating the 
activity of α-kinase is worth investigating.
Example 6 – Trans-cis 
isomerisation in Rab4a switch 2 
region
The Ras-like protein Rab4 is involved in 
endosomal sorting by orchestrating a small 
GTPase cascade for recruitment of adaptor 
proteins to early endosomes (D’Souza et al., 2014). 
Despite the high level of sequence similarity 
between members of the Rab family each 
member targets specific effector proteins. 
One of the molecular regions involved in 
the discrimination between different effector 
proteins is the so-called switch 2 region (Huber 
& Scheidig, 2005). The switch 2 region is rearranged 
upon GTP hydrolysis. The structure of human 
Rab4a has been solved in the active state with 
the GTP analogue GppNHp [PDB 2bme (Huber 
& Scheidig, 2005)] and in the inactive GDP-bound 
state [PDB 2bmd (Huber & Scheidig, 2005)].
Residue Phe72 is located at the start of 
α-helix H2 in the switch 2 region of Rab4a and 
has the trans conformation in the GppNHp-
bound state. The trans conformation is also 
present in the GDP-bound structure. Recently, 
a method was created to detect cis peptides 
erroneously modelled as trans peptides (Touw et al., 
2015b). The method predicted that Phe72 in the 
GDP-bound state should have been modelled 
as a cis peptide rather than a trans peptide and 
this prediction was validated by re-refinement 
(Touw et al., 2015b) (see Fig. 1.9).
Although it cannot be excluded that the cis 
conformation was induced by crystallisation, 
these findings strongly suggested that Arg71 
– Phe72 trans-cis isomerisation plays a role in 
the discrimination between different effector 
proteins that hitherto was unknown.
Figure 1.9. Rab4a trans-cis flip in the switch 2 
region of Rab4a. Left: the peptide between Arg71 
(side chain not shown for clarity) and Phe72 in 
PDB entry 2bmd (Huber & Scheidig, 2005) has the trans 
conformation but deviating local geometry and the 
electron density around the peptide bond suggest 
that the peptide should have the cis conformation. 
Right: the cis peptide fits the experimental data 
much better. The 2mFo-DFc maps are shown at a 
contour level of +1.5σ.
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Figure 1.10. Active site of one-cysteine peroxiredoxin AhpE with Cys45 in the reduced state. Left: Cys45 is located in helix α2 that 
unwinds during MD simulations based on PDB entry 1xxu (Li et al., 2005). Right: in the PDB_REDO structure the flipped Gln46 side chain 
optimises the local hydrogen bonding network with Asp50, Trp80, and Ser84 and increases the stability of MD simulations.
Example 7 – Peroxiredoxin active 
site in MD simulations
The human pathogen Mycobacterium 
tuberculosis is responsible for millions of 
deaths every year (WHO, 2014). The bacterium 
gets engulfed by host macrophages, exposing 
it to a toxic environment of reactive oxygen 
species (ROS), but it can survive these hostile 
conditions by expressing peroxidases (Manca et 
al., 1999) such as the one-cysteine peroxiredoxin 
AhpE (Li et al., 2005). When AhpE scavenges ROS, 
Cys45 is sulfenylated. The sulfenic acid form 
of Cys45 can be reduced by mycothiol or 
mycoredoxin-1 (Van Laer et al., 2012).
Palló et al. carried out MD simulations 
to study the active site in atomic detail2. 
MD simulations are sensitive to errors 
in macromolecular structures. Palló et al. 
observed that simulations were not stable 
when PDB entry 1xxu (Li et al., 2005) was used as 
a starting structure. The α-helix that contains 
Cys45 started to unwind during a 30 ns 
simulation. In contrast, simulations using the 
PDB_REDO structure were stable, probably 
because of the optimised hydrogen bond 
network in the active site (Fig. 1.10).
2. Personal communication, 2015. Palló A, van Bergen L, Alonso M, 
Nilsson L, de Proft F & Messens J. The revisited AhpE structures affect the 
molecular dynamics simulations of the Mycobacterium tuberculosis one-
cysteine peroxiredoxin.
The improved AhpE structure model allows 
for mechanistic studies of the M. tuberculosis 
peroxiredoxin at atomic detail.
Example 8 – Malaria drugs
Plasmodium falciparum is the parasite that 
causes Malaria, which still ranks as one of 
the diseases with the highest death toll. The 
parasitic aspartic acid protease plasmepsin 
II is involved in degradation of the host cell 
haemoglobin (Le Bonniec et al., 1999) and is therefore 
an interesting drug target. The structure of 
plasmepsin II was thought to be determined in 
complex with two inhibitors rs367 and rs370 
in PDB entries 1lee and 1lf2, respectively 
(Asojo et al., 2002). The difference between the two 
inhibitors is the position of the amino group 
that is meta in the benzamide in rs367 and 
para in rs370. The structures in 1lf2 and 1lee 
are nearly identical with an all-atom r.m.s. 
deviation of just 0.32 Å.
Inspection of the electron density around 
the inhibitor in 1lee suggests that the amino 
group should be modelled as a para-substituent 
(see Fig. 1.11), which meant that both 1lee 
and 1lf2 contained the same inhibitor, likely 
as the result of a mix up during the structure 
determination. The detection of this mix up is 
currently beyond the capabilities of validation 
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↑ Figure 1.11. The benzamide moiety of the plasmepsin II 
inhibitor in PDB entry 1lee (Asojo et al., 2002). The electron density 
suggests that the amino group of the benzamide moiety should 
be modelled para instead of meta. The 2mFo-DFc and mFo-DFc 
maps are shown up to 1.5 Å and 2.5 Å from the displayed inhibitor 
fragment, respectively. The 2mFo-DFc map is shown at +2σ.
routines and instead relies on critical inspection 
of the electron density by the crystallographer, 
which should be a key step in determining 
structures with ligands (Pozharski et al., 2013).
Docking studies on both structures (Kasam et 
al., 2007) led to new candidate inhibitors, but it is 
a pity that twice as much time and computing 
power was used as needed. Low-throughput 
rational drug design projects aimed at better 
inhibitors will suffer even more from this para-
meta error.
Example 9 – The chemistry of 
autotaxin inhibitors
Autotaxin (ATX; also known as ENPP2) 
is a secreted enzyme that converts 
lysophosphatidyl-choline into the lipid 
signalling molecule lysophosphatidic acid 
(LPA). The ATX-LPA signalling axis is involved 
in normal physiology and pathophysiology 
(Moolenaar & Perrakis, 2011). ATX expression is found 
to be up-regulated in several carcinomas and is 
implicated in motility of tumour cells (Moolenaar 
& Perrakis, 2011) and, as such, a target for developing 
drugs for cancer treatment. One class of ATX 
inhibitors is based on a boronic acid moiety 
that binds covalently to the hydroxyl group 
of active-site residue Thr209 (Hausmann et al., 2011). 
In this process, the hybridisation of the boron 
↓ Figure 1.12. Correcting chemical representation of boron. 
Left: fragment of the inhibitor 3BoA (white) bound to the active 
site of ATX [PDB 3wax (Kawaguchi et al., 2013), pink)] The boron atom 
(grey) is modelled as sp2 hybridised and covalently bound to the 
benzene moiety (orange broken lines) but not covalently bound 
to Thr209. The blue Glu576 is from a different ATX molecule 
related by crystal symmetry. Right: PDB_REDO-optimised version 
of 3wax with the correct boron hybridisation and a covalent bond 
to Thr209. Manually generated restraints are required to deal 
with the complex chemistry of the inhibitor-ATX interaction.
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atom changes from sp2 to sp3, analogous to the 
formation of tetrahydroxyborate from boric 
acid.
The structure of ATX with inhibitor 
3BoA [PDB 3wax (Kawaguchi et al., 2013)] shows the 
problem of dealing with changing chemistry 
in refinement. Although the authors correctly 
report that 3BoA is covalently bound to 
Thr209, this is not reflected in the structure 
model because the distance between the 
boron atom and the Thr-Oγ1 is 2.28 Å and 
the boron atom is sp2 hybridised in the model 
(Fig. 1.12). The structure of ATX and 4BoA 
from the same study (PDB 3way) suffers from 
the same problem. In the PDB_REDO 3wax 
structure model the B-Oγ1 distance is 1.38 Å 
and the boron atom is properly sp3 hybridised. 
The earlier published structure of ATX and 
the boronic acid inhibitor HA155 also shows 
the correct geometry [PDB 2xrg (Hausmann et al., 
2011)], but the other structure models may lead 
to misinterpretation of the ligand binding 
interaction.
Correct chemical representation is crucial 
for the design or optimisation of ATX 
inhibitors.
Example 10 – Xylose isomerase 
active site
Figure 1.13 shows the active-site pocket of 
xylose isomerase, an enzyme that catalyses 
the interconversion between D-xylose and 
D-xylulose and between D-glucose and 
D-fructose (Lavie et al., 1994). The reaction involves 
hydrogen transfer and two magnesium ions.
PDB entry 3xia (Farber et al., 1989) was superseded 
by 1xya (Lavie et al., 1994) after, for example, packing 
quality analysis (Vriend & Sander, 1993) and inspection 
of the electron density revealed that many 
amino acids were mis-identified or mis-
threaded. 1xya is in much better agreement 
with the biochemistry. Neutron diffraction 
later also showed that a water molecule rather 
than a hydroxyl ion should have been modelled 
in the active site (Katz et al., 2006).
The comparison of 3xia and 1xya clearly 
shows that a mis-threaded structure model 
can place the wrong amino acids at the wrong 
positions. Correct answers to biological 
questions related to the function of the protein 
can only be obtained from correctly threaded 
structure models. We are reasonably certain 
that the work of the X-ray VTF will lead to the 
situation that structures such as 3xia will not 
be passed on to the life science community. 
Fortunately, the deposition of reflection data 
is mandatory now. The problems described 
here might be identified more readily when 
experimental data are available.
Validation-related facilities
Many facilities to validate protein structures 
exist. Several have been mentioned in this 
article already. Table 1.2 lists a series of protein 
Figure 1.13. Threading errors around the active-site pocket of 
xylose isomerase. The one-letter amino acid codes are shown on 
top of the Cα trace. Orange: 3xia (Farber et al., 1989) is mis-threaded 
at many locations. Cyan: 1xya (Lavie et al., 1994). Magnesium and a 
hydroxyl ion are shown as yellow and red spheres, respectively. 
This figure was prepared with YASARA (Krieger & Vriend, 2014).
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structure validation facilities that are freely 
accessible on the internet (Touw et al., 2015a). Of 
course, the validation modules mentioned 
here can be used not only for checking 
X-ray structure models but also for checking 
structure models derived by NMR, EM, or 
in silico modelling. NMR- and EM-specific 
validation methods and methods based on 
structure factors are beyond the scope of this 
article.
Much of the validation work has found 
its way already into the PDB_REDO 
project. PDB_REDO entries are freely 
available from http://www.cmbi.ru.nl/pdb_
redo/. Crystallographers can freely use the 
PDB_REDO server at http://xtal.nki.nl/
pdb_redo/ to optimise their work-in-progress 
structure models.
Concluding remarks
Today, experimental data deposition is an 
obligatory aspect of structure deposition in 
the PDB. Indeed, data are missing for only 
one recent crystal structure entry deposited 
in the PDB in 2014 [4ux6 (Cheshire et al., 2011)]. 
We congratulate those who have set a great 
example by depositing datasets that were 
missing for thirty years [e.g., for the structural 
studies of leghemoglobin by Steigemann and 
co-workers (Arutynyan et al., 1980)].
The highly improbable features in 
Schwarzenbacher’s structure model of the birch 
pollen allergen Bet v 1 protein (Zaborsky et al., 2010) 
were detected (Rupp, 2012) by studying anomalies 
in the statistics of PDB_REDO’s model 
optimisation. Extremely unusual features, 
such as those shown in Fig. 1.2, might remain 
undetected for longer if the corresponding 
reflection data are not made available.
Deposition of reflection data was not 
mandatory until recently (February 1, 2008). 
We believe that it is beneficial if missing 
reflection data sets are recovered and deposited 
because we believe that transparency by 
depositors and validation by others will lead 
to a higher-quality archive. Not necessarily 
because we expect any cases of fraud or gross 
error in PDB entries that do not have deposited 
reflection data but because the validation 
of alternative structure models against 
reflection data allows post-deposition model 
improvements. The oldest structure models 
in the PDB can be improved using today's 
methods. The average Molprobity clash score 
of the oldest models, for example, was at the 
Facility Description
PDB_REDO (Joosten et al., 2012, 2014) Constructive validation by re-refinement and partial re-building
WHAT_CHECK (Hooft et al., 1996d,Touw et al., 2015a) Extensive macromolecular validation
Molprobity (Chen et al., 2010; Davis et al., 2007) Macromolecular validation
PROCHECK (Laskowski et al., 1993a) Protein structure geometry checks
PDB validation server (Read et al., 2011; Gore et al., 2012) Pre- and post-validation of PDB entries
QMEAN (Benkert et al., 2008, 2009) Global model quality estimation
ProSA (Sippl, 1993; Wiederstein & Sippl, 2007) Knowledge-based potentials of mean force to evaluate macromolecular structure model accuracy
CheckMyMetal (Zheng et al., 2014) Validation of metal-binding sites
VHELIBS (Cereto-Massagué et al., 2013) Validation of ligands and binding sites
ValLigURL (Kleywegt & Harris, 2007) Ligand validation
Twilight (Weichenberger et al., 2013) Ligand visualisation and validation
PSVS (Bhattacharya et al., 2007) Metaserver that includes many of the above
Table 1.2. Macromolecular-structure validation facilities.
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48th percentile relative to Molprobity’s reference 
set and ended up at the 80th percentile after 
re-refinement and re-building (Joosten et al., 2011b). 
As better computational crystallographic 
techniques continue to be developed, the 
quality of the archive can be improved ever 
further.
As with any scientific endeavour, validation 
of models and data are a component of 
sound application of the scientific method. 
Macromolecular structures solved by X-ray 
crystallography are the result of experiments - 
performed by humans, and may thus contain 
experimental and human errors.
Although there were a small number of 
individuals resistant to validation for many 
years (Petsko, 1992), the majority were in favour. 
Research into geometric, thermodynamic, 
electrostatic, and many other aspects of 
protein structures has continued, and the 
series of recent highly visible cases of very 
unlikely structures that had to be retracted 
have further anchored validation tools in the 
protein structure solution pipelines.
Our experiences with PDB_REDO lead 
us to conclude that more emphasis should be 
placed on the deposition of raw data (diffraction 
images and/or unmerged reflections) and 
experiment-related metadata. A computer-
readable description of the crystallisation 
conditions is an important example. This will 
allow the development of more and better tools 
aimed at making the best possible structure 
models. We also suggest that referees of articles 
mentioning novel PDB entries should receive 
a structure validation report, without having 
to ask for it, rather than be made to assess 
a structure model's quality from the very 
limited information in a manuscript and its 
supplemental data. To this end, we reiterate 
the importance for crystallographers to finish 
and deposit their structure models and the 
reflection data before submitting a manuscript, 
rather than just before it is accepted (Joosten et 
al., 2013). Current PDB deposition procedures 
make this possible and have the option to 
“suppress entry titles at the time of submission 
to the PDB until the structure is released” 
(Berman et al., 2013). In the long term, a validation 
report can be accompanied by a report from 
PDB_REDO or another automated model 
optimisation procedure that shows whether 
the model can be improved beyond the effort 
delivered by the depositor. This will certainly 
further improve the average quality of PDB 
structure models. These structure models, like 
all scientific results, are predestined to be re-
used by others. Therefore, a higher average 
model quality will also improve the quality of 
many projects directed at answering important 
biomedical questions.
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We present a series of databanks (http://swift.cmbi.ru.nl/gv/facilities) that hold information that is computationally derived from Protein Data Bank (PDB) entries and that might augment macromolecular structure 
studies. These derived databanks run parallel to the PDB, i.e. they have one entry 
per PDB entry. Several of the well-established databanks such as HSSP, PDBREPORT 
and PDB_REDO have been updated and/or improved. The software that creates 
the DSSP databank, for example, has been rewritten to better cope with π-helices. 
A large number of databanks have been added to aid computational structural 
biology; some examples are lists of residues that make crystal contacts, lists 
of contacting residues using a series of contact definitions, or lists of residue 
accessibilities. PDB files are not the optimal presentation of the underlying data 
for many studies. We therefore made a series of databanks that hold PDB files in an 
easier to use or more consistent representation. The BDB databank holds X-ray PDB 
files with consistently represented B-factors. We also added several visualisation 
tools to aid the users of our databanks.
Introduction
The Protein Data Bank (PDB) is the worldwide 
repository of macromolecular structures 
determined experimentally mainly by X-ray 
crystallography, NMR, or electron microscopy 
(Bernstein et al., 1977; Berman et al., 2003; Berman, 2014; Gutmanas et 
al., 2014). The more than 100 000 entries in the 
PDB form a valuable source of information, 
and PDB entries are used all over the world in 
a wide variety of research projects in academia 
and industry alike.
When the PDB was conceived in 1971 (Protein 
Data Bank, 1971), the initiators could hardly have 
imagined that their punchcard based PDB file 
format (Bernstein et al., 1977; Berman, 2008) would survive 
for more than 40 years. Although the PDB has 
superseded its archaic punchcard compromise 
between inclusiveness and human readability 
by the PDBx/mmCIF file format (Berman, 2008, 
2014), in practice the old format is still used by 
most software applications. The PDB format is 
the source of many problems, some of which 
are addressed by our databanks.
All databanks are available from http://
swift.cmbi.ru.nl/gv/facilities/. This site also 
provides extensive documentation that 
 
includes help for downloading individual files 
or whole databanks.
Update on existing 
databanks
Table 2.1 lists the main databanks with a brief 
description of their content. In the following 
sections we will describe the progress on the 
existing systems since we previously reported 
on them (Joosten et al., 2011a).
Most of our systems have been prepared for 
the PDB’s transition from the PDB file format 
to the mmCIF file format. Most databanks are 
now also available derived from PDB_REDO 
structure models.
DSSP is the de facto standard for the 
assignment of secondary structure elements 
in PDB entries. The DSSP (Kabsch & Sander, 1983) 
software has been rewritten to better recognize 
π-helices (Kabsch & Sander, 1983; Cooley et al., 2010; van der Kant 
& Vriend, 2014). The determination of π-helices still 
follows the original description by Kabsch and 
Sander (Kabsch & Sander, 1983), but the assignment 
of π-helices is now given precedence over the 
assignment of α-helices, which should prevent 
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underestimating the number of π-helices (Cooley 
et al., 2010; van der Kant & Vriend, 2014).
HSSP (Sander & Schneider, 1991, 1993; Schneider & Sander, 
1996; Schneider et al., 1997; Dodge, 1998) multiple sequence 
alignments (MSAs) are now created with an 
improved version of the original Sander and 
Schneider (Sander & Schneider, 1991) algorithm. These 
files are available in the original HSSP format 
and in Pfam Stockholm format (Finn et al., 2014). 
The Stockholm format is used by applications 
like HMMER (Eddy, 1998) and Jalview (Waterhouse et al., 
2009). Projects like BioJava (Prlić et al., 2012), BioPerl 
(Stajich et al., 2002), and Biopython (Cock et al., 2009) provide 
parsers for these Stockholm-formatted files.
The PDBFINDER and PDBFINDER2 
databanks (Hooft et al., 1996a) are now created using 
a slightly modified algorithm that better deals 
with exceptions in PDB files. The changes to 
the DSSP and HSSP software have also been 
taken into account. Furthermore, the two 
single flat text files are now compiled from 
separate files for each PDB id. 
New developments in the PDB_REDO 
decision-making algorithms were described 
elsewhere (Joosten et al., 2012). Many recent 
improvements in PDB_REDO focus on 
enabling user-friendly data-mining and 
visualisation. A list of all significant structural 
changes like changed rotamers and flipped 
peptide planes (Joosten et al., 2014) is available in 
an easy-to-mine format to quickly figure out 
whether PDB_REDO has changed residues-
of-interest in a particular PDB entry. Model 
validation data such as WHAT_CHECK Z 
scores, crystallographic R factors, per-residue 
measures of fit to the crystallographic data 
[real-space R factors (Jones et al., 1991), and real-
space correlation coefficients (Brändén & Jones, 1990)], 
as well as comprehensive descriptions of ligand 
quality and structural interactions (Cereto-Massagué 
et al., 2013) are now also provided. A description 
of all data from PDB_REDO entries is given in 
supplementary Table S2.1.
PDB_SELECT (Hooft et al., 1996b) now also 
provides quality-sorted sequence-redundant 
lists. These lists do not include entries deemed 
unwanted for bioinformatics purposes, e.g. 
entries that contain too many severe errors, 
too many incomplete or non-canonical amino 
acids, or homology models.
The WHY_NOT indexing algorithm has 
been adapted to deal with the many novel 
databanks.
A new major databank
Macromolecules are not static. The 
displacement of atoms in crystal structures 
Existing databanks
DSSP Secondary structure of proteins (http://swift.cmbi.ru.nl/gv/dssp/)
HSSP Multiple sequence alignments of UniProtKB against PDB (http://swift.cmbi.ru.nl/gv/hssp/)
PDBFINDER and PDBFINDER2 Searchable PDB entry meta-data and derived information (http://swift.cmbi.ru.nl/gv/pdbfinder/)
PDBREPORT Lists many types of anomalies and errors in structures (http://swift.cmbi.ru.nl/gv/pdbreport/)
PDB_REDO Re-refined and rebuilt crystallographic structure models (http://www.cmbi.ru.nl/pdb_redo/)
PDB_SELECT Quality-sorted sequence-unique PDB chains (http://swift.cmbi.ru.nl/gv/select/)
WHY_NOT Explains why entries in any bank do not exist (http://www.cmbi.ru.nl/WHY_NOT/)
New databanks
BDB PDB entries with a consistent B-factor representation (http://www.cmbi.ru.nl/bdb/)
WHAT IF Lists Lists for protein structure bioinformaticians (http://swift.cmbi.ru.nl/gv/lists/)
YASARA Scenes YASARA scenes showing protein structure properties (http://www.cmbi.ru.nl/pdb-vis/)
Table 2.1. Macromolecular-structure validation facilities.
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can be modelled at various levels of detail. 
B-factors are commonly used to model the 
displacement of single atoms, while TLS 
parameters model the displacement of groups 
of atoms. Unfortunately, the meaning of the 
B-factor values on the ATOM records of 
PDB files is not always unambiguous. For 
example, ‘residual’ rather than ‘full’ B-factors 
have been reported for thousands of PDB 
structure models for which both B-factors and 
TLS parameters had been refined. Residual 
B-factors do not include the contribution of the 
TLS motion (Winn et al., 2001). The BDB (Touw & Vriend, 
2014) homogenises the B-factor representations 
in PDB files to aid the bioinformatics and 
protein engineering applications that depend 
on B-factors [e.g. (Linding et al., 2003; Neuvirth et al., 2004; 
Reetz et al., 2006; Chung et al., 2006; Schlessinger et al., 2006; Craig 
& Dombkowski, 2013)]. For every crystallographic 
PDB entry there is a BDB entry. The files in 
the BDB are simply identical to those in the 
PDB if full B-factors have been reported, but 
they contain full B-factors calculated from the 
PDB file data if the meta-data in the PDB file 
suggests that this is necessary.
What good is beauty, if it is 
not to be seen?
The main users of PDB files are bioscientists 
in fields as diverse as drug design, molecular 
biology, or biofuel engineering. These 
researchers often are not aware of all problems 
that come with the use of PDB files; see, 
for example, the B-factor problems that we 
addressed with the BDB.
A problem that is ubiquitous for all 
structures solved by X-ray crystallography is 
the implicit description of symmetry related 
ions, waters, and ligands [the absence of 
symmetry related macromolecules has been 
solved, for example, with PISA (Krissinel & Henrick, 
2007)]. Figure 2.1 illustrates this problem.
The problem illustrated in Fig. 2.1 has been 
addressed in two databanks. One databank 
holds PDB files that include the symmetry-
related waters. A second databank has been 
compiled from PDB files with a shell of 
symmetry-related residues.
Solvent exposed amino acid side chains 
tend to be mobile, and as a consequence are 
not observable in the electron density map that 
is at the basis of modelling atomic coordinates 
in X-ray crystallography. The absence of side 
chains is unlikely to remain unnoticed, but may 
cause problems for protein structure software 
or perturb structural analyses otherwise. We 
therefore made one databank in which we 
computationally filled in the missing side 
chains using the rotamer library that is also at 
the basis of WHAT IF’s homology modelling 
module (De Filippis et al., 1994).
Databanks specifically for 
bioinformaticians
Any aspiring protein structure bioinformatician 
Figure 2.1. Schematic illustration of the absence of symmetry 
related waters, ions, and ligands. Three crystal cells are shown. 
These three cells, obviously, contain the same molecules. The 
ellipses a and b are two macromolecules, and the small circle is 
a small molecule, e.g. water, that sits packed between two copies 
of macromolecule A. Each macromolecule A thus has a contact 
with two small circles. The PDB file corresponding to this example 
will only contain the content of one cell. So when the PDB file is 
inspected visually, only one of the circles will be seen.
a b
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will need to write or obtain a PDB file parser 
before he or she can start working on the 
intended research project. Writing a parser 
that can cope with a large enough fraction 
of all problems in PDB files can be a major 
practical problem. We made a large number of 
databanks to overcome this problem in many 
cases. These databanks include the per-residue 
molecular and solvent accessible surface area, 
the secondary structure in 4 states (helix, 
strand, turn, loop), the number of crystal 
contacts, torsion angles, and backbone angles. 
Lists of salt bridges and metal-coordinating 
residues are also created. 
Recently, several groups made 
breakthroughs in the field of ab initio protein 
structure prediction (Hopf et al., 2012; Jones et al., 2012; Marks 
et al., 2012). The idea behind these methods is that 
correlations between the variability patterns of 
residue positions i and j in a multiple sequence 
alignment are indicative for a contact between 
those residues i and j. We believe that these 
studies could benefit from a better definition 
of what constitutes an inter amino acid 
contact. To support research in this field a large 
group of databanks has been made in which 
contacting amino acids are listed. In each 
databank contacts are defined in a different 
way (direct atomic contacts; Cα–Cα distances; 
side chain contacts only; etc.).
New visualisation tools
The CMBI databanks provide a wealth of 
structure-related information. We aim to 
provide this information in files that are 
bioinformatician-friendly. Not all users, 
however, may feel equally comfortable writing 
scripts to show the number of crystal contacts 
per residue in 3D, to create entropy-variability 
plots from an HSSP alignment, or to visualise 
the structural changes in a PDB_REDO 
optimised structure model. For convenience, 
and simply to speed up protein structure 
analyses, we created a set of visualisation tools.
Optimised PDB_REDO structure models and 
their corresponding electron density maps are 
now directly available within the programs 
Coot (Emsley et al., 2010) and CCP4mg (McNicholas et al., 
2011), structure models are also directly available 
in YASARA (Krieger & Vriend, 2014). Coot additionally 
shows a list of all significant structural changes. 
A plugin for PyMOL (Schrödinger, LLC, 2010) to show 
structure models and their electron density 
is available from the PDB_REDO website. 
The required maps are generated on-the-fly 
in the CCP4 (Winn et al., 2011) format and are also 
supported by many other programs such as 
Jmol (Hanson, 2010).
Combined PDB and BDB B-factor plots 
on the BDB website allow the user to rapidly 
see the corrections made to the PDB B-factors.
On our recently developed web tool 
pdb-vis (http://www.cmbi.ru.nl/pdb-vis/) 
secondary structure, symmetry contacts, 
and several accessibility representations are 
visualised in 2D together with the protein 
sequence. PDBsum (de Beer et al., 2014) provides 
many complementary pictures. Several types 
of 3D structure scenes are also available from 
pdb-vis, such as scenes of residues that make 
crystal contacts, or close-ups of metals and 
bound ligands. Scenes provide a convenient 
way of highlighting a specific structural feature 
or local region since the structure, visualisation 
style, and viewpoint are stored in a scene file. 
All scenes can always be inspected with the 
freely available molecular graphics program 
YASARA_View (Krieger & Vriend, 2014).
It has long been known that entropy-
variability (EV) analysis of MSAs can elucidate 
the functional role of residues (Oliveira et al., 2003; 
Folkertsma et al., 2004). EV values can be calculated 
from the HSSP alignment and they can be 
interpreted in a 3D context. We developed 
the visualisation tool VASE (Visualisation of 
Alignments, Structure, and Entropy)(Vroling et 
al., 2011) that connects the three components 
structure, alignment, and entropy/variability 
in a single browser window. Selected residue 
positions in the HSSP MSA are color-coded in 
the 3D structure and vice versa (Fig. 2.2). The 
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Figure 2.2. VASE screenshot. A selected position in the HSSP alignment (red column in the top panel) is shown in the structure (bottom 
right) and in the calculated entropy and variability table (bottom left). The inset shows an entropy-variability plot.
web interface also shows the EV values (Oliveira et 
al., 2003) for the selected residues in a table or for 
all residues in an EV plot (Fig. 2.2 inset).
Methods
DSSP files are produced with the newly 
written DSSP 2.2.1. HSSP files are produced 
using HSSP 2.0. PDBFINDER files currently 
have version 9.0. PDBREPORTs currently 
are produced with WHAT_CHECK 8.4 
(Hooft et al., 1996d), but we are planning to release 
version 11.0 very soon. The PDBREPORT 
databank will be updated accordingly. The 
most recent version of PDB_REDO is 5.35. 
PDB_REDO is under active development and the 
PDB_REDO databank is continuously being 
renewed. At the time of writing all files have 
been created with PDB_REDO version 5.00 or 
newer which means that all structure models 
have undergone rebuilding of side chains and 
flipping of peptide plane orientations when 
needed (Joosten et al., 2011b). BDB files currently 
are created with version 0.6.5. Most other 
databanks are produced using the WHAT IF 
software (Vriend, 1990a).
Availability
All CMBI’s macromolecular structure 
databanks are freely available and can 
be accessed in many different ways. The 
single way of accessing PDB_SELECT 
lists is through the PDB_SELECT pages. 
WHY_NOT can be queried for single 
databank or WHY_NOT entries. Reversely, 
lists of all absent and annotated entries, present 
entries, obsolete entries, etc. are available from 
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WHY_NOT. The previously described 
databanks are indexed by our search system 
MRS (http://mrs.cmbi.ru.nl/)(Hekkelman & Vriend, 
2005), but the ‘Lists’ and scenes databanks are 
not. MRS also handles REST or SOAP web 
service requests. All databanks can be retrieved 
via rsync and ftp. The rsync protocol allows 
mirroring entire databanks or a subset of the 
databank, since all databanks are composed 
of individual files. Detailed instructions 
are provided at http://swift.cmbi.ru.nl/gv/
facilities/.
The DSSP and HSSP web servers have been 
renewed and are provided at a single location: 
http://www.cmbi.ru.nl/xssp/. Existing DSSP 
and HSSP files can be accessed through this 
website. Secondary structure assignment of 
uploaded structure models is also possible 
via this xssp web server, and additionally via 
the WHAT IF web servers (http://swift.cmbi.
ru.nl/) or the WHAT IF web services (Hekkelman et 
al., 2010). A sample script explains the use of the 
xssp REST API. The ‘check model’ WHAT IF 
web server section constructs WHAT_CHECK 
reports from uploaded PDB files. PDB_REDO 
files can be created using the PDB_REDO 
web server (Joosten et al., 2014). Some users might 
prefer creation of databank files on a local 
workstation. The software for creating BDB, 
DSSP, HSSP, WHAT IF lists, PDBREPORT, 
PDB_REDO, and YASARA scene databanks is 
freely available.
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Description URL‡,§
Summary of the PDB_REDO entry ##/????/index.html or cgi-bin/redir2.pl?pdbCode=????
Initial crystallographic data and map coefficients  
[similar to the Electron Density server (Kleywegt et al., 2004)] ##/????/????_0cyc.mtz.gz
Initial structure model ##/????/????_0cyc.pdb.gz
Crystallographic data and map coefficients after partial optimisation (re-refinement) ##/????/????_besttls.mtz
Intermediate structure model after partial optimisation ##/????/????_besttls.pdb 
Cystallographic data and map coefficients after full optimisation (re-refinement and 
rebuilding) ##/????/????_final.mtz
Final structure model after full optimisation ##/????/????_final.pdb 
Structure model after full optimisation with total B-factors (similar to the BDB data bank) ##/????/????_final_tot.pdb
2mFo-DFc electron density map for the final structure model cgi-bin/map.pl?id=????
mFo-DFc electron density difference map for the final structure model cgi-bin/dmap.pl?id=????
WHAT_CHECK report for initial structure model ##/????/wo/pdbout.txt
WHAT_CHECK report for intermediate structure model ##/????/wc/pdbout.txt
WHAT_CHECK report for final structure model ##/????/wf/pdbout.txt
Ligand and ligand interaction data for the initial and final structure model¶ ##/????/????_ligval.txt
Per-residue real-space R factors and correlation coefficients for the final structure model ##/????/????_final.eds
Plot of change in per-residue real-space correlation coefficient from the initial to the final 
structure model (colour-coded by significance of the change) ##/????/????_dRSCC.png
Description of structural changes as Coot scripts (suitable for data mining) ##/????/????_final.py (Python) or ##/????/????_final.scm (Scheme)
Visualisation scenes for YASARA that show structural changes and TLS (Schomaker & Trueblood, 
1968) group selections ##/????/????_scenes.tar.bz2
PDB_REDO statistics (crystal parameters, R factors, validation scores, etc.) for data mining
##/????/data.txt (for one    
PDB_REDO entry) or others/alldata.
txt (for the entire data bank)
‡ ???? is the PDB id of the entry and ## are the middle two characters of the PDB id. 
§ All URLs start with http://www.cmbi.ru.nl/pdb_redo/
¶ Data file only available for PDB entries with ligands
Supplementary Material
Table S2.1. Data available from PDB_REDO entries.
3Wouter G. Touw
Gert Vriend
Protein Engineering, 
Design & Selection (2014) 
27, 457-462
BDB: Databank of PDB files 
with consistent B-factors
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Protein structures available from the PDB contain for each atom the coordinates, the occupancy, and the B-factor that indicates the mobility of the atom. The values that should represent B-factors can relate to atomic 
motions in different ways. We present here a databank, called BDB, in which all 
B-factors have been converted to the one, homogeneous representation that 
is most useful for protein engineering applications. The BDB is freely available 
through http://www.cmbi.umcn.nl/bdb/.
Introduction
X-ray crystallography is the pre-eminent 
technique to obtain models of macromolecules 
that include their atomic coordinates and 
mobility. The mobility can range from large-
scale domain motions to high-frequency 
low-amplitude vibrations. In macromolecular 
crystallography, all types of mobility will 
be observed as disorder in the crystal if the 
motion is not restricted by the crystal packing.
Crystal structures are calculated from 
the X-rays diffracted by the crystal, called 
reflections. The number of reflections 
determines the number of parameters that can 
be used to describe the structure model. There 
are barely enough reflections to estimate the 
X, Y and Z positions of the atoms if only low 
resolution data, e.g. around 3.0 Å, are obtained 
from the crystal. Additional parameters that 
describe mobility might be estimated if the 
crystal is of better quality and diffracts to ~2.0 
Å. A detailed description of the occupancy and 
mobility of the atoms is possible if high-quality 
reflections are measured, e.g. from a crystal 
diffracting to 1.0 Å. The model parameters 
are determined in a process crystallographers 
refer to as refinement. The final goal of 
this refinement is to obtain a model for the 
macromolecule in which these parameters 
agree optimally with the observed reflections.
The most widely adopted measure of 
mobility available in Protein Data Bank (PDB) 
(Berman et al., 2003) files is the so-called B-factor 
(Fig. 3.1). A non-exhaustive literature search 
revealed that B-factors are used in a wide 
variety of protein engineering applications, and 
that some applications even critically depend 
on them. For example, B-factors have been 
used to select flexible residues as candidates 
for mutation in order to enhance thermal (Reetz 
et al., 2006; Craig & Dombkowski, 2013) or kinetic (Xie et al., 2014) 
enzyme stability, or to engineer disulfide bonds 
(Craig & Dombkowski, 2013). B-factors have also been 
used as a flexibility measure for prediction of 
protein–ligand binding affinity (Liu et al., 2013) or 
protein–protein binding sites (Chung et al., 2006). We 
also found a large number of web servers that 
use B-factors as part of the input (see Table 
3.1). Furthermore, many molecular graphics 
software packages such as YASARA (Krieger & 
Vriend, 2014), PyMOL (Schrödinger, LLC, 2010), and VMD 
(Humphrey et al., 1996) assist structure analysis by 
visualising B-factors.
Figure 3.1. Thr1 from PDB entry 1crn. For every ATOM the coordinates X, Y, and Z in Å, the occupancy, and the B-factor in Å2 (bold) are 
listed.
Keyword   atom descriptor         X       Y       Z    Occu-   B     Mendeleev
                                                       pancy            symbol
ATOM      1  N   THR A   1      17.047  14.099   3.625  1.00 13.79           N
ATOM      2  CA  THR A   1      16.967  12.784   4.338  1.00 10.80           C 
ATOM      3  C   THR A   1      15.685  12.755   5.133  1.00  9.19           C 
ATOM      4  O   THR A   1      15.268  13.825   5.594  1.00  9.85           O 
ATOM      5  CB  THR A   1      18.170  12.703   5.337  1.00 13.02           C 
ATOM      6  OG1 THR A   1      19.334  12.829   4.463  1.00 15.06           O 
ATOM      7  CG2 THR A   1      18.150  11.546   6.304  1.00 14.23           C
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The distribution of B-factors has been 
studied in active sites (Carugo & Argos, 1998; Yuan et 
al., 2003), in thermophilic proteins (Vihinen, 1987; 
Parthasarathy & Murthy, 2000), and has been compared 
between amino acid types (Parthasarathy & Murthy, 1997), 
and between the side chain and the main chain 
as a function of refinement program (Parthasarathy 
& Murthy, 1999). B-factors have been correlated 
with solvent accessibility, secondary structure, 
crystallographic resolution, and crystal-
packing contacts (Zhang et al., 2009,Carugo & Argos, 1997a,b), 
with order parameters and residual dipolar 
couplings determined by solution NMR (Haliloglu 
& Bahar, 1999,Wang et al., 2004a; Schlessinger & Rost, 2005; Clore & 
Schwieters, 2006), with root-mean-square (r.m.s.) 
deviation from mean positions in solution 
NMR ensembles (Yang et al., 2007), or with dynamic 
solid-state NMR data (Reichert et al., 2012).
Application Name Website Reference
E disulfide bonds DbD2 cptweb.cpt.wayne.edu/DbD2/ Craig & Dombkowski, 2013
P hinge point FlexServ mmb.irbbarcelona.org/FlexServ Camps et al., 2009
P limited proteolysis NICKPRED bioinf.man.ac.uk/nickpred/ Hubbard et al., 1998
P residue mutability MAP2.03D map.jacobs-university.de/map3d.html Verma et al., 2012
P phosphorylation Phos3d phos3d.mpimp-golm.mpg.de/ Durek et al., 2009
P mutation effect PolyPhen genetics.bwh.harvard.edu/pph2/ Adzhubei et al., 2010
P PPI PROMATE bioinfo.weizmann.ac.il/promate/ Neuvirth et al., 2004
P PPI VORFFIP www.bioinsilico.org/VORFFIP Segura et al., 2011
V metal sites CheckMyMetal csgid.org/csgid/metal_sites/ Zheng et al., 2014
V ADPs PARVATI skuld.bmsc.washington.edu/parvati/ Merritt, 1999
G molecular graphics FirstGlance firstglance.Jmol.org/a -
E, engineering. G, visualisation of crystal structures. P, prediction. PPI, protein–protein interaction (binding sites). V, validation. 
aUsed on several journals’ and protein structure bioinformatics websites such as Nature, RCSB PDB, ExPASy and Protopedia.
Table 3.1. Selection of web servers using B-factors.
Inspired by the studies of B-factor 
behaviour in protein structures, there have 
been many attempts to predict B-factors from 
sequence [e.g. (Karplus & Schulz, 1985; Radivojac et al., 2004; 
Yuan et al., 2005)]. Therefore, the availability of a 
crystal structure is not always a precondition 
for using B-factor applications. For example, it 
has been suggested that predicted B-factors can 
be used for increasing protein thermostability 
if crystallographic data are not available (Reetz et 
al., 2006). Table 3.2 lists webservers that predict 
mobility in a wide variety of ways at a wide 
variety of levels of detail.
Burnley et al. (2012) showed that disorder 
can best be accounted for by representing the 
macromolecule by an ensemble of structures. 
Such an ensemble, though, is difficult to use in 
molecular visualisation, protein engineering, 
Name Website Reference
DisEMBL dis.embl.de/ Linding et al., 2003
Local contact model spin.ccic.ohio-state.edu/index.php/bfactor/ Li & Brüschweiler, 2009
PredBF www.csbio.sjtu.edu.cn/bioinf/PredBF/ Pan & Shen, 2009
PredyFlexy www.dsimb.inserm.fr/dsimb_tools/predyflexy/ de Brevern et al., 2012
PROFbval www.predictprotein.org/ Schlessinger et al., 2006
Table 3.2. Web servers predicting B-factors, flexibility and/or disorder.
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or related applications. 
More commonly, crystal structures describe 
disorder with average atomic displacement 
parameters (ADPs) and an occupancy factor 
if distinct alternate conformations can be 
resolved.
The most detailed ADP model available in 
the PDB requires six parameters to represent 
displacements along three orthogonal 
directions. For each atom these six anisotropic 
ADPs are stored in the ANISOU record 
of the PDB files (Fig. 3.2). The isotropic 
approximation Beq of the anisotropic ADPs 
(Hamilton, 1959; Trueblood et al., 1996) is stored in the 
B-factor field of the corresponding ATOM 
record (Fig. 3.2) when anisotropic ADPs have 
been refined.
When crystals do not diffract to atomic 
resolution, insufficient reflections are available 
to extensively parameterize the structure 
model. The data-to-parameter ratio can be 
improved in several ways. Known geometric 
aspects of macromolecules such as bond lengths 
and bond angles can be used as extra data (Engh 
& Huber, 1991), or B-factors can be restrained to 
plausible values (Konnert & Hendrickson, 1980; Tronrud, 1996; 
Murshudov et al., 2011; Afonine et al., 2012; Thorn et al., 2012). The 
number of parameters is reduced, for example, 
when occupancies are not refined or when the 
description of the ADPs is simplified. 
A commonly used way to improve the 
data-to-parameter ratio is to assume that the 
ADPs are isotropic, so that modelling atomic 
Figure 3.2. Gly4 from PDB entry 4b4e. Six atomic ADPs U11, U22, U33, U12, U13, and U23 (units are 10
-4 Å2) are stored in the ANISOU records 
(thin font). The ATOM records list the X, Y, and Z coordinates in Å, the occupancy, and the isotropic approximation Beq in the B-factor 
field in Å2 (bold). Beq is calculated as Beq = 8π
2 Ueq in which Ueq = (U11 + U22 + U33)/3, which is the mean-square displacement averaged 
over all directions.
Keyword   atom descriptor         X       Y       Z    Occu-   B     Mendeleev
                                                       pancy            symbol
ATOM     28  N   GLY A   4      15.000  -3.180  13.299  1.00 10.24           N 
ANISOU   28  N   GLY A   4     1583   1343    963    101    178    379       N 
ATOM     29  CA  GLY A   4      16.145  -3.567  14.104  1.00 10.44           C 
ANISOU   29  CA  GLY A   4     1697   1350    918     58    100    333       C 
ATOM     30  C   GLY A   4      17.204  -4.225  13.231  1.00  9.66           C 
ANISOU   30  C   GLY A   4     1570   1162    936    -22     26    301       C 
ATOM     31  O   GLY A   4      16.917  -4.713  12.142  1.00  9.72           O 
ANISOU   31  O   GLY A   4     1490   1185   1018     41    -14    202       O 
                                U11     U22     U33     U12     U23     U33
displacement requires only one spherically 
symmetric ADP per atom rather than six 
anisotropic ones. The B-factors in the PDB 
file are calculated as B = 8π2<u2> where <u2> 
is the isotropic ADP that represents the mean-
square displacement from the atom’s mean 
position1. B-factors of 5, 20, 80, and 180 Å2, 
correspond to r.m.s. displacements from the 
atom’s mean position of 0.25, 0.5, 1 and 1.5 
Å, respectively. If the displacement of the atom 
follows a Gaussian distribution, this means 
that at any time 68.2 % of the atoms in the 
crystal are within 0.25, 0.5, 1 and 1.5 Å of the 
mean position.
Protein engineering applications tend to use 
only these B-factors as a measure of mobility 
while anisotropic ADPs are usually ignored 
(see Table 3.1 for examples).
Most modern refinement programs allow 
even simpler parameterization by refining only 
one or a few ADPs per residue or chain (Brünger 
et al., 1998; Blanc et al., 2004; Sheldrick, 2008; Murshudov et al., 2011; 
Afonine et al., 2012).
In practice ADPs do not only reflect the 
mobility of the atom, but also static disorder 
in the crystal and a series of other effects such 
as missing, spurious or mis-identified atoms, 
unresolved alternate positions and data scaling 
problems. Furthermore, at low resolution the 
data often do not allow accurately separating 
atom mobility from the existence of multiple 
1. see http://www.cmbi.umcn.nl/bdb/theory/ for an extensive explanation of 
the theory behind the determination of B-factors in X-ray crystallography.
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conformations, and occupancies and ADPs 
will often be highly correlated after refinement. 
Nevertheless, ADPs are generally considered 
good descriptors of the mobility of atoms. 
Rather than modelling the displacement of 
each atom individually, groups of atoms can 
be treated as mobile pseudo-rigid bodies. The 
displacement of each group is modelled by 
20 translation, libration, and screw-rotation 
(TLS) parameters (Schomaker & Trueblood, 1968; Winn 
et al., 2001). Therefore, TLS refinement is often 
applied in combination with ADP refinement 
to model bulk motion and local motion at the 
same time. The use of TLS allows estimating 
anisotropic atomic mobility even when the 
reflection-to-atom ratio is not very high (Painter 
& Merritt, 2006; Merritt, 2012). TLS group parameters 
normally are present in the PDB file header.
 In summary, several methods exist 
to model the displacement of atoms in crystal 
structures. Unfortunately, several methods also 
exist to represent mobility-related parameters 
in PDB files. For example, for several years 
‘residual’ rather than ‘full’ B-factors have 
been reported for structure models with TLS 
groups refined by REFMAC. The isotropic 
contribution of the TLS motion is not 
included in residual B-factors (Winn et al., 2001) so 
that the full B-factors can only be obtained 
through matrix algebra [e.g. TLSANL, (Howlin 
et al., 1993)]. Although PDB management now 
demands that all new depositions contain full 
isotropic B-factors2, many thousands of older 
PDB files have not been converted yet, and we 
still found eight entries deposited with the new 
deposition system that also needed a B-factor 
conversion.
When analysing all B-factors in the PDB, 
we also found that the mean square atomic 
displacement instead of B may be stored 
in the ATOM cards, or that the isotropic 
contribution of the overall scale factor (Sheriff, 
1987) may or may not be included in B-factors 
(explained on the associated website), and a few 
more inconveniences. The different meanings 
2. http://www.wwpdb.org/docs.html
of apparent B-factor values in existing PDB 
files may confuse non-experts, provided that 
they are aware of these inconsistencies at all. 
Prediction algorithms like the ones listed in 
Tables 3.1 and 3.2 are based on large data sets 
of B-factors. A larger set of more consistently 
represented B-factors might lead to improved 
predictions. Moreover, many of the tools in 
Table 3.1 make use of B-factors to identify the 
most flexible residues in a protein chain. These 
residues will often be different if the selection 
is based on residual B-factors rather than full 
B-factors (see below and Figs. 3.3 and 3.4).
The average protein engineer will probably 
be hard-pressed to correct the inconsistent 
B-factor representations in order to obtain 
full B-factors. We created a procedure to 
detect inconsistent B-factor representations 
and convert all PDB files into PDB files with 
consistent B-factors (BDB files), thereby 
increasing the number of PDB entries suitable 
for B-factor analyses. BDB files are fully 
identical to PDB files, except that in BDB files 
B-factors are the ‘full’ isotropic B-factors that 
relate to atomic mobility most intuitively.
The BDB databank currently contains 89 
440 BDB entries, 7290 of which have B-values 
different from the corresponding PDB entries. 
In two-thirds of the corrected chains, the 
B-factor maximum is different from the 
maximum in the corresponding PDB chain and 
in the majority of the corrected structures the 
secondary structure element with the highest 
B-factors is different. The local maximum is 
two times more often different than the same.
Methods, results and 
discussion
The protocol for constructing a BDB file starts 
with gathering information from REMARK 
records in X-ray PDB files. It uses this 
information to determine the most likely type of 
B-value in the ATOM records. The most useful 
information is extracted from the information 
in REMARK 3 and includes software and 
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version number, TLS group information, and 
messages automatically produced by the X-ray 
software in the “OTHER REFINEMENT 
REMARKS” section or elsewhere in REMARK 
3. The PDB staff has recently performed a 
large remediation of the whole PDB3 and has 
identified many entries that probably contain 
residual B-factors. In this same remediation 
many TLS group definitions have been 
corrected. In our scripts these annotations by 
PDB staff are given precedence over our own, 
automatic interpretation of the PDB file. TLS 
group definitions are otherwise assumed to be 
correct and used to convert residual B-factors 
into full B-factors using TLSANL (Howlin et al., 
1993). 
In case the protocol failed to create a BDB 
entry, the corresponding WHY_NOT (Joosten et 
al., 2011a) entry will inform the user why the BDB 
entry could not be created. If the PDB file was 
found to contain full B-factors, the BDB file is 
simply identical to the PDB file.
The information extracted from the PDB 
file headers is interpreted and the combination 
of all information can lead to many different 
situations, the most important of which are:
1. B-factors resulting from TLS refinement 
with old versions of REFMAC (Murshudov et 
al., 2011) tend to be residual. REFMAC 5.0, 
5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, and 5.8 
account for 0.67, 9.91, 56.40, 3.40, 4.36, 
22.02, 1.19, 0.59, and 0.06% of the PDB 
files with residual B-factors, respectively. 
An additional 1.40% did not report the 
particular REFMAC version.
2. R.m.s. displacements instead of B may be 
stored in the ATOM records of structures 
refined by RESTRAIN (Driessen et al., 1989).
3. The isotropic contribution of the overall 
scale factor may or may not be included 
in B-factors refined by PHENIX (Afonine et al., 
2012). Unfortunately, this cannot be detected 
properly from the metadata provided by 
this software.
4. Beq values calculated from the ANISOU 
3. http://www.wwpdb.org/remediation.html
records were not the same as the B-factors 
in the corresponding ATOM records of 
237 files and were therefore not included in 
the BDB. In 10 other cases the Beq-factors 
could be reproduced by swapping the order 
of U11, U22, U33, U12, U13, and U23 on the 
ANISOU record so these 10 entries are in 
the BDB with correct B-factors but still 
with the original U values in the ANISOU 
record.
5. Some residual B-factors could not be 
converted to full B-factors because TLS 
groups were not defined in the PDB file 
header (5 times), or because of problems 
with TLS group definitions (19 times).
6. In a number of PDB files the metadata 
needed to determine whether full B-factors 
are present, simply is missing. These files 
were therefore excluded from the BDB. 
Examples are that the B-factor type could 
not be determined in the remediation 
of the PDB (97 times), that TLS group 
definitions are present but B-factor type 
details and ANISOU records are absent 
(192 times), that TLS group definitions are 
absent but a remark about TLS refinement 
is present in the PDB file header (14 times).
7. Several other conditions were observed less 
than 5 times (see WHY_NOT). 
If none of these conditions were met, then 
it was assumed that full isotropic B-factors 
were present in the PDB file. The BDB file 
then simply is identical to the PDB file. The 
full protocol can be inspected since the source 
code is freely available from the BDB website.
Currently, 82 150 BDB files are identical 
to the corresponding PDB files and 7290 
BDB files are different. 917 X-ray PDB entries 
could not be converted to BDB entries. Figure 
3.3 shows that residual B-factors observed in 
PDB entries often differ dramatically from 
the full isotropic B-factors which include the 
TLS contribution to the B-factors. Figure 3.3 
also shows that in many cases the residues in 
a protein with the highest or lowest residual 
B-factors are not the residues with the highest 
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or lowest full B-factors. This latter problem is 
of substantial concern for protein engineering 
experiments that use B-factors as a measure of 
mobility as part of their experimental design.
The studies listed in Tables 3.1 and 3.2 
commonly use normalized B-factors (Karplus 
& Schulz, 1985; Smith et al., 2003) prior to comparing 
B-factors of different chains and structures. 
The apparent local and global maxima and 
minima of normalized residual B-factor 
distributions typically are also different from 
those of the corresponding normalized full 
B-factor distributions. Figure 3.3 shows 
examples of normalized B-factor distribution 
differences for individual structures. Figure 
3.4 illustrates that normalized chain maxima 
in BDB entries are very often tens of residues 
away from the maxima in corresponding 
PDB entries. We observed that the B-factor 
maximum is different in 62% of the corrected 
chains even when the B-factors were smoothed 
using a sliding window of five residues.
We also analysed local Cα B-factor maxima 
in windows of seven residues in the 14 000 
corrected chains and counted how often the 
local full B-factor maximum is the same as 
the local residual B-factor maximum and how 
often the two local maxima are located at a 
different residue position. It was found that 
the local maxima are two times more often 
different than the same.
A histogram of the absolute difference of 
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Figure 3.3. Selected B-factor differences between residual (PDB entries, grey) and full (BDB entries, black) B-factors. (a) Insulin, 
atomic B-factor for the residues 4-17 (PDB 2c8q). (b) Cα B-factors from T4 lysozyme M102E/L99A mutant, residues 1-135 (PDB 3gui). 
(c) Normalized atomic B-factors from the regulator of G-protein signalling 17, residues 97-166 (PDB 1zv4). (d) Normalized Cα B-factors 
from phosphomannomutase/ phosphoglucomutase S108D mutant, residues 346-454 (PDB 2fkm). These proteins are frequently used 
in protein engineering applications [e.g. (Markussen et al., 1987; Brems et al., 1992; Ueda et al., 1993; Crowther et al., 1994; Jordan et al., 1999; Ueda et al., 2000; Koganesawa et al., 
2001; Regni et al., 2006; Hagan et al., 2010; Mathew et al., 2013)]. 2c8q, 3gui, 1zv4, and 2fkm all report individual isotropic ADPs, one or more TLS groups, 
and REFMAC 5.2 as refinement program. The TLS contribution to the B-factors is included in the full B-factors but not in the residual 
B-factors. Normalization was performed so that the normalized B-factor distribution of atoms in each macromolecular chain has zero 
mean and unit variance. Graphs of all PDB and BDB B-factors are available from the BDB website.
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the location of the global B-factor maximum 
between scaled PDB and BDB Cα B-factors is 
presented in Fig. 3.5.
In 53% of the 5615 corrected structures 
with few (<2%) missing side chains, the 
secondary structure element with the highest 
average Cα B-factor was different from the 
secondary structure element containing the 
highest B-factors in the corresponding PDB 
entries. In 1260 structures the BDB secondary 
structure element was also of a different type 
than the element in the corresponding PDB 
structure. For example, for 584 structures the 
PDB maximum was found in an α-helix, while 
the BDB maximum was found in a loop. The 
reverse is true for 394 structures.
In summary, we found that approximately 
10% of the X-ray entries deposited in the 
PDB do not contain full B-factors and that 
the full B-factors in converted BDB files on 
average are different from the corresponding 
residual B-factors in PDB files. Some authors 
of software in Tables 3.1 and 3.2 have 
detected a few of the inconveniences that 
we have described. It is to be expected that 
many of those methods might benefit from a 
revision using BDB files instead of PDB files. 
Schneider et al. (2014), for example, realized 
the problems that BDB addresses and decided 
to simply not use files with residual B-factors 
in their macromolecular dynamics study.
The metadata that was used to guess the 
most probable B-factor type can be inspected 
at the BDB website. This website also shows 
the ADP model used upon refinement. 99.4% 
of the converted entries with residual B-factors 
report individual ADPs and 98% of all BDB 
structures report individual B-factors for all 
atoms.
BDB files can be downloaded in several 
different ways, and the entire data bank can 
also be retrieved via rsync. The BDB is updated 
weekly and is freely available through http://
www.cmbi.umcn.nl/bdb/.
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Figure 3.4. Distribution of the distance in primary structure 
between the global Cα B-factor maximum of a PDB chain and 
the corresponding BDB chain in 13 968 chains for which the 
TLS contribution was added to residual B-factors to obtain full 
B-factors. Around 1700 entries were excluded from the analysis 
because >2% of the side chains were absent in the structure. The 
maximum is determined using a sliding window of five Cα atoms 
that moves along all residues in a chain except residues close to 
termini and chain breaks. B-factors were normalized as in Fig. 3.3. 
5288 chains have the same maximum in the PDB and BDB entries 
(not shown). The difference is one residue for 2046 chains and 
two or more for 6634 chains.
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Figure 3.5. Distribution of the average absolute scaled Cα 
B-factor difference in 5556 PDB and BDB entry pairs for which 
the TLS contribution was added to residual B-factors to obtain 
full B-factors. Before calculating the differences, the B-factors in 
a PDB entry were first normalized as described in Fig. 3.3, and 
then scaled so that the B-factor distribution has the same mean 
and variance as the distribution of the corresponding BDB entry.
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A method is presented to detect B-factor distributions that are similar to those found in fabricated protein structure models. The intuition for the method is based on Benford’s law of first significant digits. Despite lacking a solid 
theoretical foundation, the method can in practice be used for B-factor validation.
Introduction
The principal technique to elucidate the 
molecular shape of a macromolecule in 
atomistic detail is single-crystal X-ray 
diffraction. Crystallographic structure 
determination has been introduced in chapter 
1a. The coordinates of a crystallographic 
structure model describe the average atom 
position; the B-factor describes disorder in the 
crystal. The theoretical background and some 
practical aspects of working with B-factors 
have been discussed in chapter 3.
Benford’s law
Newcomb discovered (Newcomb, 1881) that the 
first significant digits (FSDs) d of many 
naturally occurring sets of numbers follow the 
probability distribution
P(d) = log10[1+1/d]     d∈{1, ..., 9}      (eq. 4.1)
Benford noted the phenomenon again in 
1938 (Benford, 1938) and it has become known 
as Benford’s law (BL) for base 10. The law 
is satisfied best when the data span many 
orders of magnitude uniformly and are not 
constrained by rules designed by humans. 
A well-known distribution that satisfies the 
law is the lognormal distribution with high 
variance. Other distributions satisfying the law 
have been listed elsewhere (Formann, 2010). Several 
methods have been proposed to test whether 
a set of numbers satisfies BL (Morrow, 2010). These 
include Pearson’s χ2 test and the Kolmogorov-
Smirnov test. BL has been applied to detect 
fraud in diverse areas ranging from finance 
(Nigrini, 2012) to science (Diekmann, 2007).
PDB fraud
The Murthy fraud became one of the biggest 
scandals in science when it was discovered in 
2009 that most of H.K.M. Murthy's protein 
structures had been fabricated rather than 
experimentally determined (Janssen et al., 2007; Borrell, 
2009; University of Alabama at Birmingham, 2009). Fig. 4.1 
shows an example of sequential B-factors of a 
typical structure model and a structure model 
fabricated by Murthy.
Murthy’s B-factor distributions violate BL 
and we explored ways based on BL to detect 
B-factor distributions that are similar to 
Murthy’s B-factor distributions.
B-factor distributions do not 
satisfy BL
B-factors are proportional to the variance of 
atomic displacement when the displacement is 
assumed to be Gaussian. In Bayesian statistics, 
the inverse Gamma distribution (IGD) is 
frequently used as a conjugate prior for the 
variance of a Gaussian distribution with known 
mean (Murphy, 2012). We observed that individual 
isotropic B-factor distributions of a structure 
model often fit an IGD that is slightly shifted 
towards higher B-factor values, as has been 
noted before (Dall’Antonia et al., 2012; Negroni, 2012). IGD 
Figure 4.1. B-factor profiles of a normal PDB entry (3fvl, grey) 
and an entry fabricated by H.K.M. Murthy (1bef, black).
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scale parameters typically vary between 10 
and 1000 for structure models in the PDB 
(Negroni, 2012). Although Murthy’s fabricated 
B-factor distributions can be described by 
IGDs with relatively high scale parameters 
(between 100 and 1000), IGDs that were fit to 
fabricated B-factor distributions could not be 
distinguished easily from IGDs that were fit to 
normal B-factor distributions.
In practice B-factor distributions almost 
never satisfy BL. This might be explained 
by the fact that the majority of B-factor 
distributions do not even span two orders 
of magnitude (5-120 Å2). Furthermore, 
constraints (e.g. lower and/or upper limits set 
by the crystallographer), restraints (inducing 
similarity), the choice of B-factor model 
during refinement, or other types of human 
manipulation may produce computational 
artefacts in the resulting B-factor distribution. 
However, B-factors generated from a perfect 
IGD do not satisfy BL either (plus signs in Fig. 
4.2).
Transformation 
Morrow found that for every random 
variable X there is an α* such that for all α ≥ 
α*, (X/σ)α ε-satisfies BL for all σ (Morrow, 2010). A 
distribution ε-satisfies BL if the deviation of 
the observed FSD fractions from the expected 
FSD fractions is smaller than ε, a small 
positive number such as. 0.01. The triangles 
in Fig. 4.2 show that B-factors sampled from 
a representative IGD better satisfy BL when 
they are raised to the power 2.8.
Validation method
We attempted to estimate α* from an IGD 
fit to an observed B-factor distribution and 
use α* to bring the observed distribution in 
approximate agreement with BL. A hypothesis 
test could then be used to verify whether the 
transformed B-factor distribution satisfied BL. 
Unfortunately, robust estimation of α* proved 
to be too difficult in our hands and valid 
B-factor distributions often did not satisfy 
BL after transformation with the estimated 
α*. Therefore, a fixed value of α* = 2.8 was 
assumed in subsequent analyses.
It was found that many typical distributions 
of individual isotropic B-factors satisfy BL 
approximately when they are raised to the power 
2.8. Fabricated B-factor distributions and 
distributions similar to fabricated distributions 
often do not satisfy BL when they are raised 
to the power 2.8. Murthy’s entries could be 
distinguished from genuine entries when the 
observed sequential differences between FSD 
fractions, SDFobs (eq. 4.2), were compared to 
the expected sequential differences, SDFexp (eq. 
4.3), using a summation of absolute scaled 
differences (eq. 4.4):
SDFobs = P(FSD = d) - P(FSD = d+1)  (eq. 4.2)
SDFexp = log10[1+1/d] - log10[1+1/(d+1)]  (eq. 4.3)
Score = ∑d | SDFobs /a - SDFexp /b |  (eq. 4.4)
where d∈{1, ..., 8}, a and b correspond to 
the first terms of eq 4.2 and 4.3, respectively, 
plus a small constant. Fabricated and genuine 
B-factor distributions could be discriminated 
Figure 4.2. Distribution of B-factor FSDs. The plus signs are the 
FSDs for 1000 B-factors simulated from a representative IGD. The 
triangles are the FSDs of B2.8. The solid and dashed horizontal lines 
indicate the expected FSD fractions according to BL and the 95% 
confidence intervals (Joenssen, 2015), respectively.
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better with this score (based on expected 
sequential frequency differences) than with a 
score based on expected frequencies.
The BDB (see chapter 3) was used to select 
PDB entries that had most likely been refined 
with individual isotropic B-factors. The 
criteria in Table 4.1 were applied to filter out 
PDB entries that might contain refinement 
artefacts. The distribution of the validation 
scores for the remaining 64 165 PDB entries 
is shown in Fig. 4.3.
Murthy’s fabricated entries score rank 
among the top-891 (1.39 %).
The genuine PDB entries that scored 
higher than the fabricated entries all showed 
at least one or more unusual feature, such as 
a very limited B-factor range, a lower B-factor 
boundary for some atoms, a small number of 
B-factor groups among otherwise individually 
refined B-factors, or a systematic difference 
Structure model‡ B-factor model‡ B-factors
Ensemble of 
models Global
< 10 unique 
values
Cα-only Grouped s.d. < 1.0
< 500 valid atoms Anisotropic s.d. < mean/10
Lower and/or upper 
boundaries†
† Extreme values occur at least twice as often as the 
penultimate extreme values
‡ See chapter 3 for details
Table 4.1. Quality filter for B-factor distributions. between side-chain B-factors and backbone 
B-factors. Some of these features might be 
considered refinement artefacts that were not 
detected by our quality filter (Table 4.1).
Murthy’s fabricated B-factor distributions 
have limited width (the difference between the 
minimum and maximum B-factor is less than 
33 Å2 in 9 out of 11 cases) while the difference 
between the B-factors of connected atoms is 
relatively high.
Concluding remarks
We designed a method that detects B-factor 
distributions that are similar to Murthy’s 
fabricated B-factor distributions. The method 
lacks a solid theoretical basis but might 
be useful in practice because it can detect 
refinement artefacts or other unusual features. 
Future work will concentrate on refinement 
of the method and analysis of high-scoring 
B-factor distributions.
Figure 4.3. Validation score for 64 
165 PDB entries. The rank for Murthy’s 
14 entries is indicated. PDB entries 
1ay1 and 1bgx (grey solid lines) are 
not fraudulent according to Murthy’s 
former institute UAB (University of Alabama 
at Birmingham, 2009). The B-factors of PDB 
entry 1cmw (grey arrow) had been 
copied from 1taq.
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On the complexity of Engh and 
Huber refinement restraints: 
the angle τ as example
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The Engh and Huber parameters for bond lengths and bond angles have been used uncontested in macromolecular structure refinement from 1991 until very recently, despite critical discussion of their ubiquitous validity by many 
authors. An extensive analysis of the backbone angle τ (N—Cα—C) illustrates 
that the Engh and Huber parameters can indeed be improved and a recent study 
(Tronrud et al., 2010) confirms these ideas. However, the present study of τ shows 
that improving the Engh and Huber parameters will be considerably more complex 
than simply making the parameters a function of the backbone φ, ψ angles. 
Many other aspects, such as the cooperativity of hydrogen bonds, the bending of 
secondary-structure elements and a series of biophysical aspects of the 20 amino-
acid types, will also need to be taken into account. Different sets of Engh and Huber 
parameters will be needed for conceptually different refinement programs.
Introduction
Engh and Huber determined standard bond-
length and bond-angle parameters (Engh & 
Huber, 1991, 2001) from crystal structures in the 
Cambridge Structural Database (CSD) (Allen, 
2002). They analysed fragments equivalent to 
amino-acid side chains and the polypeptide 
backbone. The Engh and Huber (EH) values 
are applied as stereochemical restraint targets 
in most macromolecular refinement programs.
Two important assumptions have silently 
become accepted as facts by the use of the 
EH libraries in protein structure refinement. 
The first is that the stereochemistry in the 
peptide fragments in the CSD is the same 
as that in proteins and the second is that the 
stereochemical restraints are not a function of 
the environment.
Restraint targets for proteins are ideally 
derived from protein structures refined at 
atomic resolution without the use of any 
restraints. Only a very small number of such 
structures had been deposited in the Protein 
Data Bank (PDB) (Bernstein et al., 1977; Berman et al., 2000) 
at the time when Engh and Huber first defined 
the restraint targets. Geometrical parameters 
could not, of course, be extracted from low- 
and intermediate-resolution structures as 
these were biased by the geometric restraints 
that were (necessarily) applied during the 
refinement. Therefore, at the time the peptide 
fragments in the CSD constituted the best 
source for defining target values for protein 
geometric restraints (EU 3-D Validation Network, 1998).
The EH parameters have been discussed 
ever since their introduction. Laskowski 
observed values other than those of Engh 
and Huber for bond lengths and angles in a 
data set consisting of the 186 ‘best’ structures 
in the PDB in 1993 (Laskowski et al., 1993b) and 
found that the refinement software used was 
a significant factor. Although they did not 
explicitly mention it, they observed that the 
N—Cα bond length depended on the residue 
type. Parameters calculated from unrestrained 
full-matrix refinement models of crambin (Stec 
et al., 1995) and ColE1 repressor of primer (ROP) 
(Vlassi et al., 1998) showed statistically significant 
differences to the EH parameters. In both 
cases, the authors suggested adjustment of 
the EH parameters by taking into account 
parameters determined from atomic resolution 
protein structures. More recently, a correlation 
between the refinement program and the 
r.m.s. deviations from bond-length targets was 
observed (Jaskolski et al., 2007b). In the same study, an 
analysis of ten ultrahigh-resolution structures 
suggested that several EH main-chain target 
values should be adjusted and weighted 
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differently. This suggestion initiated a dispute 
over the adjustment of stereochemical restraints 
and their weights in refinement (Jaskolski et al., 2007b; 
Stec, 2007,Jaskolski et al., 2007a; Tickle, 2007; Karplus et al., 2008).
The concept that the EH parameters 
should be independent of the stereochemical 
environment has also been questioned. The 
backbone torsion angles were found to correlate 
with the backbone geometry in empirical and 
theoretical studies (Karplus, 1996; Jiang et al., 1997; Van 
Alsenoy et al., 1998). A stereochemical analysis of the 
0.87 Å resolution RNase A structure revealed 
significantly different N—Cα—C (τ) angle 
values for α-helices and β-strands (Esposito et al., 
2000).
The number of atomic resolution 
structures has increased enormously since 
the introduction of the EH parameters, so 
that they can now be used to reinvestigate 
geometric protein parameters in a statistically 
meaningful way. The analyses of a large 
number of atomic resolution structures indeed 
confirmed that ideal geometry is more complex 
than the context-independent geometry of the 
EH target values (Berkholz et al., 2009). It has been 
suggested that refinement methods should 
incorporate ‘ideal geometry functions’ that 
define the ‘ideal’ target values as a function 
of φ, ψ (Karplus, 1996; Berkholz et al., 2009; Karplus et al., 2008). 
Tronrud et al. (2010) recently re-refined a 
series of ferredoxin reductase data sets using 
their so-called CDL (Berkholz et al., 2009) library of (φ, 
ψ)-dependent standard values for the protein-
backbone bond lengths and bond angles. The 
CDL target values for angles vary by as much 
as 3.5 Å from the EH values. They found that 
re-refinement did not improve the R factors, 
but did improve the overall geometry.
A geometrical parameter must take into 
account all factors that can influence it and 
great care should be taken to avoid new biases, 
especially when the parameter will be used in 
refinement methods. We studied the backbone 
angle τ (N—Cα—C) in great detail because the 
normality score of this angle is one of the checks 
in the WHAT_CHECK software (Hooft et al., 1996b,d) 
and when calling something ‘not normal’ we 
must know very well what is ‘normal’. We 
started by asking which parameters could 
influence . The residue type, φ, ψ angles 
and refinement software have already been 
mentioned. Looking at elementary biophysical 
aspects of amino acids, we came up with 
several other factors. The β-branched nature 
of Val, Ile and Thr, the possibility that several 
residue types (most prominently Ser, Asp 
and Asn) can form hydrogen bonds to their 
own local backbone, the cooperative nature 
of the hydrogen-bond pattern inside regular 
secondary structures and perhaps even the 
global bending of entire secondary-structure 
elements all seem to be good candidates to 
have an influence on τ.
Our analysis shows that all these factors are 
part of a large and complex set of factors that 
contribute to τ and that investigating their 
individual influences is not straightforward.
Methods
The PDBFINDER database (Hooft et al., 1996a) 
release of 19 January 2010 was used to collect 
administrative information about PDB 
entries, such as the experimental method, 
resolution and refinement software used. The 
WHAT IF web services (Hekkelman et al., 2010) were 
used to determine structure-wide parameters 
such as Ramachandran plot score (Hooft et al., 
1997) and packing quality (Vriend & Sander, 1993) and 
to determine parameters at the residue level 
such as τ, DSSP (Kabsch & Sander, 1983) secondary 
structure and area in the Ramachandran 
plot. A PostgreSQL (v.8.3.10) database was 
constructed to store the administrative and 
geometrical information. The database has 
separate sets of tables for PDB-file-wide data 
and for data at the level of the individual amino 
acid. In cases in which multiple refinement 
programs were mentioned in a PDB entry, 
we used common sense to guess which one 
was used last and thus left the strongest mark 
on the fine geometric detail. For example, 
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we guessed that REFMAC (Murshudov et al., 1997) 
was used in the final stage of refinement if 
both X-PLOR (Brünger, 1992) and REFMAC were 
mentioned. All observed combinations of 
refinement programs, and our decision on 
which one was used last, are described in Table 
S5.1 of the supplementary material.
Molecular graphics were produced with 
YASARA (Krieger & Vriend, 2014).
The PISCES data-set culling server (Wang & 
Dunbrack, 2003) was used to select sequence-unique 
structures.
We used WHAT IF’s internal database (Vriend, 
1990a,b) to calculate Ramachandran plots for 
residues at the beginning of an α-helix and for 
residues in the middle of an α-helix.
The statistical language R (R Core Team, 2016) was 
used to perform statistical tests and to create 
dot plots. All statistical tests in this study were 
two-sided two- sample t-tests performed using 
the R function t.test. The dot plots were created 
using the R package lattice (Sarkar, 2008).
Results
This study was based on a data set comprising 
>50 000 PDB files. These files were selected 
using the criteria listed in Table 5.1. More than 
23 million residues were selected for further 
study. The criteria for using a residue are listed 
in Table 5.2.
Structures were divided into five resolution 
bins: <1.0, 1.0–1.5, 1.5–2.0, 2.0–2.5 and 
≥2.5 Å. Selected residues were grouped by 
residue type and by the three secondary-
structure classes H (α-helix), S (β-strand), and 
C (everything else, which we will refer to from 
here on as ‘loop’). This resulted in initially 5 × 
20 × 3 = 300 groups for which τ was analysed. 
By the term ‘all residues’ we mean 18 of the 20 
canonical amino-acid types, excluding Gly and 
Pro. Similarly, average values are always taken 
over these 18 residue types, unless mentioned 
otherwise.
Because of the enormous number of counts 
in each category, almost all differences are 
Selection parameter Criterion
Experimental method X-ray
PDB-file content >25 amino acids
Refinement software Must be mentioned
DSSP file Must be determinable
Table 5.1. Selection criteria for PDB files.
Table 5.2. Selection criteria for residues.
Selection parameter Criterion
Type Only 20 canonical amino-acid types
DSSP secondary structure H, S or C/T/etc.
Position in structure
Not a C- or N-terminus; not 
next to a terminus;
not next to Gly; not next to Pro
Backbone atoms All four must be present
∠(N—Cα—C) (τ) value Within 10σ of group average
statistically significant, with p- values much 
better than 0.01. For example, the τ angles 
for residues in a β-strand at 1.5–2.0 and 2.0–
2.5 Å resolution are 109.2 ± 3.0° and 109.5 ± 
3.1°, respectively. These numbers are obtained 
from 1.2 million and 1.7 million observations, 
respectively, so that the significance of this 
small angular difference is very high (p << 
10−10). Even in the highest resolution bin, 
which contains the fewest observations, 
many differences are still highly significant. 
For example, the difference between Glu, H 
(111.5°, 817 counts) and Glu, C (111.1°, 504 
counts) is significant, with p = 0.001. On the 
other hand, the difference between Lys, H and 
Lys, C is 0.1° in the highest resolution class 
and owing to the low number of counts in this 
bin this difference is not significant (p = 0.381, 
674 counts). According to Student’s t-test, a 
0.1° difference in the mean of two Gaussians 
both with σ = 2.5° is significant with p = 0.01 
if the number of observations is 8300. For 
our data set, this means that the number of 
observations in all bins apart from that with 
the highest resolution is large enough to 
make differences of 0.1° in the average τ angle 
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significant. All differences 
that we will mention are 
significant at p = 0.01 or 
better, unless specified 
otherwise.
Figure 5.1 shows the 
τ angles as function of 
secondary structure, residue 
type and resolution bin. 
Just like Karplus (1996) and 
Esposito et al. (2000), we 
observed that τ in a β-strand 
is significantly lower than τ 
in an α-helix or loop. We see 
that this is true for all residue 
types in all resolution bins. τ 
is generally slightly higher in 
an α-helix than in a loop.
The τ value in β-strands 
strongly depends on the 
resolution. In the highest 
resolution bin the average 
τ is 109.0 ± 1.9°, while 
it is 110.0 ± 3.3° if the 
resolution is worse than 
2.5 Å. In α- helices τ tends 
to be slightly lower at the 
lowest resolution (111.3 
± 2.5°) than at the highest 
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Figure 5.1. The average τ angle per 
residue type as function of resolution 
(from top to bottom ≥ 2.5, 2.0-2.5, 1.5-
2.0, 1.0-1.5, < 1.0 Å), and secondary 
structure (red, β-sheet; green, loop; 
blue, α-helix). The pink tick marks on 
the horizontal axis indicate the EH 
values (Engh & Huber, 2001) for Gly (G), Pro (P) 
and the 18 other amino-acid types (18).
EH (1999) EH2 (2001) This study
Gly 112.5 ± 2.9 113.1 ± 2.5 113.1 ± 3.4
Pro 111.8 ± 2.5 112.1 ± 2.6 112.8 ± 3.0
Rest 111.2 ± 2.8 111.0 ± 2.7 111.0 ± 3.0
Table 5.3. The average τ with standard 
deviation (°) for Gly, Pro and the rest of 
the residue types (secondary-structure 
and resolution classes pooled).
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resolution (111.4 ± 1.4°), while τ in loops is a 
little lower in the highest resolution bin (111.0 
± 2.4°) than in the other resolution classes 
(111.3 ± 3.4°). The most recent EH value is 
111.0° for all residues (Table 5.3). As expected, 
τ  converges to this value at low resolution, 
especially in β-strands. At low resolution, the 
low amount of X-ray data causes the target 
restraints to be applied with more emphasis 
during refinement than at high resolution.
Several groups have performed analyses on 
culled data sets in order to avoid biases in their 
studies (Laskowski et al., 1993b; Holmes & Tsai, 2004,Jaskolski et al., 
2007b; Berkholz et al., 2009). We performed several data-
selection experiments in which we measured τ 
either after the removal of poor structures or 
after sequence-identity culling.
The same trends were observed when we 
removed the worst 25% of the structures 
(36% of the residues) according to a series of 
WHAT_CHECK validation scores. Structures 
were discarded if more than 5000 amino acids 
were present in the structure, if more than 25% 
of the residues had missing atoms, if more than 
10% of the amino acids had missing backbone 
atoms, if the resolution was worse than 3.5 Å, 
if the Ramachandran Z score was below−5.0, if 
the χ1/χ2 correlation Z score was less than −5.0, 
if the root-mean-square Z scores (r.m.s.Z) for 
bond lengths or bond angles were smaller 
than 0.25 or larger than 1.50, if multi-model 
refinement had been applied to the structure 
or if the packing quality was worse than 
commonly observed for homology models. We 
did not observe significant differences between 
the results obtained from the full data set and 
the reduced data set. This shows that the 
observed τ values are not dictated by a series 
of poor (or old) structures but are the genuine 
result of the refinement process.
The characteristics of τ also were not altered 
when we culled the data set using sequence 
identity. Selection of only proteins that are 
sequence-unique at the 90% or the 25% 
sequence-identity level negatively affected 
the counting statistics, but had no significant 
influence on the observed averages for τ. This 
was to be expected because almost all structures 
in the PDB are refined by a different person 
who might have used a different program 
and might have used different settings. Thus, 
the heterogeneity in unculled data sets is also 
observed in culled data sets.
Gly and Pro systematically have a higher 
τ than other amino acids in all secondary-
structure types at all resolutions. Gly in loops 
has a higher τ than Pro in loops, whereas 
in α- helices this is the other way around. 
The aberrant geometry of Gly and Pro was 
previously noted by Engh & Huber (Engh & Huber, 
1991).
The Cγ atoms of both Ile and Val (Fig. 
5.2) ‘push’ the backbone, which must result 
in a smaller τ. Indeed, these residues typically 
have a much lower τ than other residues. In 
the third β- branched residue Thr, τ is closer 
to the τ of ‘normal’ residue types. Berkholz et 
al. (2009) concluded that “Thr behaves more 
like a general residue because of stabilizing 
side chain–backbone hydrogen bonds”. We 
also observe that the reduced τ value seen for 
the β- branched Val and Ile is not seen for Thr. 
We explicitly looked for hydrogen bonds for 
the Thr Oγ atoms, but could find no trends, 
perhaps because Thr does not easily form 
hydrogen bonds with its own local backbone.
To find out whether the observed τ is 
influenced by the refinement software, we 
analysed τ separately for structures refined 
with CNS [(Brünger et al., 1998); 18 000 PDB files], 
REFMAC (21 000 PDB files), X-PLOR (7000 
PDB files) and SHELXL [(Sheldrick, 2008); 2000 
Figure 5.2. Both Cγ atoms 
in Val push against their 
own backbone. The two 
circles that are centred on 
the Cγ atoms have a radius 
of about 1.8 Å, reflecting 
a commonly used Van der 
Waals radius for these CH3 
groups.
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Figure 5.3. τ as 
function of refinement 
program. (a) CNS, (b) 
REFMAC, (c) X-PLOR, 
(d) SHELXL. The sub-
divisions in resolution 
and secondary struc-
ture are the same as 
in Fig. 5.1. The red and 
blue circles are the 
same in all four panels 
and are the same as in 
Fig. 5.1. The τ angles 
that resulted from 
structures refined 
with the indicated 
refinement software 
are shown in pink 
(sheet), brown (loop), 
and light blue (helix). 
We gave all plots 
the same dynamic 
range on the x axis for 
clarity. Points on the 
vertical axes actually 
fall outside the range 
of the x axis. The true 
values are available 
from the associated 
web pages1.
1. http://swift.cmbi.ru.nl/
gv/whatcheck/HTML/
TAU/
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Figure 5.4. The standard deviation 
on τ per residue type as function of 
secondary structure and resolution. 
Secondary-structure colours and 
resolution bins are the same as in 
Fig. 5.1. The pink tick marks on the 
horizontal axis indicate the EH values 
(Engh & Huber, 2001) for Gly (G), Pro (P), and 
the 18 other amino-acid types (18).
PDB files]. Other refinement programs have not been used 
often enough to allow any meaningful statistics. More than 80% 
of the whole data set (76% of the entries) had been refined with 
CNS or REFMAC.
Some of the early refinement programs have been replaced 
by newer and better ones. We left out most of the old programs 
in our analysis. X-PLOR has been superseded by CNS and is no 
longer used very frequently; it was used to refine only 0.25% of 
all X-ray structures in 2009. 
It was nevertheless included 
because 13.6% of all PDB 
files in our data set had been 
refined with X-PLOR.
In structures refined with 
CNS (Fig. 5.3a) τ is generally 
lower than in structures 
refined with REFMAC 
(Fig. 5.3b). X-PLOR (Fig. 
5.3c) produces even lower 
τ angles, especially in 
β-strands. Compared with 
other programs, SHELXL 
(Fig. 5.3d) shows more 
convergence to the EH 
value of 111.0° towards 
lower resolution.
REFMAC and CNS show 
a consistent increase or 
decrease of τ as a function of 
resolution for many residue 
types. In some cases a 
different pattern is observed 
for specific residue types. 
CNS gives a relatively low 
τ value for Asp in strands, 
while τ for Asn in helices is 
relatively high in structures 
refined with REFMAC. 
Understanding where these 
small anomalies come from 
seems hardly possible at 
present.
The EH parameters not 
only provide refinement 
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target values for τ but also their standard 
deviations. These standard deviations are 
actually equally as important as the mean 
values because they determine the relative 
strengths of the restraints in refinement and 
the allowed deviations in structure validation. 
The observed standard deviations are lowest 
in helices and highest in loops (Fig. 5.4). The 
average standard deviations increase towards 
lower resolution. This trend is observed for 
all secondary structures and all residue types. 
This trend seems to be counterintuitive, 
as a lower standard deviation would be 
expected when the contribution of the 
target restraints becomes more important. 
However, the solution space of X-ray structure 
determination contains many local minima. 
A major cause of the existence of these local 
minima is the use of torsion-angle restraints on 
the side chains; these restraints are available in 
REFMAC and CNS but not in SHELXL. The 
local minima caused by the target restraints are 
probably more prominent at low resolution 
than at high resolution, so that in many low-
resolution cases the local structure will remain 
in a (wrong) local minimum. These ideas are 
supported by the observation that structures 
refined with SHELXL do converge more 
towards the EH values (Fig. 5.3d) and have a 
decreasing standard deviation towards lower 
resolution (Fig.  5.5d). Indeed, none of the 
other programs showed this trend.
The standard deviation is a function of 
resolution for SHELXL and REFMAC (Fig. 
5.5b), although reverse trends are observed 
for these programs. In structures refined 
with CNS (Fig. 5.5a) and X-PLOR (Fig. 
5.5c) the standard deviation on τ is generally 
higher than the average and is much less a 
function of the resolution. A similar impact 
of the refinement program has been observed 
previously (Laskowski et al., 1993b,Jaskolski 
et al., 2007b), although in these studies a 
slightly different set of refinement programs 
was analysed and a rather different analysis 
approach was used. In our study, it is shown 
that in addition to resolution, secondary 
structure and residue type, refinement program 
is also a factor which influences τ.
Residues at the beginning of a secondary-
structure element experience different forces 
than residues in the middle of a secondary-
structure element. For example, the backbone 
of a residue at the first few positions of an 
α-helix only accepts a hydrogen bond, while 
at a position further in the helix the backbone 
both donates and accepts a hydrogen bond. 
Additionally, small deviations from the ideal 
backbone angles will cause much less structure 
disturbance near the ends of secondary-
structure elements than in the middle. To 
investigate whether the cooperative effect 
of the hydrogen-bonding pattern inside 
secondary-structure elements influences τ, 
we compared the overall τ values in α-helices 
and β-strands with residues in the middle of 
an α-helix and in the middle of a β- strand. 
The middle of an α-helix is defined as being 
at least five residues away from either end 
of the helix and the middle of a β-strand is 
defined as being at least two residues away 
from either end of the strand. Averages and 
standard deviations for helices and strands 
are shown in Figs. 5.6a and 5.6b, respectively. 
For both helices and strands τ is lower in the 
middle than at the ends. Inside an α-helix τ is 
more than 0.5° lower than the average τ of all 
α-helical residues. Inside β- strands τ is about 
0.1° lower than the average τ of all residues in 
a β-strand. As the whole data set includes ends 
and middle sections of secondary structures, 
the actual differences between the middle 
sections of secondary structures and their ends 
is actually even larger than these values. The 
standard deviations also are smaller in the 
middle of secondary-structure elements than 
at their ends. Both effects are stronger in α- 
helices than in β-strands.
Most residues have backbone φ, ψ angles 
that fall in the areas of the Ramachandran 
plot commonly called ‘the helix area’ (φ, ψ ≃ 
−60, −40°) or ‘the strand area’ (around φ, ψ ≃ 
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Figure 5.5. The 
standard deviation 
on τ of the four 
refinement programs 
(a) CNS, (b) REFMAC, 
(c) X-PLOR and (d) 
SHELXL. Resolution 
bins and secondary-
structure colouring as 
in Fig. 5.4. The global 
σ, indicated in red 
and blue, is the same 
in all four panels and 
is the same as in Fig. 
5.4.  The σ values 
that resulted from 
structures refined 
with the indicated 
refinement software 
are shown in pink 
(sheet), brown (loop), 
and light blue (helix). 
We gave all plots 
the same dynamic 
range on the x axis for 
clarity. Points on the 
vertical axes actually 
fall outside the range 
of the x axis. The true 
values are available 
from the associated 
web pages.
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−150, 150°). This is also true for residues that 
are in a loop or turn according to DSSP. An 
α- helix, for example, is only observed if a series 
of residues in a row have φ, ψ ≃ −60, −40° and 
if the hydrogen bonds are all of the proper type 
for an α-helix (Oi→Ni+4—H), while several 
types of β-turn consist of a residue with helical 
φ, ψ followed by a residue with strand-like φ, 
ψ. As it seems likely that a residue with helical 
φ, ψ angles in a loop feels different forces from 
a residue in the middle of a helix, we decided 
to compare the τ angles of these two classes. 
The cooperative effect for residues in the 
middle of regular secondary structures will not 
be felt by nonhelical residues in the helix area 
or nonstrand residues in the strand area. The 
absence of co operative forces in loops might 
also explain the observation that the difference 
in τ between Val/Ile and the other 16 non-Gly, 
non-Pro residue types is larger in loops than 
in helices and strands (Fig. 5.1). We defined 
the β-strand area (B) by φ < −4° and ψ > 100°. 
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Figure 5.6. The 
average τ (a) and 
standard deviation 
on τ (b) for residues 
in the middle of a 
secondary-structure 
element compared 
with the average 
values for the whole 
element. Whole-helix 
and whole-strand 
values are in blue and 
red, respectively, and 
are the same as in Figs. 
5.1 and 5.4. Values 
for the middle of the 
secondary-structure 
elements are shown 
in light blue (helix) 
and pink (strand). 
For clarity the same 
x-axis ranges are used 
as in Figs. 5.1 and 5.4. 
Some residues in de 
middle of a helix have 
a standard deviation 
lower than 1.0° in the 
highest resolution 
bin. The blue points 
on the x axis indicate 
those values (top to 
bottom): Val 0.91, Trp 
0.95, Pro 0.95, Ala 
0.94.
The α-helix area (A) was 
defined as −120 < φ < −40° 
and −60 < ψ < 20°. The left-
handed helix area (L) was 
defined as 40 < φ < 120° 
and −20 < ψ < 60°. The 
rest of the Ramachandran 
plot is called U. These 
areas are a little wider than 
the Ramachandran plot 
suggests, especially in the 
corners. This does not cause 
problems because the corners of these areas 
are barely populated anyway. Each residue 
now has a double code: one for its secondary 
structure (H, S, C) and one for its area in the 
Ramachandran plot (A, B, L, U).
Figure 5.7 shows a comparison of τ angles 
in α-helices and β- strands with residues that 
are in a loop according to DSSP but with φ, 
ψ angles in the helix area and the strand area, 
respectively.
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Residues in a loop (according to DSSP) 
with local φ, ψ angles in the helix area of 
the Ramachandran plot (‘C_A’) have a more 
than 1.0° higher τ than residues in an α-helix 
(Fig.  5.7a). τ in the helix area of α-helices 
(‘H_A’) is not different from the superset ‘H’ 
(and only about one in 1000 of these residues 
fall in the left-handed helix area or the strand 
area, as can be seen from the material available 
from the associated web pages). ‘C_A’ has an 
increasingly higher standard deviation than 
‘H’ towards lower resolution. Loops in the β- 
strand area (‘C_B’) have a significantly higher 
τ of about 0.5° than β-strands (‘S’), while 
‘S_B’ is not different from ‘S’ (and less than 
one in ten residues in β- strands fall outside the 
β-strand area). Our results indicate that τ is 
more a function of secondary structure than of 
backbone torsion angles.
The combination of secondary structure 
and the region in  the Ramachandran plot 
influence τ. A two-dimensional Ramachandran 
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Figure 5.7. The ave-
rage τ (a) and standard 
deviation on τ (b) for 
residues in a helix ('H', 
dark blue), in a strand 
('S', red), in a loop with 
φ,ψ angles in the helix 
area ('C_A', light blue) 
and in a loop with φ,ψ 
angles in the strand 
area ('C_B', pink). Dark 
blue and red circles are 
the same as in Figs. 
5.1 and 5.4. We chose 
to use the same x-axis 
range as in other 
figures for clarity. Gly 
and Pro τ angles that 
are higher than 114° 
are shown at 114°. 
The true numbers are 
available from the 
associated web pages.
plot cannot distinguish between, for example, 
residues in α-helices with helical φ, ψ angles 
and residues with helical φ, ψ angles not in 
α-helices, which is a pity as these groups have 
a different τ angle, as shown above. Neither 
can the difference be seen between the ends of 
helices and the middle. To illustrate this, we 
compared the Ramachandran plots of residues 
in the middle and in the N-terminal turn of an 
α-helix to see whether (at least) the difference 
in τ between these groups is reflected in the 
φ, ψ angle distribution. Figure 5.8 shows 
the relevant part of Ramachandran plots for 
residues positioned inside an α-helix (position 
5) and residues in the first turn of an α-helix 
(positions 1–3). The φ, ψ angle distributions 
show much overlap, but it is clear that the 
residues at position 5 in a helix cluster much 
more tightly around the core of the helical 
area.
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Discussion
The angle τ in proteins depends on many factors 
and the single-value paradigm is too simple, 
as has been pointed out previously [see, for 
example, (Karplus et al., 2008; Berkholz et al., 2009; Tronrud et al., 
2010)]. Resolution, secondary structure, residue 
type and refinement program all influence 
τ significantly. Our results also indicate that 
things are actually much more complicated. 
Many bio physical factors (residue type, 
secondary structure, location in the secondary 
structure, accessibility etc.) and computational 
factors (refinement software, target restraints 
(Tronrud et al., 2010), strategy and data resolution) 
influence this angle, although this does not 
always happen in the expected direction. 
The latter, of course, tells us more about our 
understanding of the biophysics of protein 
structures than about either the τ angles 
themselves or the way that they are refined in 
crystallography. We observe, for example, that 
the average τ angle for residues at the buried 
side of an α- helix is on average 0.2° smaller 
than for residues at the solvent-accessible 
side. We also observe that in the middle of 
helices τ tends to be lower than at the ends, 
which may be caused by a combination of the 
cooperativity of the hydrogen bonds and the 
planarity of the peptide bonds. Sometimes the 
exact reasons for an observation are hard to 
understand, while the consequences for future 
activities are clear.
Many more parameters can be thought 
of that influence τ. We looked at the 
intramolecular contacts made by the residues, 
including in some cases the hydrogen bonds, 
but did not find statistically significant effects 
on τ. Tryptophan is very large and hydrophobic 
and thus normally makes many contacts 
that push and pull it into its conformation. 
The τ angle of tryptophan does not differ 
significantly from those of other residues, but 
it has a relatively high standard deviation. Asn 
and Ser, and to a lesser extent Asp, are known 
to form hydrogen bonds to the local backbone. 
Obviously, a hydrogen bond to the local 
backbone exerts a force on that backbone that 
will influence the τ angle. Asp often has a much 
lower τ than most other residues in β-strands, 
and Ser and particularly Asn have a high τ in 
helices. Structures refined with REFMAC show 
a rather high τ angle for Asn in all secondary 
structures and this thus also increases the τ 
angles observed for Asn in general. Inspection 
of the REFMAC dictionary revealed that the 
value given for Asn is 112.2 ± 2.8°. This differs 
significantly from the EH value of 111.2 ± 
2.8° and suggests a typographical error in the 
REFMAC dictionary.
The leptokurtic τ distributions for residues 
in helices and loops, especially at low 
resolution, indicate that τ values are pulled 
towards the EH values during refinement. The 
τ angles in β-strands become closer to the EH 
value in lower resolution structures. However, 
these τ distributions are less leptokurtic than 
the corresponding ones in helices and loops, 
which is probably the result of two partly 
overlapping distributions stemming from the 
different hydrogen-bond patterns in parallel 
and antiparallel sheets.
We will need many more structures solved 
at better than 1.0 Å resolution that are refined 
without or with minimal use of refinement 
target constraints to find significantly distinct 
(a) (b)
Figure 5.8. Ramachandran plots of the helical area for (a) 
residues five positions away from both ends of helices that 
are nine residues long or longer and (b) residues at one of the 
first three positions of an α-helix. The contour lines are for the 
18 normal residues in a helix (purple) and in a loop (green), 
contouring at 50-90% of what is observed in the WHAT IF 
database of 500 sequence-unique, high-quality X-ray structures 
solved at 1.4 Å resolution or better (Hooft et al., 1997).
70
5
Chapter 5|
subgroups related to hydrogen-bonding 
differences, systematic van der Waals contacts 
or β-sheet arrangements (parallel versus 
antiparallel or edge strand versus central 
strand). The effects of β-sheet curvature on the 
τ angles still need to be studied.
Even with the enormous volume of data 
available today in the PDB, many effects 
cannot yet be determined with sufficient 
significance. Residues will have different EH 
parameters when they sit adjacent to a glycine, 
a proline or a cis-peptide to when they sit next 
to one of the other 18 residues in the trans 
conformation.
The use of (new) EH parameters should, 
of course, be different for different refinement 
programs. Programs that combine X-ray 
data with energy calculations (e.g. X-PLOR 
and CNS) should not, in principle, use a 
large number of different τ angles because all 
structure-dependent effects will already be 
introduced by the energy terms. Programs such 
as REFMAC and SHELXL (at medium and 
low resolution), for example, should use more 
differentiated τ angles. Care should be taken 
to not introduce any effects twice. The lower 
τ angles observed for valine and isoleucine are 
mainly caused by 1–4 repulsive interactions 
between the backbone and the side-chain γ 
atoms. Careful calibration will be required 
if such repulsive interactions are already an 
integral part of the software. Programs such 
as CNS and X-PLOR combine the X- ray data 
terms with molecular-dynamics force-field 
terms in the simulated-annealing stage of the 
refinement process. It is noteworthy that they 
lead to τ angles that are closer to the EH values 
at low resolution than at high resolution. 
CNS and X- PLOR use reduced van der Waals 
(or repulsive) radii for 1– 4 interactions. In 
light of this, it is gratifying to see that the 
actually observed average τ angles for the 
β-branched residues are rather independent of 
the refinement programs used. It might be a 
prudent step to lower the restraints on the τ 
angles (i.e. use a large standard deviation) in 
the refinement software at present in order to 
bridge the time until we know how to include 
differentiated τ-angle restraints in refinement 
software. Generally, it might be a suggestion 
to completely re- evaluate the force fields used 
in molecular-dynamics-based refinement 
software, as these have improved significantly 
over the last decade.
Hydrogen bonds are shorter on the concave 
side of bent helices than on the convex side. In 
parallel, τ angles on the buried side of helices 
are smaller than τ angles on the accessible side. 
We do not know what is caused by what. Are 
the shorter hydrogen bonds pulling harder at 
the backbone or is the reduced space on the 
concave side easiest compensated by τ-angle 
shrinking? These questions are not so relevant 
for structure validation, but are very important 
for refinement software that uses molecular-
dynamics energy terms.
The first experiments with differentiated EH 
parameters by Tronrud et al. (2010) suggest 
that many experiments along these lines will 
follow. The so-called CDL restraints used by 
Tronrud are a large step in the right direction, 
but they will be improved many times in the 
years to come, probably first by making the 
parameters secondary structure-dependent 
and (φ, ψ)-dependent rather than just (φ, ψ)-
dependent. As long as all structural biologists 
keep faithfully depositing their experimental 
data, projects such as PDB_REDO  (Joosten et al., 
2009a) will re-refine the structures when, in due 
time, it becomes clear which is the ideal new 
EH target set to use.
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PDB File Interpretation PDB File Interpretation
CNS + ARP CNS REFMAC + X-PLOR REFMAC
CNS + NUCLSQ CNS RESTRAIN + ATOM RESTRAIN
CNS + REFMAC REFMAC SHELXL + CNS SHELXL
CNS + X-PLOR CNS SHELXL + NUCLSQ SHELXL
EREF + PROLSQ PROLSQ SHELXL + X-PLOR SHELXL
NUCLIN + NUCLSQ NUCLSQ TNT + NUCLSQ TNT
PROFFT + NUCLSQ NUCLSQ TNT + PROLSQ TNT
PROLSQ +AMORE PROLSQ TNT + X-PLOR TNT
PROLSQ + ATOM PROLSQ X-PLOR + AMORE X-PLOR
PROLSQ + EREF PROLSQ X-PLOR + ARP X-PLOR
PROLSQ + X-PLOR X-PLOR X-PLOR + FRODO X-PLOR
PROTIN + NUCLSQ NUCLSQ X-PLOR + NCS CNS
REFMAC + AMORE REFMAC X-PLOR + NUCLSQ X-PLOR
REFMAC + ARP REFMAC X-PLOR + QUANTA X-PLOR
REFMAC + NCS REFMAC X-PLOR + RESTRAIN X-PLOR
REFMAC + NUCLSQ REFMAC
Supplementary material
Table S5.1. List of refinement program combinations that were found in PDB entries and our decision on which one was used last.
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Many crystal structures in the Protein Data Bank contain zinc ions in a geometrically distorted tetrahedral complex with four Cys and/or His ligands. A method is presented to automatically validate and correct 
these zinc complexes. Analysis of corrected zinc complexes showed that average 
Zn–Cys distances and Cys–Zn–Cys angles are a function of the number of cysteines 
and histidines involved. These observed trends can be used to develop more 
context-sensitive targets for model validation and refinement.
Introduction
Many efforts have been directed towards 
improving the identification of ion types in 
macromolecular structures [e.g. (Sodhi et al., 2004; Hsin 
et al., 2008; Andreini et al., 2009, 2013; Hemavathi et al., 2010; Brylinski 
& Skolnick, 2011; Echols et al., 2014; Zheng et al., 2014; He et al., 2015; 
Morshed et al., 2015)]. The geometry of ion binding 
sites often needs to be improved too. Stronger 
even, the bond valence method (Brown & Altermatt, 
1985; Brese & O’Keeffe, 1991; Brown, 2009) that is generally 
used to identify ion types (Hooft et al., 1996d; Nayal & Di 
Cera, 1996; Müller et al., 2003; Zheng et al., 2014) only works well 
if the modelled geometry of the binding site 
accurately represents the crystallographic data.
Zinc ions (Zn2+) are the most common 
transition metal ions in protein crystal 
structures in the Protein Data Bank (PDB) 
(Berman et al., 2007; Gutmanas et al., 2014) and the second 
most common metal ions overall after 
magnesium. Zn2+ ions can play a more 
catalytic role or a more structural role in 
proteins [e.g. (Alberts et al., 1998; Lee & Lim, 2008; Sousa et 
al., 2009; Laitaoja et al., 2013)], but they are sometimes 
also found to have non-biological functions 
as crystal packing mediators. Structural zinc 
sites typically consist of four Cys and/or His 
ligands [e.g. (Torrance et al., 2008; Laitaoja et al., 2013; Daniel & 
Farrell, 2014)] that coordinate Zn2+ in a tetrahedral 
fashion [e.g. (Simonson & Calimet, 2002; Dudev & Lim, 2003; 
Lee & Lim, 2008; Torrance et al., 2008)]. The zinc finger is 
the most commonly observed zinc-binding 
motif in the PDB (Krishna, 2003). It is present in 
protein domains with diverse functions such 
as binding DNA, RNA, proteins, or lipids 
(Laity et al., 2001). Cysteines that coordinate Zn2+ 
tend to be deprotonated (Dudev & Lim, 2002; Simonson & 
Calimet, 2002) and often are stabilized by hydrogen 
bonds with backbone HN protons (Maynard & Covell, 
2001). In some protein families anionic zinc 
environments are stabilized by the positive 
charges of arginine and lysine (Maynard & Covell, 2001).
Several studies have reported on Zn2+–S 
and Zn2+–N distances observed in crystal 
structures in the PDB or Cambridge Structural 
Database (CSD) (Groom & Allen, 2014). These studies, 
summarized in supplementary Table S6.1, 
indicate that Zn2+ coordination geometries are 
rather complex and depend, for example, on 
the combination of ligand types [e.g. (Simonson 
& Calimet, 2002; Daniel & Farrell, 2014)]. Stereochemical 
restraint targets that are commonly used to 
refine Zn2+ complexes, though, still tend to be 
simple and undifferentiated.
We recently reported on inaccuracies and 
severely distorted geometries observed in 
crystallographic structure models in the PDB 
around tetrahedral complexes in which Zn2+ is 
coordinated by four cysteines (Evers et al., 2015). The 
impossible chemistry that one could naively 
derive from such distorted complexes was 
described. Although the article was published 
in jest on April 1st, the underlying problem we 
described was rather serious. Many Zn2+ sites 
in the PDB poorly describe the experimental 
data and show structural features that are not 
supported by known chemistry. This can lead 
to misinterpretation of the protein and wrong 
answers to biological questions (Touw et al., 2016). 
It is easy to accidentally introduce errors 
during model building and refinement of zinc 
sites because the use of geometric restraints 
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between Zn2+ and the coordinating amino 
acids is not yet the default in today's refinement 
programs, which, of course, is especially a 
problem at low resolution. The PDB_REDO 
databank (Joosten & Vriend, 2007) contained several 
entries in which distorted Zn2+ sites were 
accidentally introduced. Automatic detection 
of disulfide bridges can draw two Zn2+-binding 
cysteine side chains into a cysteine bridge, 
leading to the aforementioned impossible 
chemistry. There is currently no systematic 
validation of distorted metal binding sites in 
the PDB validation pipeline (Read et al., 2011; Gore et 
al., 2012) which leaves distorted Zn2+ sites mostly 
undetected.
We present a method to validate Zn2+ 
complexed by cysteine and histidine ligands. 
The validation is based on parameters that 
characterize the geometry of zinc complexes 
and is available as WHAT IF (Vriend, 1990a) web 
server and through WHAT_CHECK (Hooft et 
al., 1996d). A method to improve the geometry 
of zinc complexes by re-refinement, and 
side-chain rebuilding if required, has been 
implemented in PDB_REDO (Joosten et al., 2009a) 
and was applied to all PDB entries with Zinc–
CysxHisy sites. 
In the resulting structure models, it was 
observed that the ideal ion-ligand distance is 
not a constant, but rather a function of at least 
the chemical identity of the other ligands. The 
ideal Zn2+—Sγ distance, for example, shortens 
when more of the ligands are histidines (and 
thus fewer are cysteines). The ideal Sγ—
Zn2+—Sγ angle widens when more cysteines 
are replaced by histidine. These observations 
provide a starting point from which more 
sophisticated, context-specific, geometric 
restraints for Zn2+ coordination sites can be 
developed.
Methods
Geometric restraint generation
The present study considered Cys or His 
side chains coordinating zinc in a tetrahedral 
fashion. These zinc binding sites will be 
referred to as ZnCysxHisy with x and y in {0, 
1, 2, 3, 4} and x + y = 4. The ligand atoms are 
Sγ for Cys and either Nδ1 or Nε2 for His. For 
brevity, the latter two will be referred to as Nδ 
or Nε, respectively. The Zn2+ double positive 
charge will be implicit in notations such as 
Zn—Nε. With tetrahedral complexes we mean 
the collection of both tetrahedral and nearly 
tetrahedral complexes.
An automated method to properly 
refine metal complexes ideally includes the 
identification of the ion, the ligands, and 
the preferred coordination number and 
geometric arrangement. The program Zen 
was created to perform all tasks necessary for 
preparing refinement scripts and parameters. 
Zen identifies putative ZnCysxHisy complexes 
in PDB entries and assumes that the ion is 
indeed Zn and that the ligands are arranged 
tetrahedrally. The reader is referred to 
WHAT_CHECK (Hooft et al., 1996d) or 
CheckMyMetal (Zheng et al., 2014) for validating the 
identity of ions when the ligands are not Sγ, 
Nδ, or Nε atoms.
Zen searches around Zn for Sγ atoms within 
4.8 Å and Nδ/Nε atoms within 3.8 Å. Dixon’s 
Q-test (Dean & Dixon, 1951) is performed on the Zn–
ligand distances when five or more potential 
coordinating atoms are found. If four ligands 
are left after outlier rejection, they are assumed 
to constitute a ZnCysxHisy site. Complexes are 
discarded if i) a different type of ligand (neither 
Cys Sγ nor His Nδ/Nε) is found close to Zn (2.9 
Å or closer) and ii) a Sγ/Nδ/Nε ligand is found 
3.25 Å or further away from Zn. In order to 
prevent the detection of octahedral Zn sites, 
such as the Zn site observed in polyketide 
cyclase RemF [PDB 3ht2 (Silvennoinen et al., 2009)], 
ZnHis4 complexes are also discarded if only 
requirement i) is satisfied. Additionally, all sites 
with at least three His ligands require all ligand 
atoms to be present within 3.0 Å from Zn. 
Clusters of tetrahedral Zn complexes in which 
individual Sγ atoms coordinate more than one 
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Zn ion are also detected by Zen. Many distance 
cutoffs were optimised manually.
 The fact that many PDB file headers 
have missing or spurious LINK records for 
distorted sites as well as SSBOND records 
between cysteines coordinating a zinc ion (Evers 
et al., 2015) poses a problem for the refinement 
program REFMAC (Murshudov et al., 2011) which is 
used for PDB_REDO. Incorrect annotation 
of the covalent and metal coordination 
bonds causes REFMAC to generate incorrect 
geometry restraints. Therefore, all SSBOND 
and LINK records involving ZnCysxHisy 
complexes are corrected by Zen, resulting in 
so-called Cys-cleaned PDB files.
Based on the re-annotated LINK records, 
REFMAC imposes distance and angle restraints 
during refinement. The distance restraint 
targets presently are 2.340 ± 0.020 Å for Zn—
Sγ, 2.057 ± 0.064 Å for Zn—Nδ and 2.058 ± 
0.073 Å for Zn—Nε. Zn—Sγ—Cβ angles are 
restrained to 109.000 ± 3.000°. Zn—Nδ—Cγ, 
Zn—Nδ—Cε, Zn—Nε—Cδ, and Zn—Nε—
Cε angles are restrained to 125.350 ± 3.000°. 
The Zn–Cys distance and angle targets were 
already present in the REFMAC dictionary 
(Vagin et al., 2004). The Zn-His distance targets 
were obtained from tetrahedral complexes in 
the MESPEUS database (Hsin et al., 2008) solved at 
1.6 Å or better and added to the REFMAC 
refinement dictionary. The associated Zn—
Nδ—Cγ, Zn—Nδ—Cε, Zn—Nε—Cδ, and 
Zn—Nε—Cε angle targets were set to be 
the same as the values for the Hε2 and Hδ1 
hydrogen atoms.
The REFMAC dictionary currently does not 
provide a mechanism to add angle restraints 
that involve three separate compounds (i.e. the 
Zn and two coordinating residues). Therefore, 
the [ligand 1]–Zn–[ligand 2] angles cannot 
be restrained automatically. The absence of 
these restraints allows Zn sites to depart from 
tetrahedral geometry without severely violating 
the other geometric restraints. Additionally, 
without these restraints it is difficult to 
recover, by refinement only, from the distorted 
geometries we described earlier (Evers et al., 2015). Zen 
therefore creates specific angle restraints that 
can be applied in refinement using REFMAC’s 
external restraints mechanism (Nicholls et al., 2012). 
The target for Sγ—Zn—Sγ angles was set to the 
ideal tetrahedral value of 109.5 ± 3.0°. Angles 
involving histidine are not restrained because 
the position of histidine side chains in Zn sites 
is much better defined than those of cysteine 
side chains because of the size and rigidity of 
the imidazole group.
Updates to PDB_REDO
The PDB_REDO pipeline (Joosten et al., 2009a) 
was extended to include the refinement of 
ZnCys xHisy complexes. In the initial stage, Zen 
is run on all input models that contain Zn ions. 
The PDB_REDO program extractor (Joosten et al., 
2009b) was updated to add Zn ions to the TLS 
(Schomaker & Trueblood, 1968) group of the coordinating 
residues, provided they are all part of the same 
macromolecular chain. This applies only to 
the TLS group selections created by extractor; 
TLS group selections provided by the user or 
extracted from the header of the PDB file are 
purposely left unchanged. During the initial 
re-refinement with REFMAC, any external 
restraints generated by Zen are applied with 
default weights relative to other geometric 
restraints. Automated disulfide bridge 
detection in REFMAC is switched off. 
Re-refinement and subsequent model 
rebuilding (Joosten et al., 2011b) can change the 
structure model to such an extent that 
previously undetected ZnCysxHisy complexes 
are identified. If this is the case, Zen updates 
the model annotation and external restraints 
and the second round of model refinement is 
extended till convergence.
The updated PDB_REDO pipeline was 
used to replace all entries of the PDB_
REDO databank (Joosten & Vriend, 2007) containing 
ZnCysxHisy sites.
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ZnCysxHisy geometry validation
Features characterizing the ZnCysxHisy 
coordination complexes were determined 
using WHAT IF (Vriend, 1990a). These features 
included bond distances, angles, torsion angles, 
point charge distributions, the presence and 
apparent multiplicity of cysteine bridges, Zn 
tetrahedral off-centeredness and parameters 
such as occupancies and B-factors. His side 
chain flips (Hooft et al., 1996c) and crystallographic 
symmetry (Hooft et al., 1994) were taken into account. 
The sample mean and standard deviation of 
each feature were determined as a function of 
the ligand composition. In order to prevent 
bias from different refinement strategies, 
these statistics were not derived from original 
sites but from sites that had been re-refined 
with PDB_REDO using the aforementioned 
undifferentiated restraint targets. Z scores were 
calculated for the distances, angles, and Zn 
position in the tetrahedron because manual 
inspection showed these features were most 
indicative of the quality of the ZnCysxHisy 
complex. A combined quality metric was 
constructed by calculating the root-mean-
square Z score (r.m.s.Z). The optimal value of 
an r.m.s.Z statistic varies between 0.0 at low 
resolution and 1.0 at high resolution (Tickle, 2007).
Results
The geometric quality of 
ZnCysxHisy complexes is improved
PDB_REDO optimisation of 2635 PDB entries 
containing 6955 tetrahedral ZnCysxHisy 
complexes resulted in nearly all cases in a higher 
overall tetrahedral coordination geometry 
quality (Fig. 6.1). The average r.m.s.Z that was 
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Figure 6.1. r.m.s.Z for the five possible ZnCysxHisy site types. The optimal value of r.m.s.Z depends on the data-to-parameter ratio in 
model refinement and varies between 0.0 and 1.0 (Tickle, 2007). The scales on the two axes are different; black lines indicate the situation 
where r.m.s.Z is the same for complexes in the PDB and in PDB_REDO. Ligand atoms and site counts are indicated in the legend.
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1.70 ± 1.23 before optimisation was reduced 
to 0.89 ± 0.29. The biggest decrease in r.m.s.Z 
was 12.45 and r.m.s.Z at most increased by 
1.45. For 5162 complexes the initial r.m.s.Z 
was greater than 1.00. For this subset, r.m.s.Z 
improved on average by 1.06 ± 1.21. For only 
37 complexes r.m.s.Z was below 1.00 (0.93 ± 
0.07) in PDB and above 1.00 in PDB_REDO 
(1.10 ± 0.08).
Generally, the individual Z-score 
components of r.m.s.Z improved too. This 
is exemplified for the features capturing the 
geometric quality of ZnCys3His1 complexes 
in Fig. 6.2. The parameters that were directly 
targeted because they had been restrained (e.g. 
Zn—Sγ, Zn—Nδ, and Zn—Nε distances and 
Sγ—Zn—Sγ angles) or Cys-cleaned (Sγ—Sγ 
distances) on average improved most. Notably, 
the Zn—Sγ Z-score distribution is essentially 
symmetric in the PDB, i.e. Zn—Sγ distances are 
either too long or too short, whereas Zn—Nδ 
or Zn—Nε distances in the PDB are typically 
too long. This may be caused by the absence of 
a standard target in the restraint dictionaries, 
but, for structure models refined by REFMAC, 
also by the presence of ‘riding’ hydrogens on 
the Nδ or Nε atoms during refinement. These 
hydrogens push the Zn ions and the histidine 
nitrogens apart. The changes in geometric 
parameters for the other four ZnCysxHisy 
complexes are shown in Supplementary Figure 
S6.1 and follow similar patterns.
Visual inspection showed that a lower 
r.m.s.Z corresponds to more plausible 
geometry and that most of the severely 
distorted ZnCysxHisy complexes improved 
dramatically upon re-refinement. Special, 
complicated cases like the Cys3–Zn–Cys1–
Zn–Cys2His1 complex in the UBR box of E3 
ubiquitin ligase [PDB 3nih (Choi et al., 2010)] and 
the ZnCys4 site between the two Get3 chains 
in the Get3-Get1 complex [PDB 3sjb (Stefer et al., 
2011)] were handled correctly by our method. 
Figure 6.3 shows several examples of complex 
problems that were solved satisfactorily.
Sγ Sγ Sγ Nδ
Sγ Sγ Sγ Nε
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Z
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Sγ-Zn-Nδ
Sγ-Zn-Sγ
Sγ-Nδ
Sγ-Sγ
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Zn-Nε
Zn-Sγ
Zn position
Figure 6.2. Box-and-whisker plots of the Z scores characterizing 
ZnCys3His1 complexes in original PDB (white) and PDB_REDO 
(grey) structure models. The whiskers extend to the nearest 
value that is within 1.5 times the inter-quartile range; outliers 
are marked as dots. The Z score for 'Zn position' indicates Zn 
tetrahedral off-centeredness. 94 outliers with a Z score smaller 
than -15 or larger than 15 are not shown for clarity. All of these 
outliers come from PDB structure models.
ZnCysxHisy refinement targets are context-dependent
The Zn—Sγ distance and Sγ—Zn—Sγ angles 
were calculated as a function of ligand identity 
for the set of re-refined complexes from 
which 5σ outliers were iteratively removed. 
Figure 6.4 shows that the refined distances 
and angles are different from the refinement 
target and that the refined distances and angles 
are not constant but a function of the ligand 
composition of the ZnCysxHisy complex.
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(a)
(b)
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2.43
2.29
1.91
2.20
2.01
C252
R251
Y34
4001
4003
C53
K10G12
C305
C302
PDB PDB_REDO Figure 6.3. ZnCysxHisy complexes before (left) and after 
(right) PDB_REDO. Side chains are coloured by atom type; grey 
spheres are Zn. Figures were prepared with CCP4mg (McNicholas et 
al., 2011). Electron density maps were omitted for clarity and are 
available from the PDB_REDO databank. (a) Zn300, chain A, of 
8-oxoguanine DNA glycosylase MutM [PDB 1l1z; 1.7 Å (Fromme & 
Verdine, 2002)]. Cys252 points away from the Zn ion. The LINK between 
Cys252 and Zn was not annotated in the PDB model. The ZnCys4 
site was correctly identified by Zen. In the PDB_REDO model the 
Cys252 Sγ has moved 2.8 Å. Arg251 has also been refitted to a 
more plausible conformation. (b) Zn203, chain I, of the RNA 
polymerase II - Transcription Factor IIB complex [PDB 1r5u; 4.5 Å 
(Bushnell et al., 2004)]. Zn203 is modelled far away from the centre of 
the four Sγ ligands. The presence of a LINK record between Zn and 
Cδ2 of Tyr34 and the absence of three Sγ—Zn LINK records in the 
PDB file precludes complex formation in a standard refinement. 
Correction of the Zn site required the Zn to move more than 5 Å. 
(c) Zn313, chain B, of Aspartate transcarbamoylase [PDB 3d7s; 
2.8 Å (Stieglitz et al., 2009)]. Several types of cysteine bridge problems 
exist in the PDB (Evers et al., 2015), and the four cysteines next to Zn313 
form an extreme example. Only three of the four necessary LINK 
records are specified in the original PDB file and at the same 
time superfluous SSBOND records are present for three of the 
six bridges shown. (d) Zn4001, chain D, of the DDB1-Cul4A-
Rbx1-SV5V complex [PDB 2hye; 3.1 Å (Angers et al., 2006)]. The three 
cysteines and the histidine are not arranged tetrahedrally around 
Zn4001 and the three cysteines appear to form one big cysteine 
bridge. The Zn4003 site is located close to the Zn4001 site and 
has a tetrahedral conformation. In the PDB entry the distance 
from the Cβ atom of Cys53 to Zn4001 is 4.38 Å whereas the 
distance to Zn4003 is 4.20 Å. It was detected correctly that Cys53 
only coordinates Zn4003. (e) Zn61, chain B, of the Box H/ACA 
ribonucleoprotein protein particle – RNA complex [PDB 3lwq; 2.7 
Å (Zhou et al., 2010)]. Four cysteines are tightly connected near the Zn. 
In the PDB entry SSBOND records are present for these cysteines 
while LINK records for the Zn are found to the backbone N atoms 
of Gly12 and Lys10. Normal ZnCys4 geometry in the PDB_REDO 
model is obtained after moving the ion by 3.5 Å. (f) Zn6, chain C, 
of the Simian Virus 40 large T-antigen – human p53 complex [PDB 
2h1l; 3.2 Å (Lilyestrom et al., 2006)]. For 12 of the 24 chains in the PDB 
model SSBOND records are specified between Cys302 and Cys305, 
while these two residues actually coordinate the Zn together with 
two histidines. (g) Zn4, chain B, of the catalytic domain of human 
AMSH [PDB 3rzu; 2.5 Å (Davies et al., 2011)]. The coordination distances 
are too large. The distances in the PDB_REDO model were closer 
to expected values.
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Figure 6.4. Zn—Sγ distance (top) and Sγ—Zn—Sγ angle 
(bottom) distributions as a function of the number of cysteines 
and histidines in ZnCysxHisy complexes determined at 1.6 Å 
resolution or better. The contours of the violin plots are kernel 
density estimates and the boxplots are shown as in Fig. 6.2. The 
light grey background areas show one standard deviation around 
the refinement targets for the Zn—Sγ distance (2.340 ± 0.020 Å) 
and the Sγ—Zn—Sγ angle (109.5 ± 3.0°). A significant difference 
was observed between the types of ZnCysxHisy complexes [one-
way ANOVA with a Welch correction for non-homogeneity (Welch, 
1951)] for both the average Zn-Sγ distance (F=51.7, p=1.7x10-14) 
and the Sγ—Zn—Sγ angle (F = 129.4, p << 10-14). When Zn 
is coordinated by Nδ in ZnCys3His1 complexes, the S
γ—Zn—Sγ 
angle distribution is somewhat bimodal and partly depends on 
the rotameric state and backbone conformation of the cysteines.
Discussion
Automated restraint generation
The feasibility of fully automatically 
generating refinement restraints for metal 
sites depends on the quality of the structure 
model and the prior knowledge of the 
correct geometry. Here we show that effective 
restraints can be generated for Zn sites with 
predicted tetrahedral geometry, even when the 
input model is severely distorted. However, 
if not all Zn ligands are modelled, the site 
will remain undetected and no restraints are 
generated. For catalytic Zn sites it is difficult 
to predict the geometry and restraints must 
be made manually. Alternatively, refinement 
can be performed using computationally 
more expensive methods based on quantum 
mechanics (QM), such as the semi-empirical 
QM refinement in Phenix/DivCon (Borbulevych 
et al., 2014). Metal sites may be refined without 
restraints when crystallographic data are of 
sufficient quality and resolution.
The methods developed here can, when 
enough examples are available in the PDB, 
be extended to other ligand compositions of 
tetrahedral zinc complexes, e.g. Zn sites that 
involve water, but also to other geometries and 
other ion types, such as octahedral magnesium 
sites that are often observed in nucleic acid 
structures.
Validation using electron density
Improvement of a crystallographic structure 
model generally leads to an improvement 
of the corresponding electron density map 
(EDM). The real-space correlation coefficient 
(RSCC) measures the fit of the atoms to the 
EDM, but correlates strongly with metrics of 
model precision such as the atomic B-factors 
(Tickle, 2012). Particularly at low resolution the 
RSCC metric becomes less reliable. Tickle 
(2012) suggested the real-space difference 
density Z score (RSZD) as an EDM metric 
that only correlates with model accuracy and 
not with model precision. We did not observe 
a clear correlation between the geometric 
quality of ZnCysxHisy complexes and their fit 
to the EDM measured by either the RSCC or 
RSZD. It was observed that a complex can 
have reasonable EDM metrics even when it is 
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very bad in terms of geometry, and vice versa. 
In our hands these EDM metrics therefore 
were not very helpful in determining whether 
re-refinement of ZnCysxHisy complexes 
was successful or not. We observed a slight 
improvement in the average RSCC for all sites 
(0.959 ± 0.042 to 0.974 ± 0.033), but this 
may be a general result of the PDB_REDO 
pipeline rather than specifically of the Zinc-
site improvement methods. The validation was 
therefore solely based on geometric parameters. 
We did observe in many cases, though, that 
re-refinement with inclusion of anisotropy for 
just the Zn ions led to visually more pleasing 
EDMs with less difference density around the 
Zn (see Fig. 6.5 for an example). Anisotropic 
atomic displacement can be partially 
modelled using the TLS formalism and this 
is currently implemented in PDB_REDO. Zn 
and other heavy atoms may be refined with 
anisotropic B-factors systematically in a future 
implementation, provided that the model 
refinement data-to-parameter ratio is not 
severely affected. This implementation may 
also need to include and optimise sphericity 
restraints in order to balance residual difference 
density and B-factor anisotropy.
(a) (b)
Figure 6.5. Zn1702, chain B, of jumonji H3K27 demethylase 
[PDB 4eyu (Kruidenier et al., 2012)]. mFo-DFc difference electron density 
maps after a PDB_REDO run with (a) an isotropic B-factor for Zn2+ 
(grey sphere) or (b) an anisotropic B-factor for Zn2+ (grey thermal 
ellipsoid). The maps (+, green mesh; -, red mesh) have been 
contoured at 3σ, have been rendered with a grid size of 0.77 Å, 
and for clarity are shown only in the vicinity of the Zn. The largest 
atomic displacement between any atom in this ZnCys4 complex 
between (a) and (b) is 0.16 Å.
Context-specific refinement 
targets
The original Engh & Huber parameters (Engh 
& Huber, 1991, 2001) are targets for bond lengths 
and angles and are averages for all conceivable 
situations. The very large number of high 
resolution structures available from today's 
PDB allows for fine-detailing of these 
parameters, as was, for example, shown in a 
study on the angle τ, the N—Cα—C angle 
(Touw & Vriend, 2010). This large data volume allows 
us to start determining better parameters for 
restraints for distances and angles in ZnCysxHisy 
complexes. Clearly, these parameters are 
also determined by the local environment. 
For example, the Zn—Sγ distance is shorter 
when the number of coordinating cysteines 
is smaller. QM calculations have suggested 
that this trend partly correlates with a smaller 
electrostatic repulsion between the thiolate 
sulfur atoms and that steric and stabilizing 
electrostatic interactions from the secondary 
coordination sphere have an effect on zinc site 
geometry (Simonson & Calimet, 2002; Daniel & Farrell, 2014). 
These findings imply that further fine-detailing 
will in the future be possible as function of the 
presence of nearby positive or negative groups. 
We indeed observe an excess of positively 
charged amino acids close to many, but not 
all ZnCysxHisy complexes. Counting statistics 
presently still preclude taking such details 
into account. Only when more data become 
available, especially at high resolution, will we 
be able to express target values as a function 
of more environment factors and determine 
which environment factors influence the target 
values most. The Zn—Sγ, Sγ—Zn—Sγ, and 
Zn—N parameters for tetrahedral ZnCysxHisy 
complexes we observe in the PDB_REDO 
databank are listed in Table 6.1.
There are not yet enough data to 
discriminate between Nδ and Nε and there 
is limited data available for ZnCys1His3 and 
ZnHis4 sites. Nevertheless, the values from 
Table 6.1 provide a starting point for making 
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Zn—Sγ (Å) Sγ—Zn—Sγ (°) Zn—N (Å) ZnCysxHisy
2.331 ± 0.029 (991) 109.44 ± 5.38 (1488) n/a Cys4
2.318 ± 0.026 (849) 112.21 ± 3.99 (849) 2.086 ± 0.039 (281) Cys3His1
2.305 ± 0.033 (66) 116.98 ± 4.49 (33) 2.055 ± 0.033 (65) Cys2His2
2.291 ± 0.021 (11) n/a 2.013 ± 0.030 (33) Cys1His3
n/a n/a 2.187 ± 0.067 (16) His4
Table 6.1. Suggested refinement targets for the five possible ZnCysxHisy complex types. The targets have been derived from 
crystallographic structures determined at a resolution of 1.6 Å or better and are listed as mean ± standard deviation. Numbers in 
brackets indicate the number of observations.
more sophisticated sets of restraints and the 
growth of the PDB and the PDB_REDO 
databank will provide more reliable statistics 
over time. 
Extracting restraints from the PDB_REDO 
databank and subsequently applying them 
in the PDB_REDO pipeline introduces 
circularity. This important practical issue can 
be avoided by only applying these restraints 
to low resolution structure models (where the 
restraints are most needed) and not to the high 
resolution structure models that will be used to 
derive new refinement targets. That way, future 
datasets will remain unbiased. Restraint targets 
ideally are derived from unrestrained Zn 
sites, but the number of available ZnCysxHisy 
complexes solved at atomic resolution will 
for some time to come preclude extraction 
of reliable targets from unrestrained structure 
models.
Conclusion
There are not yet enough data to discriminate 
between Nδ and Nε and there is limited data 
available for ZnCys1His3 and ZnHis4 sites. 
Nevertheless, the values from Table 6.1 provide 
a starting point for making more sophisticated 
sets of restraints and the growth of the PDB 
and the PDB_REDO databank will provide 
more reliable statistics over time. 
Extracting restraints from the PDB_REDO 
databank and subsequently applying them 
in the PDB_REDO pipeline introduces 
circularity. This important practical issue can 
be avoided by only applying these restraints 
to low resolution structure models (where the 
restraints are most needed) and not to the high 
resolution structure models that will be used to 
derive new refinement targets. That way, future 
datasets will remain unbiased. Restraint targets 
ideally are derived from unrestrained Zn 
sites, but the number of available ZnCysxHisy 
complexes solved at atomic resolution will 
for some time to come preclude extraction 
of reliable targets from unrestrained structure 
models.
Availability
The functionality to improve the refinement 
of ZnCysxHisy sites is available through the 
PDB_REDO web server (Joosten et al., 2014). Zen is 
distributed with PDB_REDO and the source 
code is available upon request. The WHAT IF 
web servers and web services are freely available 
and WHAT IF is shareware. WHAT_CHECK 
will become part of the CCP4 software suite 
(Winn et al., 2011) soon.
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Study Zn—S (Å) Zn—N (Å) Databank Resolution (Å) and other criteria
Site 
type
Alberts et al., 1998 2.35 ± 0.09 (30) 2.09 ± 0.12 (42) PDB ≤ 2.0Structural sites only T4
2.30 ± 0.05 (147) 2.02 ± 0.03 (27) CSD - T4
Simonson & Calimet, 2002 2.33 ± 0.05 (60) n/a PDB ≤ 2.25 Cys4
2.34 ± 0.10 (51) 2.19 ± 0.19 (17) PDB ≤ 2.25 Cys3His
2.25 ± 0.09 (28) 2.12 ± 0.18 (28) PDB ≤ 2.25 Cys2His2
2.36 ± 0.06 (44) n/a CSD - SSSS
2.31 ± 0.03 (24) 2.12 ± 0.03 (8) CSD - SSSN
2.28 ± 0.02 (30) 2.09 ± 0.04 (30) CSD - SSNN
2.22 ± 0.08 (3) 2.06 ± 0.02 (9) CSD - SNNN
Harding, 2006 2.34 ± 0.05 (59) 2.04 ± 0.04 (62) PDB ≤ 1.25 All
2.28 ± 0.04 (28) 2.01 ± 0.04 (34) CSD R < 0.065 All
2.31 ± 0.10 2.03 ± 0.05 * * All
Tamames et al., 2007 2.32 ± 0.11 (1877) N
δ: 2.09 ± 0.14 (1115)
Nε: 2.12 ± 0.15 (2347) PDB ≤ 2.5 All
n/a (0) 2.02 ± 0.04 (11) PDB 0.5-1.0 All
2.33 ± 0.05 (90) 2.08 ± 0.09 (180) PDB 1.0-1.5 All
2.32 ± 0.09 (732) 2.10 ± 0.13 (1967) PDB 1.5-2.0 All
2.32 ± 0.13 (1094) 2.13 ± 0.16 (1470) PDB 2.0-2.5 All
Lee & Lim, 2008 2.33 ± 0.09 (137) 2.05 ± 0.16 (36) PDB ≤ 3.0Structural sites only T4
2.32 ± 0.05 (246) 2.04 ± 0.04 (603) CSD R < 0.065 T4
Laitaoja et al., 2013 2.31 ± 0.03 (24) 2.03 ± 0.04 (33) PDB <1.0 All
2.32 ± 0.06 (436) 2.08 ± 0.08 (637) PDB 1.0-1.5 All
2.34 ± 0.10 (2116) 2.13 ± 0.15 (2279) PDB 1.5-2.0 All
2.36 ± 0.20 (1928) 2.18 ± 0.17 (1579) PDB 2.0-2.5 All
2.36 ± 0.23 (920) 2.25 ± 0.28 (953) PDB 2.5-3.0 All
2.40 ± 0.28 (428) 2.26 ± 0.23 (211) PDB 3.0-3.5 All
2.64 ± 0.67 (131) 2.58 ± 0.43 (19) PDB 3.5-4.0 All
2.45 ± 0.49 (119) 2.86 ± 1.26 (5) PDB >4.0 All
Table S6.1. Distances between Zn and S or N are listed as mean ± standard deviation.
From left to right are listed the source reference, any Zn—S and Zn—N distances listed, the data source, resolution cutoffs when the 
source was PDB and R-factor cutoffs when the source was CSD, and the type of cluster studied (with all indicating lack of discrimination, 
SSSS indicates the general case of Zn coordination by four sulphur atoms, and T4 indicating that the coordination number had to be 4). 
Numbers in brackets indicate the number of observations. *: suggested targets by Harding (2006).
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Figure S6.1. Box-and-whisker plots of the Z scores characterizing ZnCysxHisy complexes in original PDB (red) and PDB_REDO (blue) 
structure models. The whiskers extend to the nearest value that is within 1.5 times the inter-quartile range; outliers are marked as dots. 
The Z score for 'Zn position' indicates Zn tetrahedral off-centeredness. 525 outliers with a Z score smaller than -15 or larger than 15 are 
not shown for clarity. All of these outliers come from PDB structure models.
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The question why cysteine bridges always contain only two cysteines has been raised many times because energy calculations strongly suggest that triple and quadruple cysteine bridges can also exist. The unprecedented growth 
of the PDB has stimulated us to once again search for these elusive products of 
protein structure evolution. And this time we were successful. In total, 36 triple 
cysteine bridges in 18 different PDB entries, and 30 quadruple cysteine bridge in 5 
different PDB entries were observed. On top of that 6 cysteine structures in which all 
four cysteines are bridged to each other were found in 6 different PDB entries. Our 
excitement got combined with amazement when we realized that in all cases we 
observed a zinc atom at a short distance of the sulfur atoms. A thorough quantum 
chemical analysis revealed that zinc ions can catalyse cysteine bridge formation. 
A modelling study suggests that cysteine bridges consisting of five cysteines can 
also exist, and we believe that it is only a matter of time before we will observe this 
intriguing structure element in a PDB file.
Introduction
A PubMed search reveals only six articles 
with the term ‘cysteine bridge’ in the title, the 
oldest of these by Ross, Zhang and Selman (Ross 
et al., 1995). This is a bit surprising as the oldest 
recorded cysteine bridge in the PDB (2cha) 
dates from 1972 (Birktoft & Blow, 1972). Clearly, the 
importance of cysteine bridges has long been 
underestimated, which can be explained 
only from our limited understanding of their 
path of formation. Studies on cysteines have 
been published as early as 1981 (Thornton, 1981). 
Many researchers have attempted to study 
cysteine bridge formation [e.g. (Weissman & Kim, 
1995; Darby et al., 1995)], but this topic has been 
marred in controversy, and we believe that the 
underlying problem has been the incomplete 
understanding of the most important process 
in the process: zinc-catalysed sulfur–sulfur 
binding. This idea gets further corroborated 
by the observation that the PDB contains 
almost 2500 entries in which a zinc ion (Zn2+) 
is observed in close proximity to the Sγ atom of 
one or more cysteines.
Although Zn2+ is considered to be redox-
inert in biological systems (Laitaoja et al., 2013), 
Zn2+ can be involved in redox reactions when 
Figure 6A.1. PDB code: 2zp8, chain E, Zn54. The Sγ atom of Cys12 
(left) is located 1.63 Å away from the zinc ion (gray sphere). The 
other cysteines are located at a much bigger distance from the 
zinc than the “ideal” distance of 2.340 ± 0.020 Å according the 
REFMAC dictionary (Vagin et al., 2004). The distances are 3.04 Å, 2.89 
Å and 3.79 Å for Cys15 Sγ (top right), Cys26 Sγ (middle right) 
and Cys29 Sγ (bottom right) respectively. Note that the zinc ion 
is shown at 30% of its Van der Waals radius. The 2mFo-DFc map 
and mFo-DFc map are contoured at +1.5σ (blue mesh) and at 
+3σ and -3σ (green and red meshes), respectively. The electron 
density map sampling rate is a third of the resolution.
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coordinated by redox-active cysteines (Krezel et 
al., 2007). Moreover, zinc-coordinating cysteines 
form disulfide bonds upon dissociation of 
Zn2+ from Metallothionein (Babu et al., 2014). 
Experimental evidence for the existence of a 
general mechanism of zinc-catalysed sulfur–
sulfur binding was not reported, though, in a 
recent survey of zinc coordination in protein 
structures (Laitaoja et al., 2013). 
Here we report the property of cysteines 
to form more than one cysteine bridge in the 
presence of Zn2+. This poly-bridging can reach 
up to three cysteine bridges per sulfur atom, 
leading to an entire cysteine cluster.
Results
The Protein Data Bank (PDB) (Berman et al., 2000, 
2003; Gutmanas et al., 2014) was searched for X-ray 
structures that contain zinc (~6000 entries) 
and a subset was generated in which the zinc 
was located close to a cysteine (~2500 entries). 
All representative cases were visually inspected. 
Figure 6A.1 shows a typical case of a zinc–
cysteine couple.
The location of the zinc close to the 
cysteine Sγ in Fig. 6A.1 can easily be explained 
using standard quantum chemistry software. 
In Zn·Cys4 complexes, all four S
γ atoms 
normally are deprotonated and thus negatively 
charged (Dudev & Lim, 2002). A quantum dynamics 
simulation reveals the rapid equilibrium for 
the Cys closest to the zinc:
Zn2+ + [Sγ]-        ↔ Zn2+—[Sγ]-                (eq. 6A.1)
The Zn2+—[Sγ]- species is reactive, and prefers 
to react with lone-pairs on soft Lewis bases like 
those of sulfur or nitrogen. We ran a quantum 
dynamics simulation on the situation in which 
one sulfur is very close to the Zn2+ and another 
reduced cysteine ready to form a disulfide 
bridge (see Fig. 6A.2a). This simulation 
suggested that the reaction as given in eq. 2, is 
highly likely to occur.
Zn2+—[Sγ]- + [Sγ]-  ↔  Zn2+—[Sγ]-—[Sγ]-  ↔
  Zn2+ + Sγ—Sγ + 2e-        (eq. 6A.2)
And indeed, each stage in this process has 
occurred in some entries in the PDB (Fig. 
6A.2). The negatively charged Zn·Cys4 
complexes tend to be screened by positively 
charged amino acids (Maynard & Covell, 2001). These 
basic residues are most likely responsible for 
the generation of hydrogen gas:
(a) (b) (c)
Figure 6A.2. (a)  PDB code 1r9s, chain B, Zn1307. The Zn2+—[Sγ]- + [Sγ]- situation where the distance to Zn2+ is 1.94 Å for Cys1166 Sγ 
(left) and 2.93 Å for Cys1185 Sγ (center). The cysteines are about to form a disulfide bridge. (b) PDB code 3gtk, chain I, Zn204. The Zn2+—
[Sγ]- —[Sγ]- situation where Cys103 (top, Sγ 1.71 Å from Zn2+) and Cys106 (left, Sγ 2.08 Å from Zn+) have just formed a disulfide bridge. 
(c) PDB code 3h0g, chain N, Zn2225. The Zn2+ + Sγ—Sγ situation where the Sγ atoms from Cys1155 (top left) and Cys1173 (bottom left) 
are 2.16 Å and 2.35 Å away from the Zn2+, respectively. The disulfide bridge is 2.04 Å long.
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2NH3
+ + 2e-       ↔  2NH2 + 2H
+ + 2e- → 
  2NH2 + H2             (eq. 6A.3)
The protons may need to be bound temporarily 
to any hydrogen acceptor. We assume that this 
is the main reason that we so often observe 
histidine side-chains in close proximity to zinc 
ions.
Equation 6A.2 can easily be extrapolated 
to obtain chained or even triangular cysteine 
bridges. However, as the reaction releases 
hydrogen gas, and as H3 doesn’t exist, we believe 
that the final product in these cases must be 
a complex bridge including four sulfurs from 
four cysteines. The latter would then cause 
the release of the quantum chemically much 
more sensible 2H2. A scan of the PDB revealed 
something surprising (Fig. 6A.3).
In Fig. 6A.3c we see the final intermediate, 
the Zn2+—[Sγ]-—[Sγ]-—[Sγ]- situation. 
Figure 6A.3. (a) PDB code 1tug, 
chain D, Zn155; linear triple cysteine 
141 (top centre). Ser116 helps to 
coordinate the zinc, as well as the 
Cys114 Sγ (at 0.79 Å from the zinc 
ion) and Cβ (at 1.99 Å) atoms. The 
SSBOND records in PDB entries 
do not yet allow the definition 
of trisulfide bonds. The authors 
solved this problem by specifying 
the two S-S bonds in two separate 
records; each of the two SSBOND 
records containing Cys141. (b) 
PDB code 4bn5, chain A, Zn1397; 
fully connected triple cysteine. 
(c) PDB code 1nlt, chain A, Zn352; 
fortunately captured intermediate. 
(d) PDB code 3d7s, chain B, Zn313; 
the final product: the quadruple 
bridge.
(a) (b)
(c) (d)
Surprisingly, the four sulfurs bind around the 
zinc catalyst (Fig. 6A.3c). This means that the 
zinc must tunnel out of this cage to reach the 
final situation as observed in Fig. 6A.3d.
A quantum dynamics simulation starting 
from the five cysteines around Zn607 in 2pvc 
chain C (see Fig. 6A.4) teaches us that cysteine 
bridges consisting of five cysteines must exist. 
We could however not yet find experimental 
evidence for such a structure element in the 
PDB.
Discussion
A famous Californian bioinformatician once 
said that “when it comes to protein structure 
geometry, there must be room for freedom 
of interpretation”. We want to issue a stern 
warning against this idea, after all, who can 
argue against quantum chemistry? Too long 
have we taken the liberty of freely interpreting 
the data (reflections) and freely choosing 
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Figure 6A.4. Five cysteines around zinc. PDB code 2pvc, chain 
C, Zn607.
the constraints upon refining protein crystal 
structures. This can lead to big anomalies as 
we determined by comparing the structures 
mentioned in this study with their PDB_
REDO (Joosten et al., 2009a,b, 2012) mates. The structure 
shown in Fig. 6A.2a, for example, suffers from 
the lack of freedom of interpretation because 
upon re-refinement with REFMAC (Murshudov 
et al., 2011) it gets forced into a dull, featureless 
and highly symmetric tetrahedron as shown 
in Fig. 6A.5b. The manual re-interpretation 
and re-refinement of the experimental data 
for PDB entry 1tug (Fig. 6A.3a) suggested an 
alternative mechanism of zinc coordination 
in aspartate transcarbamoylase that does not 
involve Ser116 (Fig. 6A.6). We prefer the 
original interpretation, however, since the 
conformation of the tetrahedron we obtained 
is too good to be true.
We believe that this article beautifully 
illustrates the power of the PDB, a power 
that mainly comes from its numbers. The 
large quantity of files of proteins solved at 
increasingly high resolution allows us to better 
separate the rules from the exceptions and the 
interpretations from the miss-interpretations. 
And at times, especially around early April, 
this can lead to amazing new discoveries.
(a) (b)
Figure 6A.5. 1tug, chain D, Zn155. 
(a) PDB structure. (b) Manually 
corrected and re-refined structure. 
Maps as in Fig. 6A.1.
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A coordinate-based method is presented to detect peptide bonds that need correction either by a peptide-plane flip or by a trans–cis inversion of the peptide bond. When applied to the whole Protein Data Bank, the method 
predicts 4617 trans–cis flips and many thousands of hitherto unknown peptide-
plane flips. A few examples are highlighted for which a correction of the peptide-
plane geometry leads to a correction of the understanding of the structure–
function relation. All data, including 1088 manually validated cases, are freely 
available and the method is available from a web server, a web-service interface 
and through WHAT_CHECK.
Introduction
Peptide bonds connect adjacent amino acids 
in proteins. The partial double-bond character 
of the peptide bond restricts its torsion. The 
dihedral angle ω (Cαi−1—Ci−1—Ni—C
α
i) 
typically has values around 180° (trans) or 0° 
(cis), although exceptions are possible (Berkholz 
et al., 2012). The Cαi–1—C
α
i distance is around 
3.81 Å in the trans conformation and around 
2.94 Å in the cis conformation. The trans 
conformation is energetically preferred over 
the cis conformation owing to unfavourable 
nonbonded interactions between the two 
Cα—Hα moieties flanking the peptide bond 
[(Zimmerman & Scheraga, 1976; Stewart et al., 1990; Jabs et al., 1999) 
and references therein]. The cis imide bond X–
Pro is more frequently observed than the cis 
amide bond X–Xnp (where Xnp is any residue 
except Pro) because the Cαi−1 and Oi−1 atoms 
have similar third neighbours in either X–Pro 
conformation (Ramachandran & Sasisekharan, 1968).
In the early days of protein crystallography 
cis peptides were almost completely absent in 
the available protein crystal structures (Ramachandran 
& Mitra, 1976). Therefore, characterization of cis-
peptide geometry in protein crystal structures 
was very difficult. In the early 1990s the 
number of structures deposited in the PDB 
allowed the first studies of the local protein 
environment of cis peptides. Stewart et al. 
(1990) characterized 17 cis X–Xnp and 99 cis 
X–Pro peptides and MacArthur & Thornton 
(1991)  analysed 58 cis X–Pro residues in 
a set of nonhomologous structures. Many 
surveys showed that the computationally 
derived energy differences between the cis 
and trans isomers are only partially reflected 
in their frequency of occurrence in the PDB. 
Jabs and coworkers reviewed the arguments 
for the rarer than expected occurrence of cis 
peptide bonds in protein structures  (Jabs et al., 
1999). These arguments were mainly related to 
protein energetics and to protein function, 
as several studies had observed cis peptides 
at functionally important locations such 
as active sites or protein binding interfaces 
[(Stoddard & Pietrokovski, 1998; Weiss et al., 1998) and references 
therein]. Several studies showed a correlation 
between the resolution of the crystal structure 
and the number of cis peptides (Stewart et al., 1990; 
Weiss et al., 1998; Pal & Chakrabarti, 1999). Several authors, 
including Jabs and coworkers, have noted that 
the underrepresentation of cis peptides is partly 
the result of the a priori assumption often made 
upon determining X-ray crystal structures that 
all peptides have a trans conformation  (Huber 
& Steigemann, 1974; Stewart et al., 1990; Weiss et al., 1998; Jabs et al., 
1999). In the 1970s it had already been noted 
that reinterpretation of electron-density maps 
might reveal many previously unnoticed cis 
peptides in protein structures (Huber & Steigemann, 
1974; Ramachandran & Mitra, 1976).
An incorrectly assigned peptide 
conformation can be in need of any of a 
number of possible corrections. The first 
and most common is a rotation of the entire 
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(a) tt+
(b) tc-
(c) tc+
ct-(d)
(e) ct+
Figure 7.1. Representative peptide flips. The left figures show the peptide conformation found in the PDB (pink structures) and electron-
density maps obtained from the Uppsala Electron Density Server (Kleywegt et al., 2004). The figures on the right show the conformation and 
electron density of the corresponding re-refined structure models (green) from the PDB_REDO databank (Joosten et al., 2011a). The flip type 
is indicated (tt− and cc− are not flips and thus are not illustrated). A cc+ example could not be found in the PDB. (a) Gly90, chain A, 
PDB 3hr7 (Cheng et al., 2012), 1.8 Å resolution. (b) Glu175, chain C, PDB 3k2g, 1.8 Å resolution. (c) Gln541, chain A, PDB 1w0o (Moustafa et al., 2004), 
1.9 Å resolution. (d) Ala82, chain A, PDB 1v6i (Kundhavai Natchiar et al., 2004), 2.15 Å resolution. (e) Pro55, chain B, PDB 1j1j (Sugiura et al., 2004), 2.2 Å 
resolution. The PDB_REDO program pepflip (Joosten et al., 2011b) performs tt+ peptide-plane flips, which are a combination of both a C=O flip 
and an N—H flip. Re-refinement alone can lead to N—H flips (tc− and ct− flips) when the signal in the X-ray data is strong enough. 
Therefore, the net result of a tt+ flip and subsequent refinement may become a tc+ flip. Consequently, PDB_REDO is able to correct 
many (but certainly not all) peptides in need of a trans–cis flip. The 2mFo-DFc (grey mesh) and mFo-DFc maps (+, green mesh; −, red 
mesh) have been contoured at 1.5σ and ±3σ, respectively, and have been rendered with a grid size of 0.2 Å for visualisation purposes. 
The figures were prepared with CCP4mg (McNicholas et al., 2011).
peptide plane by 180°, referred 
to as an amide flip (McCammon et al., 
1977), peptide-plane flip (Hayward, 
2001) or peptide flip (Joosten et al., 
2011b). In the following these 
peptide-plane flips are called tt+ 
[Fig. 7.1; the first two symbols 
are either c for cis or t for trans, 
reflecting the situation before 
and after the flip, respectively; 
the third symbol is a plus (+) 
sign if the conformational 
change includes a flip of the 
backbone carbonyl C=O, 
otherwise it is a minus (−) 
sign]. The other two corrections 
are trans↔cis flips that can 
either constitute a flip of the 
backbone C=O (tc+ or ct+) or 
a flip of the backbone amide 
N—H (tc− or ct−). A correct 
peptide is either tt− or cc−. 
Every type of flip was observed 
in crystal structures deposited 
in the Protein Data Bank 
(PDB) (Berman et al., 2007) except cc+ 
(cis-peptide flips that include 
a flip of the C=O). Figure 7.1 
shows representative examples 
for the five possible codes that 
include a flip and that have 
actually been observed in the 
PDB. More examples can be 
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found on the associated website1.
Frömmel & Preissner (1990) were the 
first to predict cis X–Pro peptides based on 
just the amino-acid sequence. Later, the 
prediction algorithms were expanded to take 
into account X–Xnp peptides (Pahlke et al., 2005; 
Exarchos et al., 2009). Machine-learning approaches 
have been applied that included multiple 
sequence alignments, predicted secondary 
structure and predicted solvent accessibility 
(Wang et al., 2004b; Song et al., 2006; Exarchos et al., 2009). These 
sequence-based algorithms correctly predict 
the conformation of about three quarters of 
the tested peptides. A detailed comparison of 
these algorithms is impossible since the only 
software still available today is that of Song et 
al. (2006). Sequence-based algorithms have 
probably become obsolete because much 
higher prediction accuracy is required in the 
everyday practice of crystallographers.
Jabs and coworkers were the first to discuss 
geometric aspects that could be used to detect 
incorrectly modelled X–Xnp tc− flips (Jabs et al., 
1999). Their algorithm was the first coordinate-
based flip-prediction method that took into 
account the locally distorted geometrical 
environment of a misassigned peptide bond. 
Initially, the algorithm was based on just 
four cis peptides in coagulation factor XIII 
(Jabs et al., 1999). This method was implemented 
in WHAT IF but suffered from many false 
positives, i.e. incorrectly predicted trans-to-cis 
flips. Weiss and Hilgenfeld (WH) later refined 
their algorithm using a set of 17 incorrectly 
assigned trans peptides (Weiss & Hilgenfeld, 1999). This 
method was implemented for comparison 
purposes, but it was found to give many 
false-negative predictions, i.e. it overlooked 
necessary tc− flips (see Table 7.5). The WH 
method was designed for X–Xnp peptides 
only. A structure-based algorithm predicting 
trans-to-cis flips in X—Pro peptides does not 
yet exist. Cis-to-trans flips are much rarer than 
trans-to-cis flips, mostly as a consequence of 
the a priori assumption that peptides are in the 
1. http://swift.cmbi.ru.nl/gv/flips/
trans isomer. Cis-to-trans flips have not been 
predicted by any algorithm known to date.
With the introduction of PDB_REDO 
(Joosten & Vriend, 2007,Joosten et al., 2009a), it became 
possible to reinterpret experimental X-ray data 
in an automated way, and when Joosten and 
coworkers developed a method called pepflip, 
peptide-plane tt+ flips could be detected 
and corrected based on the fit to the local 
electron density (Joosten et al., 2011b). It should be 
noted, however, that pepflip does not perform 
trans↔cis flips, and occasionally performs a tt+ 
flip when actually a trans–cis flip is needed.
All crystallographic PDB structures 
were compared with their PDB_REDO 
counterparts and many examples were 
observed of the different flip types in Fig. 7.1. 
With the large set of peptide flips in hand, 
we asked whether these flips could be used to 
obtain a large training set for a Random Forest 
(RF) (Breiman, 2001) machine-learning approach 
for the structure-based prediction of peptide-
plane inversions. The method predicts 70 461 
peptide-plane flips and 4617 trans–cis flips in 
the PDB.
Methods
Data selection
Pairs of X-ray structures were obtained from 
the PDB and PDB_REDO releases of 20 
October 2014 and were used only if they met 
the selection criteria listed in Table 7.1.
Selection parameter Criterion
Experimental method X-ray
Resolution 3.5 Å or better
PDB_REDO entry Must exist
DSSP entry Must be determinable
BDB entry Must exist
Composition At least one chain with ≥25 amino acids
Flip (tt+, tc−, tc+, 
cc+, ct− or ct+) At least one detected by WHAT IF
Table 7.1. Selection criteria for PDB entries.
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Table 7.2. Selection criteria for tetrapeptides.
Selection parameter for residues Criterion
Position in structure Not a C- or an N-terminus;
not adjacent to a chain break
Amino-acid type Must be canonical
Angles, dihedrals, improper dihedrals Must be determinable
Atoms All must be present;
All B-factors >0 Å2;
All occupancies = 1.0
Covalently bound atoms Only canonical bonds and no other bonds, not even disulfide bonds
Anything outside own molecule Not within 2.5 Å of O atom in central peptide planes
From these PDB files, stretches of four 
residues were selected if they met the selection 
criteria listed in Table 7.2.
The tetrapeptides in the data set were 
divided into X-X-Pro-X, X-X-Gly-X and X-X-
Xnpg-X (where Xnpg is any residue except 
for Pro or Gly), which, for brevity, are called 
X-Pro, X-Gly and X-Xnpg, respectively.
A large number of tetrapeptides were 
manually validated. These tetrapeptides 
represented both correct and incorrect 
conformations. 173 peptides in 81 
PDB_REDO files were rebuilt and re-refined 
because visual inspection suggested that the 
PDB_REDO conformation was not plausible 
(see, for example, Figs. 7.2 and 7.4). This 
resulted in a validation data set consisting 
of 1088 tetrapeptides (see Table 7.3) in 438 
PDB structures, 192 of which contained at 
least one genuine flip. Many more peptides 
were inspected, but were not included because 
the quality of the electron density was not 
good enough. The validation data were 
gathered over the course of this study. Many 
tetrapeptides were expected to be difficult for 
an automated method to predict correctly. 
These difficult cases were deliberately added 
to the validation set and included not only 
incorrect tetrapeptides but also correct ones. 
About 400 cases were included that had been 
incorrectly classified by earlier versions of the 
classification algorithm developed here or by 
the first Jabs, Weiss and Hilgenfeld algorithm.
A special menu was added to WHAT IF 
(Vriend, 1990a) that compares PDB entries with 
their PDB_REDO mates. Options in this 
menu allow the detection of many differences 
in coordinates, angles, torsion angles, B-factors 
etc. between PDB and PDB_REDO pairs. 
The WHAT IF procedure that compares the 
peptide conformations in the ~71 000 PDB–
PDB_REDO pairs of protein structures and 
that assigns the flip types was based on three 
variables describing the difference between the 
central peptide planes in the corresponding 
tetrapeptides: the (C=O, C=O) angle, the 
(N—H, N—H) angle and the ω torsion-angle 
difference. The training examples were taken 
from structures solved at 3.5 Å resolution or 
better, except for the examples for peptide-
plane flips because validation of flip assignment 
and prediction was found to be more accurate 
when only structures solved at 2.2 Å resolution 
or better were included. In total, at least one 
clearly flipped peptide was observed in 16 688 
PDB_REDO entries.
Structures were rebuilt manually with Coot 
(Emsley et al., 2010) and re-refined with REFMAC 
(Murshudov et al., 2011). The refinement strategy 
and parameters were obtained from the 
PDB_REDO protocol (Joosten et al., 2012). The 
CCP4 (Winn et al., 2011) program EDSTATS (Tickle, 
2012) was used to calculate real-space correlation 
coefficients.
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Peptide
class tt- tt+ tc- tc+ cc- cc+ ct- ct+
X-Xnpg
found 13 875 524 24 742 176 0 8001 0 0 0
train 4307 4131† 176 0 0 0 0 0
test 435 65 122 12 6 0 21 3
X-Pro
found 696,375 0 dt 88 33 236 0 0 0
train 88 0 dt 88 0 0 0 0
test 90 1 dt 69 74 0 3 13‡
X-Gly 
found 1 141 604 11 869 0 0 2329 0 0 0
train 1049 1049§ 0 0 0 0 0 0
test 77 31 7¶ 0 0 0 4 0
†Training and testing examples were only taken from structures solved at 2.2 Å resolution or better.  
‡Eight occurrences in different chains of PDB entry 1k1d (Cheon et al., 2002).  
§Training and testing examples were only taken from structures solved at better than 2.0 Å resolution.  
¶Six occurrences in different chains of PDB entry 2ef5.
Table 7.3. For each peptide class three rows are given. The first row shows the counting statistics for peptide-conformation differences 
between PDB_REDO and PDB in the 16 688 structure pairs that share at least one trans–cis difference or a peptide-plane flip. The flip 
types are illustrated in Fig. 7.1. The second row shows the subset of these cases that has been used to train Random Forest classifiers. The 
tt− cases were needed to teach the method what correct (trans) peptide planes look like. The third row shows the independent cases 
used to test the method. The 1088 cases in the test set of 438 structures have been validated manually and were corrected and re-refined 
when necessary. The test cases have been derived from PDB_REDO–PDB comparison (the test cases are not included in the first row) or 
were otherwise detected over the course of this study. Entries in grey indicate that WHAT_CHECK can now validate cases that fall into 
this category; for the other classes insufficient data are available for proper training and testing. The tc− cases for X-Pro were solved with 
a very simple, manually designed decision tree, as explained in the text.
Prediction
For each tetrapeptide a large number of features 
was calculated using WHAT IF, including 
Cα—Cα distances, Cβ—Cβ distances, O—O 
distances, backbone torsion angles, backbone 
bond lengths, backbone bond angles up to Cβ 
atoms, chiral volumes, C=O—C=O angles, the 
Oi−1 bump score and the carbonyl alignment 
with an α-helix nearby in the sequence, three-
state secondary structure as derived from DSSP 
(Kabsch & Sander, 1983,Touw et al., 2015a) and B-factors from 
BDB entries (Touw & Vriend, 2014), which consistently 
have full isotropic B-factors, unlike PDB 
entries that can have residual B-factors from 
TLS (Schomaker & Trueblood, 1968) refinement. The 
WH method was implemented in WHAT IF 
as described by Weiss & Hilgenfeld (1999). 
The WH “penalty-function score” (Dtot) is 
also one of its features. Random Forest (Breiman, 
2001) classifiers were constructed using the 
R (R Core Team, 2016) package randomForest  (Liaw & 
Wiener, 2002) and tuned using repeated fivefold 
cross-validation. The classifier objects were 
automatically converted into Fortran code for 
inclusion in WHAT IF and WHAT_CHECK 
(Hooft et al., 1996d).
Results
Peptide-plane inversion 
examples
Thousands of peptide-plane inversions were 
observed by comparing PDB structures with 
their PDB_REDO counterparts (Table 7.3).
Visual inspection of many peptide-plane 
inversions indicated that about 90% of 
the flips introduced by PDB_REDO are 
correct. Sometimes the PDB_REDO peptide 
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conformation is suboptimal. In some of the 
tc− cases, for example, the ω angle can end 
up at around 90° in the PDB_REDO output 
model (Fig. 7.2). These conformations, 
which are essentially halfway between the 
wrong and the right conformation, are the 
result of trans-peptide restraints outweighing 
the crystallographic data during refinement. 
The problems can be resolved by additional 
refinement with cis-peptide restraints.
Prediction of peptide flips
The studies by Weiss & Hilgenfeld (1999), 
and our own visual inspection of hundreds of 
peptide planes that needed a flip to better agree 
with the X-ray data, revealed that a number of 
geometric variables tend to deviate from their 
common values when a peptide plane has been 
built in the wrong conformation. For instance, 
the angle Cαi−1—Ci−1—Ni tends to be smaller 
than normal for X-Xnpg tc− peptides, and the 
B-factor of the O atom in the plane tends to 
be high if the peptide plane needs a tt+ flip. 
Therefore, all features were collected that could 
possibly characterize the local distortion of an 
incorrectly modelled peptide plane. These 
features were not limited to geometric variables 
and B-factors, but also included secondary 
structure and a description of the environment 
of the O atom in the peptide plane. Other 
Figure 7.2. Stepwise improvements from trans to cis. (a) The peptide bond between Arg71 and Phe72 
(ω = 132°) in PDB entry 2bmd (Huber & Scheidig, 2005) needs a tc− flip. (b) The peptide has been flipped only 
‘halfway’ in PDB_REDO (ω = 81°). (c) The fully flipped and refined cis peptide (ω = 9°). The side chains 
have been omitted beyond Cβ for clarity. Maps are as in Fig. 7.1.
(a) (b) (c)
variables such as 
the hydrogen-
bonding status 
and rotamericity 
of the side chains 
can be added, 
but they are 
computationally 
intensive and, for 
reasons that we 
do not yet fully 
understand, do 
not influence 
the prediction 
accuracy of the 
method very much. A comprehensive list of 
variables is available on the project's website. 
For each flip type a classifier was trained to 
determine variable combinations that can 
separate peptides in need of a flip from correct 
peptides. The flip-type specific classifiers were 
combined into one classifier per residue class 
(X-Xnpg, X-Pro and X-Gly). All classifiers 
were validated using an independent test 
set. Table 7.3 shows the number of peptides 
in the training test sets. Classifiers for cis-to-
trans flips and other small categories were not 
constructed because classifiers fitted to too 
few training examples will not be generally 
applicable. The full details of the design, 
implementation and use of the classifiers for 
the four situations for which adequate data 
was available and the manual decision tree for 
X-Pro tc− are given on the project's website.
Table 7.4 lists the results for the four 
residue and flip-type specific RF classifiers. 
The combined classifiers predict X-Xnpg flip 
types (tt−, tt+, tc−, tc+) with an accuracy of 
93%. This includes all 12 tc+ cases that were 
found in the PDB and that were not in the 
training set. The accuracy is 95% without 
these X-Xnpg tc+ cases. X-Pro tt−, tt+, tc− and 
tc+ flips in the test set can be classified with an 
overall accuracy of 93%.
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Table 7.4. Test-set performance. The performance on the test set is shown for the four RF classifiers. The performances of the WH 
method with the original threshold and with the threshold determined in the present study, respectively, are shown in parentheses. 
Note that the classification accuracy is sensitive to class imbalance, while the area under the receiver operating characteristic curve 
(AUC) and the Matthews correlation coefficient (MCC) (Matthews, 1975) are not. The values for several other performance metrics and the 
confusion tables for the combined predictions can be found on the project's website.
X-Xnpg X-Pro X-Gly
tt+ tc− tc+ tt+
AUC 0.99 0.98 (0.97/0.97) 0.94 0.98
MCC 0.91 0.89 (0.31/0.82) 0.85 0.93
Accuracy 0.98 0.96 (0.80/0.94) 0.92 0.97
X-Xnpg tc−
Table 7.5 shows the prediction outcome in 
terms of true positives (TP), true negatives 
(TN), false positives (FP) and false negatives 
(FN) for the X-Xnpg tc− and tt− test peptides. 
The confusion tables for the results obtained 
with the WH method are also shown. Weiss 
& Hilgenfeld (Weiss & Hilgenfeld, 1999) mentioned 
that their cutoff could not be validated, as the 
experimental data for most of the structures 
in their data set were not available. The 
optimal cutoff for the WH Dtot score could 
be determined using the 539 cases that were 
manually validated using electron density. 
With the new threshold both the TP and FN 
rates improved more than 75% compared 
with the original WH threshold (Table 7.5). 
The RF-based method further increased this 
performance by decreasing the FP rate at the 
cost of a small increase in the FN rate. Note 
that a low FP rate is more important for 
protein structure-validation purposes than 
for prediction-assisted rebuilding and re-
refinement.
The variables that were most important for 
separating X-Xnpg tc− from tt− were also used 
in the WH algorithm: φi, the backbone angles 
RF WH WH’
tc− tt− tc− tt− tc− tt−
tc− 107 14 15 106 110 11
tt− 6 412 0 418 24 394
Table 7.5. X-Xnpg test-set predictions. The rows give the true 
class and the columns give the predicted class. RF, the method 
developed in this study (MCC = 0.89). WH, the method developed 
by Weiss & Hilgenfeld (1999) with a Dtot score threshold of 143.10 
(MCC = 0.31). WH’, WH with a re-determined Dtot cutoff 82.256 
(MCC=0.82).
Oi−1—Ci−1—Ni, C
α
i−1—Ci−1—Ni−1, C
α
i−1—
Ci−1—Oi−1 and Ci−1—Ni—C
α
i, and the C
α
i−1—
Cαi distance. In addition, the C
α
i—Ci—Ni 
angle, the Cαi chiral volume and the C
β
i−1—
Cβi distance were found to be important for 
the RF method. Other WH bond lengths and 
angles were found to be less important. The 
full list of variables and their importance can 
be found on the associated website. In general, 
and not unexpectedly, the variables extracted 
from the inner two residues in tetrapeptides 
contributed most to the prediction accuracy of 
all flip types.
Application of the X-Xnpg tc− method to 
X-Gly cases did not reveal any new X-Gly tc− 
flips. This result suggests that the method might 
not be able to detect X-Gly tc− flips; after all, 
it was trained only on X-Xnpg tetrapeptides. 
Another explanation is that X-Gly tc− flips are 
simply very rare. This explanation is supported 
by the observation that a cis peptide modelled in 
the trans conformation is more easily corrected 
to the cis conformation automatically during 
refinement when the residue type is Gly rather 
than any other type.
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X-Pro tc+
X-Pro tc+ cases in the test set could be classified 
without any FP. Important variables are the 
angle between the carbonyl of the central 
peptide bond and the carbonyl before that, the 
Ci−1—Ni—C
α
i and Ni−1—C
α
i−1—Ci−1 angles, 
ψi−1, the C
α
i−1—C
α
i distance and the Oi−1 bump 
score. Engh & Huber (2001) observed that 
the bimodal distribution of Ci−1—Ni—C
α
i in 
high-resolution peptide fragments was caused 
by differences between the cis and trans forms. 
The median Ci−1—Ni—C
α
i angle for tc+ cases 
in the test set (116.0°) was smaller than the 
median for tt− cases in the PDB (121.0°) and 
the value Engh & Huber (2001) reported 
for trans proline (119.3 ± 1.5°), but after re-
refinement the median (129°) was just above 
the value that Engh and Huber reported for cis 
proline (127.0 ± 2.4°). This is illustrated in Fig. 
7.3. The figures on the website show the change 
in all variables before and after correction and 
re-refinement of the tetrapeptides in the test 
set.
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Figure 7.3. The Ci−1—Ni—C
α
i angle before and after correction 
of X-Pro tc+ cases. The curved lines show Gaussian kernel density 
estimates for the Ci−1—Ni—C
α
i backbone angle for 25 X-Pro tc+ 
cases in the test set before (solid line) and after (dashed line) 
correction and re-refinement. The vertical lines show the values 
for trans-Pro (119.3 ± 1.5°) and cis-Pro (127.0 ± 2.4°) reported 
by Engh & Huber (2001).
X-Xnpg tt+
The 480 X-Xnpg tt+ cases in the test set could 
be classified with seven FP and three FN. One 
FN and one FP are next to a trans–cis flip. 
The eight X-Xnpg cases in the test set that 
PDB_REDO failed to flip were correctly 
predicted by the RF method. The most 
important variables for predicting X-Xnpg tt+ 
cases are the B-factors of the O and C atoms in 
the central peptide plane, φ, ψ, the secondary 
structure and the Cβi−1—C
β
i distance.
X-Gly tt+
The B-factor of the central O atom is also very 
important for X-Gly classification, as are the 
Ci−1 B-factor, the Ci−1—Ni—C
α
i and Ni−1—
Cαi−1—Ci−1 angles and the secondary structure 
of residue i − 1. Gunasekaran et al. (1998) 
studied in vivo conversion between type I and 
type II β-turns and between type I′ and type 
II′ β-turns. They reported the importance of 
the B-factor distribution of the central O atom 
in flippable β-turns  (Gunasekaran et al., 1998). The best 
classification results were obtained for X-Gly 
(two FP and one FN) when the tt+ classifier 
was trained with data from structures solved at 
a resolution better than 2 Å, probably because 
the backbone is generally less well defined in 
low-resolution structures, resulting in higher 
B-factors caused by the low resolution rather 
than by a peptide in need of a flip. The inherent 
mobility of Gly may also explain the fact 
that many surface-located X-Gly were found 
that could not be interpreted well because of 
electron density that was too poor.
X-Pro tc−
All 40 X-Pro tc− in the test set derived from the 
PDB–PDB_REDO comparison had a positive 
φi, while the φi for tt− and tc+ cases is always 
around −60°. Remarkably, in the entire set 
of crystal structures with deposited structure 
factors 904 X-Pro cases were found with a 
positive φi, 86 of which were in structures 
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Figure 7.4. X-Pro problems characterized by positive φi angles. (a) X-Pro tc− flip; Ser339-Pro340, chain 
A, PDB 1se6 (Zhao et al., 2005), 1.75 Å resolution. (b) Pro-Gly tt+ flip; Val53-Pro54-Gly55, chain A, PDB 1hxd 
(Weaver et al., 2001), 2.40 Å resolution. (c) X-Pro tt+ flip; Leu203-Pro204, chain B, PDB 1cdd (Almassy et al., 1992), 
2.80 Å resolution. Electron-density maps were calculated using the PDB structure and are rendered as 
in Fig. 7.1. The PDB structures are shown in pink and the PDB_REDO structures in green; the manually 
corrected and re-refined structure is shown in orange.
(a) (b) (c)
solved at a resolution of between 1.2 and 
2.0 Å. These 904 cases all were either X-Pro 
tc− flips (Fig. 7.4a) or trans X-Pro with an 
otherwise incorrect nitrogen chirality (‘NCh’).
The NCh class includes tetrapeptides where 
residue i + 1 needs a tc+ flip [e.g. His173-
Leu174-Pro175-Pro176 in PDB entries 1bug 
and 1bt2 (Klabunde et al., 1998)] or a tt+ flip [e.g. 
Thr52-Val53-Pro54-Gly55 (see Fig. 7.4b) in 
chain A of PDB entry 1hxd (Weaver et al., 2001) and 
Gly152-Ala153-Pro154-Gly155 in chain B 
of PDB entry 4le4]. Surprisingly, one of the 
examples was even an X-Pro tt+ flip (Pro204 in 
chain B of PDB entry 1cdd (Almassy et al., 1992); Fig. 
7.4c). The ‘wrinkled’ tc− prolines with positive 
φi often have an almost straight Ci−1—Ni—C
α
i 
angle (Fig. 7.4a), which is probably the result 
of very tight ω restraints, and are reminiscent 
of the intermediate structure of the trans-to-cis 
transition of Gly78-Ile79 observed during the 
refinement of rubrerythrin (Stenkamp, 2005). From 
the 904 cases, 59 tc− flips and 22 NCh X-Pro 
cases were visually inspected. If the angle τ 
(Ni—C
α
i—Ci) is larger than 112.5° and the 
bump score of the O atom in the peptide plane 
is larger than 0.26 WHAT IF bump score units, 
then the X-Pro with a positive φi is not a tc− 
peptide but an NCh X-Pro. This rule predicts 
404 X-Pro tc− flips and 500 NCh X-Pro.
Cis → trans 
flips
44 clear cis-to-
trans flips have 
been found in 
this study. For 
trans X-Xnpg 
t e t r a p e p t i d e s 
modelled as cis 
tetrapeptides the 
median Cαi−1—
Cαi distance 
(3.34 Å) tends to 
be larger than the 
median Cαi−1—
Cαi distance for 
correct cis X-Xnpg tetra peptides (2.95 Å). 
Similarly, the median Ci−1—Ni—C
α
i angle 
(131°) tends to be larger than normal (125°). 
The median Cαi−1—C
α
i distance (3.55 Å) and 
Ci−1—Ni—C
α
i angle (159°) for ct− and ct+ 
X-Pro tetrapeptides also tend to be larger than 
normal (2.95 Å and 127°, respectively).
Molecular replacement
Molecular replacement (MR) using a trans 
peptide is a very common reason for failing 
to model a cis peptide correctly. This section 
describes a few examples of this problem.
In the Escherichia coli family 31 
α-glycosidase Yicl, Cys316 and Val477 adopt 
a cis conformation in both the free form [PDB 
entries 1xsi and 1xsj (Lovering et al., 2005)] and when 
bound to the sugar adduct eq-5-fluoroxylosyl 
[PDB 1xsk (Lovering et al., 2005)]. The authors listed 
both residues as part of the active site of the 
α-glycosidase and mentioned that cis-Cys316 
orients the side chain of Trp315 to direct 
Cys307 toward the sugar-binding site  (Lovering 
et al., 2005). Notably, PDB entry 1xsi was the MR 
search model for PDB entries 1xsj and 1xsk , 
but in this process the one Cys316 in chain 
A that was correctly in the cis conformation 
became trans in the latter two structures. Val477 
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Figure 7.5. Improvement of the real-space correlation coefficient (RSCC) in PDB entry 2z81 
[(Jin et al., 2007); 1.80 Å resolution] after rebuilding and re-refining incorrect peptide bonds. 
The panels show for six peptide bonds in a region of 20 surrounding residues the increase in 
average backbone-atom RSCC (including Cβ) when the peptides are corrected and the structure 
is re-refined, compared with re-refinement of the structure only. The residue after the central 
peptide bond is indicated in the top bar. Pro540 was corrected by a tc+ flip and all other 
peptides by tt+ flips. Re-refinement alone already resulted in correction of the conformation 
of Arg541. Re-refinement details and figures showing the local backbone of the peptide bonds 
can be found on the associated website.
was in the incorrect 
trans conformation in 
all six chains related 
by noncrystallographic 
symmetry (NCS) in 
each of the three PDB 
structures.
The PDB_REDO 
structure of PDB entry 
1uyq clearly showed 
that a tc− flip should 
be performed for 
Ser399. The same flip 
was predicted in all 
β-glucosidase A molecules 
listed in the PDB file as 
related structures [PDB 
entries 1bga and 1bgg 
(Sanz-Aparicio et al., 1998b) and 
1tr1 and 1e4i (Sanz-Aparicio 
et al., 1998a)]. However, the 
structure factors are not 
available for any of these 
structures. Although 
there is no paper to 
support it, it seems very likely that one of the 
related structures was used as a search model to 
solve the structure 1uyq and Ser399 should be 
cis in all related structures.
Even though it is more likely that a cis 
peptide will be accidentally refined as a trans 
peptide, cis-to-trans flips were observed in four 
different chains of PDB entry 1v6i (Kundhavai 
Natchiar et al., 2004) at residues Lys77-Asp78 and one 
additional ct− flip only in chain A at Pro81-
Ala82. The structure was solved at 2.15 Å 
resolution using MR with PDB entry 2pel 
(Banerjee et al., 1996) as a starting structure. However, 
the corresponding residues in PDB entry 2pel 
all have the correct trans conformation. It is 
therefore unclear to us how the cis peptides 
have been introduced into the 1v6i model.
Crystallographic improvement
The real- and reciprocal-space correlation 
of several representative corrected and re-
refined PDB structure models was analysed to 
investigate the effect on crystallographic quality 
metrics of flip correction and re-refinement. 
As an example, the local improvement after a 
flip in terms of fit to the electron density is 
shown for PDB entry 2z81 (Jin et al., 2007) in Fig. 
7.5. Similar figures for the other re-refinement 
examples can be found on the website.
The improvement in Rwork/Rfree as a result 
of flipping and re-refining was 0.14/0.41% 
with respect to re-refining only. The work/free 
reciprocal-space correlation improvement was 
0.08/0.22%. The largest improvement in Rwork/
Rfree (0.23/0.43%) and work/free reciprocal-
space correlation (0.18/0.28%) was found 
for PDB entry 1hi8 (Butcher et al., 2001), in which 
16 flips were necessary. Although the global 
refinement metrics improve only marginally, 
the local metrics show a clear improvement 
upon flipping and, more importantly, 
sometimes a flip alters our understanding 
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of the relationship between structure and 
function of a protein.
Biological implications of newly 
detected flips
Rab4a
A tc− flip was predicted for Phe72 in the 
GDP-bound state of human Rab4a (PDB 
2bmd). This residue is referred to as Phe70 in 
the associated paper (Huber & Scheidig, 2005). Phe72 is 
located at the start of α-helix H2 in the switch 
2 region of the small GTPase (Fig. 7.6). Fig. 
7.2 shows Phe72 in the GDP-bound Rab4a 
before and after correction and re-refinement.
In the GppNHp-bound Rab4a [PDB 
2bme (Huber & Scheidig, 2005)] Phe72 has the 
trans conformation (Fig. 7.6a). Upon GTP 
hydrolysis, the hydrogen bond between 
the γ-phosphate and Gly68 is lost and 
conformational rearrangements take place 
in the switch 2 region (Huber & Scheidig, 2005). 
We cannot exclude that the cis-form was 
selected during crystallisation, but our 
findings could also suggest that Arg71-Phe72 
trans–cis isomerization might be part of this 
rearrangement (Figs. 7.2 and 7.6b), which 
would indicate that the re arrangement process 
(a) (b)
Gly 68
Switch 2
Phe 72
GppNHp
Phe 72
GDP
Switch 2
Figure 7.6. Rab4a. (a) The active state [PDB 2bme (Huber & Scheidig, 2005)] with trans-Phe72 (inset). The grey sphere is magnesium. (b) The 
inactive state [PDB 2bmd (Huber & Scheidig, 2005)] with the corrected and re-refined cis-Phe72 in orange (inset). The incorrect trans-Phe72 
backbone is shown in pink.
might be more complicated than previously 
thought. Phe72 is 97% conserved in the 
HSSP alignment (Touw et al., 2015a) and is part of 
the homologous effector-binding epitope 
of Rab5a (Huber & Scheidig, 2005), suggesting a role 
in discrimination between different effector 
proteins.
Inosine 5’-monophosphate 
dehydrogenase
A tc− flip is predicted for Asn291 (Fig. 7.7a) in 
all four copies of Tritrichomonas foetus inosine 
5′-monophosphate dehydro genase [IMPDH; 
PDB 1lrt (Gan et al., 2002)]. Structure factors 
were not deposited for PDB entry 1lrt. We 
nevertheless believe that Asn291 adopts the 
cis conformation because the corresponding 
peptide plane in the MR search model [PDB 
1ak5 (Whitby et al., 1997)] should also be cis. Further, 
the homologous Asn in human type II 
IMPDH [PDB 1b3o (Colby et al., 1999)] should be 
cis as well (Fig. 7.7b).
Asn91 is part of the β-Me-TAD binding 
site. The Asn291 side chain hydrogen-bonds 
to the conserved Gly312 carbonyl in the so-
called active-site loop and is located less than 
4 Å away from the carboxamide of β-Me-
TAD (Fig. 7.7a). The authors write that the 
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interactions between the active-site loop 
and this carboxamide are the “most striking 
feature of the ternary complex” (Gan et al., 2002). 
They also write that the homologous Asn in 
PDB entry 1b3o directly hydrogen-bonds 
to the carboxamide (Fig. 7.7b). The authors 
extensively allude to the importance of Asn291 
in the binding differences of the two ligands. 
They however fail to notice the peptide-plane 
flip between PDB entries 1b3o and 1lrt and 
that in both structures Asn291 is most likely 
to be a cis peptide, a biological feature that in 
an active site surely is of importance.
Discussion
The present study shows that there is a great 
need for algorithms that can point out peptide 
bonds that might need flipping and require 
a crystallographer's attention. The usefulness 
of such algorithms is not limited to lower 
resolution, as flips are sometimes needed at 
atomic resolution as well (Fig. 7.8).
The validation set is not free of selection 
bias. The residue composition in the validation 
set has not been matched to the PDB-wide 
average nor to the training-set average. As 
mentioned before, the validation set contains 
relatively difficult cases. Therefore, the ‘true’ 
performance of the method is presumably even 
better than the performance reported in Table 
7.4.
The PDB_REDO rebuilding stage explicitly 
checks whether the real-space correlation of a 
peptide plane is better before or after a peptide-
plane flip (Joosten et al., 2011b). In cases where a tc+ 
flip is actually needed, a tt+ flip often still fits 
the density better than no flip at all (see Fig. 
7.1). Further refinement can often lead to the 
additionally required N—H flip. This explains 
why PDB_REDO solves many trans–cis flip 
problems using only a peptide-plane flip search 
algorithm. The RF method was trained using 
peptides that were flipped by PDB_REDO 
and therefore had never seen any cases that 
PDB_REDO failed to correct. One might 
therefore expect that the classifier might 
have been biased towards the training set and 
(a) (b)
Asn 303
Gly 324
Gly 312
Asn 291
IMP
β-Me-TAD
6-Cl-IMP
SAD
Active site loop Active site loop
Figure 7.7. Part of the active site of inosine 5'-monophosphate (IMP) dehydrogenase (IMPDH). (a) T. foetus IMPDH [PDB 1lrt (Gan et 
al., 2002)]. (b) Human IMPDH [PDB 1b3o (Colby et al., 1999)]. The correct cis-Asn303 from PDB_REDO is shown in green. The NAD+ analogue 
is β- methylene thiazole-4-carboxamide adenine dinucleotide (β-Me-TAD) in PDB entry 1lrt and selenazole-4-carboxamide adenine 
dinucleotide (SAD) in PDB entry 1b3o. The IMP analogue 6-chloropurine riboside 5'- monophosphate (6-Cl-IMP) is covalently bound to 
Cys331 in PDB entry 1b3o. The wires trace the Cα atoms. Water molecules have been omitted for clarity.
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might have learned to only recognize incorrect 
peptide conformations that are correctable by 
PDB_REDO. The independent test set 
contained 69 manually validated X-Xnpg cases 
that needed a tc− flip in both the PDB structure 
and the PDB_REDO structure. 63 of these 
cases were classified correctly, which suggests 
that the method generalizes sufficiently to 
augment the PDB_REDO process. As new 
crystal structures are continuously being solved 
and re-refined iteratively by PDB_REDO, the 
method can easily be iteratively improved as 
well.
12 of the 14 X-Xnpg tc− FN corresponded 
to cases for which a flip was observed or 
predicted in an NCS-related chain or in the 
MR search model [Asn267 in chain A and 
Glu435 in chain D of PDB entry 1fwx (Brown et 
al., 2000), Ser412 in PDB entries 1q7z and 1q85 
(Evans et al., 2004), Ala458 in PDB entries 1w9b 
and 1w9d (Bourderioux et al., 2005) and Asp273 in 
PDB entries 3fx6 (Wang et al., 2009) and 3fvl (Wang 
et al., 2010)]. These FN will therefore in practice 
not be a large problem. For example, if 
WHAT_CHECK suggests a flip for the same 
NCS-related residue in chains B, C and D, 
the crystallographer will of course also check 
the residue in chain A (e.g. Asn267 in PDB 
entry 1fwx). Conversely, a predicted flip might 
turn out to be an FP when homologous chains 
are inspected. The FP Glu277 in arginase 1 
[PDB 3lp4 (Di Costanzo et al., 2010)], for example, is 
predicted to be tc− in chain A but not in chain 
B. The FP His188 in the Y364F mutant of 
12-oxophytodienoate reductase 3 [PDB 2hs8 
(Breithaupt et al., 2006)] is not predicted to be a tc− 
flip in another mutant, the wild type or the 
MR search model. Similarly, Asn137 in the 
light chain of the antibody structure of PDB 
entry 2fbj is tt− in other immunoglobulin light 
chains and Asp383 in the caspase 8 chain of 
PDB entry 3h11 (Yu et al., 2009) is tt− in the MR 
search model (PDB 1i4e). WHAT_CHECK 
additionally shows plots in which the backbone 
torsion angles are compared between NCS-
related chains. A peptide flip in just one of the 
two chains leads to a massive peak in this plot.
As mentioned before, trans peptides are 
energetically favoured over cis peptides and 
model-building software by default attempts 
to build trans peptides first. One could also 
argue that experimentalists pay more attention 
to cis peptides, if these are recognized as such, 
than to trans peptides. The combination of 
these arguments results in a very small chance 
of observing incorrectly modelled cis peptides. 
Indeed, only very few clear cis-to-trans flips 
were observed in the present study. The fact that 
automated re-refinement without rebuilding 
results in few cis-to-trans corrections suggests 
that the crystallographic data seldom indicate 
a strong preference for the trans conformation 
in these cases. Visual inspection also seems to 
suggest that true cis peptides typically occur in 
well resolved locations. Croll (Croll, 2015) recently 
reported the high rate of X-Xnpg cis peptides in 
the PDB. His study suggests that an exhaustive 
manual search is likely to identify more cis-
to-trans flips. For example, some structure 
models in the PDB have an unexpected large 
number of cis peptides in regions with poor 
density. These are likely to be incorrect, but 
could not be used to train or validate the 
RF classifiers. An exhaustive manual search 
(a) (b)
Figure 7.8. X-Pro C=O flip at atomic resolution. The 
central peptide Val129-Pro130 is shown in (a) the 
1.2 Å resolution PDB entry 4gqr (Williams et al., 2012) and 
(b) the corresponding PDB_REDO structure. Note 
that in the PDB_REDO conformation not only the 
local backbone, but also the Val (Cγ1 pointing towards 
the reader) and Pro side chains fit the density much 
better. Colours and maps are as in Fig. 7.1.
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for additional cis-to-trans flips is beyond the 
scope of this project, but simply rebuilding 
all cis peptides in the PDB_REDO pipeline 
is computationally feasible. Many cis–trans 
flips will be available for training RF classifiers 
when all PDB structures have been re-refined 
using the new PDB_REDO pipeline.
The number of observed flips was very 
large in some classes, while some flip classes 
were almost completely absent. To increase 
the number of observations in the smaller 
classes, observations were fabricated by 
automatically performing unnecessary flips 
and subsequent extensive re-refinement. The 
simulated peptides resulting from this very 
time-consuming process unfortunately could 
not be used to successfully predict peptides of 
the same class observed in the PDB. The small 
classes will be monitored and in due course 
the analysis will be repeated when sufficient 
examples have become available.
The recommendations given recently by 
Croll (2015) will help crystallographers to 
identify spurious cis peptides. The method 
presented here may help to detect trans 
peptides in need of a flip. We believe that these 
results can help everyday crystallographic 
practice if they are used. However, the true 
solution to the problem of incorrect peptide 
conformations is the training and good 
supervision of inexperienced crystallo graphers.
Availability
The peptide-validation method has been 
implemented in WHAT_CHECK (http://
swift.cmbi.ru.nl/gv/whatcheck/) and is 
available as a web server (http://swift.cmbi.
ru.nl/servers/html/flpchk.html) and as a web 
service (http://wiws.cmbi.ru.nl/wsdl/). The 
functionality to perform flips of the tc− and 
tc+ type will be added to PDB_REDO. The 
Coot visualisation scripts for PDB_REDO 
entries (Joosten et al., 2014) show peptide-plane flips 
and trans↔cis flips since PDB_REDO version 
5.43.
The details of classifier training, the 
resulting classifiers, all tetrapeptide data 
used for training and validation, the details 
and pseudo-code for comparing peptide 
conformations and all re-refinement example 
data are available from the associated website 
at http://swift.cmbi.ru.nl/gv/flips/. WHAT IF, 
including the PDB–PDB_REDO comparison 
menu and peptide-validation method, is freely 
available from http://swift.cmbi.ru.nl/gv/
facilities/.
Conclusion
When applied to the 46 418 233 peptide 
planes in the PDB, the method predicts 1527 
X-Xnpg tc− flips, 53 974 X-Xnpg tt+ flips, 
517 X-Pro tc− flips, 2573 X-Pro tc+ flips 
and 16 487 X-Gly tt+ flips. PDB_REDO 
has already corrected ~14% of the peptide-
plane flips and ~8% of the trans-to-cis flips. 
Peptide-conformation correction leads to 
a small improvement in the R factors, but 
more importantly surprisingly often provides 
a better insight into the structure–function 
relationship.
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In the Life Sciences, ‘omics’ data are increasingly generated by different high-throughput technologies. Often only the integration of these data allows uncovering biological insights that can be experimentally validated 
or mechanistically modelled. Sophisticated computational approaches are 
therefore required to extract the complex non-linear trends present in omics data. 
Classification techniques allow training a model based on variables (e.g. SNPs in 
genetic association studies) to separate different classes (e.g. healthy subjects versus 
patients). Random Forest (RF) (Breiman, 2001) is a versatile classification algorithm 
suited for the analysis of large data sets. In the Life Sciences, RF is popular because 
the prediction accuracy of RF classification models is often high and because RF 
models provide information on importance of variables for classification. For omics 
data, variables or conditional relations between variables are typically important 
for a subset of samples of the same class. Certain SNP combinations, for example, 
may be important for a subset of patients who have a specific subtype of cancer, 
but not important for another subset of patients that have the same type of cancer 
but a different subtype. These conditional relationships might be uncovered from 
the data with RF as these are implicitly taken into account by the algorithm during 
the creation of the classification model. This review details some of the —to the 
best of our knowledge— rarely or never used RF properties that allow maximizing 
the biological insights that can be extracted from complex omics data sets with RF.
Adapted from:
Briefings in Bioinformatics (2013) 14, 315-326
Wouter G. Touw, Jumamurat R. Bayjanov, Lex Overmars, Lennart Backus, Jos 
Boekhorst, Michiel Wels & Sacha A.F.T. van Hijum
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Samenvatting
Eiwitten zijn betrokken bij bijna alle aspecten 
van leven. Er zijn vele duizenden verschillende 
typen eiwitten. Zo zijn er bepaalde typen 
enzymen die voedsel verteren door het in kleine 
stukjes te knippen, ion-kanalen die betrokken 
zijn bij het genereren van actiepotentialen 
in het centraal zenuwstelsel, antistoffen die 
specifieke delen van pathogenen herkennen, 
eiwitten die signalen in een cel doorgeven, 
eiwitten die de cel stevigheid geven en 
lichtreceptoren in de retina die ervoor zorgen 
dat de lezer deze woorden kan zien.
Eiwitten zijn polypeptideketens die bestaan 
uit aminozuren. De aminozuursequentie 
en de driedimensionale vorm van de 
polypeptideketen bepalen de moleculaire 
functie van een eiwit. Gedetailleerde kennis 
over eiwitten is daarom voor een groot gedeelte 
gebaseerd op onderzoek naar de structuur van 
eiwitten: de vorm van eiwitten op atomaire 
schaal.
Eiwitstructuurmodellen worden in vrijwel 
alle disciplines van de levenswetenschappen 
gebruikt, bijvoorbeeld om structuur–functie 
relaties te leren begrijpen, om te voorspellen 
welke aminozuren in een enzym moeten 
worden gemuteerd om dit enzym te stabiliseren 
bij speciale omstandigheden, om te voorspellen 
welke mutaties een enzym efficiënter 
biobrandstof laten maken, om beweging van 
eiwitten te simuleren, of om zogenaamde lead 
compounds verder te ontwikkelen tot echte 
medicijnen. 
DNA is de drager van erfelijk materiaal en 
het bevat instructies om eiwitten te maken in 
de cel. Soms kan een verandering in het DNA 
ervoor zorgen dat er op een bepaalde plek in 
een eiwit een ander aminozuur aanwezig is. 
Zulke mutaties kunnen ertoe leiden dat het 
eiwit anders werkt dan normaal. Als de functie 
van het eiwit sterk is aangetast en dit eiwit een 
belangrijke biologische rol vervult, kan een 
dergelijke mutatie leiden tot ziekte.
Soms kunnen medicijnen verstoorde 
biologische processen terugbrengen naar een 
gezonde toestand. Medicijnen zijn vaak kleine 
moleculen die specifiek binden aan een eiwit 
in een bepaald biologisch proces. Imatinib is 
een voorbeeld van een klein molecuul dat over-
actieve tyrosine kinases remt en daardoor de 
proliferatie van tumorcellen voorkomt. Statines 
remmen HMG-CoA reductase waardoor de 
cholesterolproductie wordt verlaagd. Soms 
beïnvloeden medicijnen de waarneming van 
de realiteit. Pijnstillers, bijvoorbeeld, remmen 
cyclo-oxygenase enzymen die betrokken zijn 
bij het ontstaan van pijn. Andere medicijnen 
proberen eiwitten juist te activeren. Een 
voorbeeld hiervan is de spierverslapper 
Baclofen die de GABAB receptor activeert. 
Recentelijk zijn nieuwe klassen van 
zogenaamde biologicals geïntroduceerd, zoals 
monoclonale antilichamen die worden ingezet 
om onder andere kanker, multiple sclerose, 
arthritis, psoriasis of de ziekte van Crohn te 
behandelen.
De Protein Data Bank (PDB) is de publieke 
database van macromoleculaire structuren. 
De PDB bevat meer dan honderdduizend 
structuurmodellen van individuele 
eiwitten, eiwitten in complex met andere 
macromoleculen zoals DNA, RNA, lipiden 
en suikers, of eiwitten met kleinere moleculen 
zoals ionen, metabolieten of medicijnachtige 
stofjes. De PDB is daarom een waardevolle 
bron van informatie over biomoleculaire 
structuur en interacties. Veel van wat we weten 
over eiwitstructuur is gebaseerd op structuren 
die gedurende de laatste 40 jaar gedeponeerd 
zijn in de PDB.
Bioinformatica is het gebruik van computers 
om biologische vragen te beantwoorden. 
Een van de uitdagingen in dit veld is het 
voorspellen van de structuur van eiwitten 
waarvan alleen de aminozuursequentie 
bekend is. Homologie-modelleertechnieken 
zijn gebaseerd op de structuurinformatie in 
de PDB. Eiwitstructuurvoorspellingen zullen 
daarom beter zijn als de kwaliteit van die 
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structuurinformatie beter is.
De meeste van de eerdergenoemde 
toepassingen zoals protein engineering, 
moleculaire dynamica, drug design en 
homologie modelleren hebben baat bij 
structuurmodellen van hoge kwaliteit. De 
duivel schuilt hierbij vaak in de details.
Eiwitstructuren kunnen experimenteel 
worden bepaald met atomaire precisie door 
middel van elektronenmicroscopie (cryo-EM), 
kernspinresonantie (NMR) of röntgendiffractie 
van eiwitkristallen (X-ray). Deze technieken 
worden kort geïntroduceerd in hoofdstuk 
1a. Ze hebben elk hun eigen voor- en 
nadelen, maar hebben gemeenschappelijk 
dat de ruwe data slechts een indirecte 
weerspiegeling van de eiwitstructuur zijn. 
In de praktijk blijkt eenduidige interpretatie 
van deze data vrijwel onmogelijk en het 
voorkomen van verkeerde interpretatie vereist 
vaak veel deskundigheid. Als gevolg hiervan 
bevatten veel structuurmodellen fouten. 
Alle structuurmodellen zijn een suboptimale 
interpretatie van de experimentele data, maar 
sommige modellen zouden nuttiger gemaakt 
kunnen worden1.
Recent zijn er wereldwijde PDB 
validatie ‘task forces’ (VTFs) opgericht die 
moeten voorkomen dat structuren met 
onwaarschijnlijke of onjuiste eigenschappen 
worden gedeponeerd in de PDB. Het 
WHAT_CHECK project heeft duidelijk 
gemaakt dat er honderden verschillende 
foutcategorieën bestaan in experimenteel 
bepaalde eiwitstructuren. Het doel van 
het PDB_REDO project is een optimale 
interpretatie van de originele experimentele 
data die vaak samen met de structuren 
zijn gedeponeerd. In het PDB_REDO 
project worden structuren herbouwd en 
-verfijnd met de nieuwste software en kennis 
over de relatie tussen eiwitsequentie en 
-structuur. Dankzij de immer toenemende 
rekencapaciteit kunnen betere coördinaten 
alsmaar sneller worden geproduceerd. Een 
1. vrij naar George Box (1979)
aantal van de problemen met kristalstructuren 
van eiwitten wordt in PDB_REDO aangepakt. 
In dit proefschrift zijn verschillende nieuwe 
aspecten opgenomen.
hoofdstuk 1b introduceert de problemen 
en beschrijft het belang van accurate 
eiwitstructuren voor het interpreteren van 
biologische functies. Tien voorbeelden laten 
zien dat een verbeterd structuurmodel een 
ander licht kan werpen op de biologische rol van 
een eiwit. Ten slotte worden in dit hoofdstuk 
het PDB_REDO project en validatie-gedreven 
structuuroptimalisatie samengevat.
Voor dit proefschrift zijn meer dan 
duizend eiwitstructuurmodellen handmatig 
geoptimaliseerd. Hiervoor waren een 
uitgebreide software- en data-infrastructuur 
onmisbaar. hoofdstuk 2 beschrijft 
de data-infrastructuur en verschillende 
bioinformaticafaciliteiten voor onderzoekers 
in de (computationele) structurele biologie.
Een goede beschrijving van atomaire 
beweging was belangrijk voor nagenoeg alle 
studies die beschreven zijn in dit proefschrift. 
Atomaire beweging in kristalstructuren kan 
op veel verschillende manieren gemodelleerd 
worden. Er bestaan daardoor ook veel 
verschillende manieren om B-factoren weer te 
geven in PDB-bestanden. Daar is wiskundig 
gezien niets mis mee, maar het is onhandig 
voor bioinformaticatoepassingen. hoofdstuk 
3 beschrijft de BDB, een database van 
PDB-bestanden waarin B-factoren op een 
consistente manier worden opgeslagen in de 
meest praktische vorm.
Bij het analyseren van B-factoren 
realiseerden we ons dat de frauduleuze 
structuurmodellen van H.K.M. Murthy 
gedetecteerd hadden kunnen worden door 
hun B-factordistributies te analyseren met 
behulp van de wet van Benford. hoofdstuk 
4 beschrijft de implementatie van deze 
validatiemethode.
hoofdstuk 1a legt kort uit waarom de 
verwachtingswaarden voor geometrische 
parameters zo gedetailleerd en correct mogelijk 
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moeten zijn voor verfijning en validatie. Voor 
dit proefschrift zijn verschillende parameters 
onderzocht. hoofdstuk 5 beschrijft een 
uitgebreide studie naar de backbone hoek τ 
(N—Cα—C) en laat zien dat geometrische 
parameters afhankelijk zijn van de lokale 
chemische omgeving in een eiwit. De 
implicaties voor context-afhankelijke 
verfijnings- en validatieparameters worden 
bediscussieerd.
hoofdstuk 6 onderzoekt de geometrische 
parameters van tetrahedrale zinkcomplexen 
die bestaan uit een zink ion en vier cysteïne- 
of histidine-liganden. Dit hoofdstuk laat zien 
dat incorrecte restraints kunnen leiden tot 
lokaal vervormde eiwitstructuurmodellen. 
Ook worden methoden beschreven om 
vervormde complexen te detecteren en 
corrigeren. Daarnaast wordt gedemonstreerd 
dat ion-ligand afstanden en ligand-ion-
ligand hoeken afhankelijk zijn van het type 
ligand. Ten slotte worden nieuwe verfijnings- 
en validatieparameters voorgesteld op 
basis van geoptimaliseerde hoge-resolutie 
structuurmodellen. De problemen omtrent 
de geometrie van zinkcomplexen waren ook 
het onderwerp van een 1 aprilartikel dat 
opgenomen is als hoofdstuk 6 appendix.
hoofdstuk 7 presenteert een methode om 
eiwitbackbones te detecteren die zijn vervormd 
als gevolg van een verkeerde conformatie 
van het peptideplaatje. De methode spoort 
systematische afwijkingen op in geometrische 
parameters en B-factoren rondom een 
trans-peptide. Gebaseerd op deze patronen 
kan worden voorspeld of het peptide een 
zogenaamde peptideflip moet ondergaan, of 
dat de conformatie van het trans-peptide moet 
worden veranderd naar cis. De cis-peptide 
validatiemethode wordt een onderdeel van het 
arsenaal aan validatietechnieken van de X-ray 
VTF.
Voor het onderzoek dat beschreven wordt 
in hoofdstuk 6, maar vooral in hoofdstuk 7, 
is gebruik gemaakt van het Random Forest 
(RF) machine-learning algoritme. Deze 
techniek is toegepast om de meest significante 
variabelen te selecteren uit vele variabelen die 
een systeem beschrijven. Een goed begrip van 
deze methode is verkregen tijdens het schrijven 
van een review over de potentie van RF voor 
data mining in de levenswetenschappen. 
hoofdstuk 7 appendix is de samenvatting 
van dit review.
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PDB formaat. 
Jon, ik heb met erg veel plezier naast je 
gezeten en heb een groot gedeelte van mijn 
programmeer-opvoeding aan jou te danken. Je 
hebt me zelfs weten te overtuigen om code te 
schrijven in Vim met allerlei nerd-plugins. Ik 
gebruik nog steeds geen i3, want de muis is 
gewoon handiger om moleculen te bekijken. 
Je bijdrage aan dit proefschrift is echter niet 
alleen technisch van aard. We hebben niet 
alleen als collega’s maar ook als vrienden vaak 
mogen genieten van mooie muziek, geweldige 
jamsessies en bijzondere bieren. Daarnaast zijn 
we allebei vader geworden in de periode dat 
we kamergenoten waren. Het was erg leuk om 
dat op hetzelfde moment mee te maken en 
ervaringen te delen met jou en Annemarieke. 
Gaaf dat je nu mijn paranimf bent!
Robin, toen we samen MLW studeerden 
hebben we ons allebei door Gert laten strikken 
om stage te komen lopen op het CMBI. Ik 
vind het erg leuk dat we daarna ook collega’s 
waren. Samen hebben we heel wat mooie 
borrels, etentjes, concerten en barbeque-
avonden bij Gert meegemaakt en hebben we 
veel lol gehad bij het zaalvoetbal. Onze lunches 
en middagwandelingen waren ook altijd 
gezellig; zelfs als we de enigen waren die ons 
buiten vertoonden omdat het (bijna) vroor. Of 
het nou over ons onderzoek, over technische 
handigheidjes in R, over muziek/sport/bier/
actualiteit of eigenlijk nergens over ging, het 
was altijd een welkome afleiding. Inmiddels zit 
jouw promotietraject er ook bijna op; ik vind 
het super dat je als paranimf onze gezamenlijke 
periode op het CMBI afsluit. Ik hoop dat we 
samen nog eens wat kunnen publiceren!
Er zijn nog een heleboel anderen die 
ervoor gezorgd hebben dat ik een leuke tijd 
heb gehad bij het CMBI. Onder andere mijn 
kamergenoten Hanka, Maarten, Joanna en 
Laurens waren daarvoor erg belangrijk. Hanka, 
jij vond elke maand weer een grappig molecuul 
en je zorgde voor leuke CMBI nieuwsupdates. 
Ook reisde je heel de wereld over om mee te 
doen aan wedstrijden of cursussen te geven. 
Als je weer op het CMBI was, verraste je ons 
elke keer weer met de lange lijst steden die 
je bezocht had. Succes met je twee carrières! 
Maarten, jouw enorme kennis en ervaring zijn 
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waardevol voor elke promovendus. Ik denk 
met veel plezier terug aan (jouw stelligheid 
tijdens) onze gesprekken over de huizenmarkt, 
het koningshuis en de opera. Leuk dat we nu 
weer gaan samenwerken! Joanna en Laurens, 
het was gezellig om kamergenoten te zijn, 
ook als was het maar voor even. Mijn Pools 
is nog steeds niet denderend, maar dat hoeft 
misschien ook niet met: ‘Chodźmy na piwo!’. 
Laurens, je enthousiasme voor zeldzame bieren 
was erg aanstekelijk. Je bent een waardige 
opvolger in de biercommissie! Succes met 
jullie verdere promotieonderzoek! Karen en 
Coos, bedankt voor de goede samenwerking. 
We hebben samen aan een paar interessante 
projecten gewerkt. Bart en Jochem, ik vond 
het leuk jullie samen met Gert te begeleiden. 
Of beter gezegd, ik mocht me af en toe 
bemoeien met jullie projecten want jullie 
waren al erg zelfstandig. Nu hebben we samen 
naast een 1 aprilartikel ook nog een mooi 
‘echt’ artikel gemaakt. Veel succes met jullie 
eigen onderzoek! Barbara, ontzettend bedankt 
voor het organiseren van alle labuitjes, borrels, 
etentjes en de logistieke ondersteuning op het 
CMBI. Het leven van een promovendus is een 
stuk gemakkelijker met iemand zoals jij op de 
afdeling! Arthur, we hebben tijdens ons IT-
overleg heel wat technische problemen kunnen 
aanpakken. Bedankt voor de ondersteuning! 
Sacha, door jou heb ik in detail kennis gemaakt 
met Random Forest. Je enthousiasme was erg 
aanstekelijk! Ik heb veel gezellige avonden 
gehad en vaak mogen lachen met Carolien, 
Coos, Daniel, Dei, Joanna, John, Jon, Kuntal, 
Laurens, Lisette, Rob, Robin, Selma en Wout. 
Ook kon ik altijd hun kamer binnenlopen voor 
een goed en/of grappig gesprek. Bedankt! Rob, 
het was erg leuk je op de afdeling te hebben. 
Je onophoudelijke vragenstroom gaat nooit 
vervelen. John, super cool dat je na Jurgen 
de eervolle taak van bierbrouwer op je nam. 
Heb je al een naam voor je brouwerij? Bedankt 
voor de gezelligheid! Wout, zelfs tijdens onze 
fietstochten bleef je praatjes houden!
Tijdens mijn stages buiten het CMBI 
heb ik zeer vakkundige begeleiding gehad 
van Vincent, Geerten, Klemens en Irmi. 
Zij hebben me de praktische aspecten van 
NMR en eiwitkristallografie bij proberen te 
brengen. Een uitstekende voorbereiding op 
mijn promotietraject! Ik ben hen daarom veel 
dank verschuldigd. Vincent, bedankt voor je 
enthousiasme. Jij hebt me laten zien dat NMR 
ontzettend cool is!
Een goede balans tussen werk en ontspanning 
is erg belangrijk. Sportieve inspanning is een 
van de beste vormen van ontspanning. Bert, 
ik heb genoten van alle kilometers die we 
samen hebben gefietst! Ik wil ook de rest van 
Team Orion en andere fietsmaatjes bedanken 
voor het gedeelde leed. Christiaan, dankzij 
jou hebben heel wat promovendi hun hoofd 
regelmatig leeg kunnen knallen. Bedankt voor 
het regelen van de voetbalzaaltjes! Muziek was 
ook een goede uitlaatklep. Ik kreeg veel energie 
van de schitterende optredens die ik met Jon, 
Rob en Robin heb bijgewoond en van de 
jamsessies met Jon!
Lieve vrienden, bedankt voor jullie 
vriendschap. De afgelopen jaren heb ik met 
jullie mogen genieten van heel wat memorabele 
momenten tijdens leuke activiteiten en 
heerlijke etentjes. Die momenten zorgden 
voor belangrijke afleiding van mijn 
promotieonderzoek. Ik wil een paar mensen in 
het bijzonder bedanken. Selmer en Madelon, 
bedankt voor alle leuke avonden. Onze 
wekelijkse eetafspraken waren erg gezellig! 
Het was ook altijd weer mooi als we met Rick 
en Jordi hard konden lachen om een slechte 
horrorfilm. Arne, Daan, Inge, Marije, Renee, 
Sander, Siroon, het is altijd weer gezellig als we 
elkaar zien. Bedankt voor de gezellige etentjes 
en in het bijzonder de heerlijke kerstdiners! 
We hebben de afgelopen jaren veel ervaringen 
kunnen uitwisselen over ons werk of het zijn 
van promovendus, ik ben benieuwd waar we 
uiteindelijk terecht komen! Arne, ik ben erg 
blij dat we onze wekelijkse lunches tot mijn 
vertrek hebben kunnen voortzetten (ook al was 
het soms even zoeken naar de dag). Misschien 
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kunnen we nog eens samen aan een project 
werken! Arne en Annika, bedankt voor de 
leuke etentjes. Ik heb ook veel gehad aan de 
praktische tips rondom het boekje. Bedankt! 
Ik wil ook Rike en Jan bedanken voor de leuke 
afspraken. Eric, Joris, Koen, Lara, bedankt 
voor alle lol die we samen hebben. Maarten, 
bedankt voor alle spontane afspraken en 
natuurlijk onze reis naar Kroatië!
Mijn familie en schoonfamilie staan 
altijd voor me klaar. Na alle leuke dagjes uit, 
vakanties en weekendjes kon ik ook altijd weer 
fris verder met mijn onderzoek. Jullie zijn erg 
belangrijk voor me en hebben ontzettend veel 
bijgedragen aan dit proefschrift! Pap, mam, 
dankzij jullie voorbeeld, steun, vertrouwen, 
liefde (en natuurlijk jullie genen) heb ik de 
mogelijkheid gehad aan dit promotietraject te 
beginnen en het te voltooien. Ik wil ook mijn 
lieve zus Jasmijn en haar Bert bedanken. Ook 
zij zijn een voorbeeld voor me. Lisa, Nienke, 
Annemieke, Wim, jullie gaven me vanaf het 
begin het warme gevoel onderdeel te zijn van 
de familie. Bedankt voor jullie betrokkenheid 
en ondersteuning!
Lieve Anne, lieve Tijn, ik ben ontzettend 
blij met jullie! Anne, je bent er altijd voor 
me. Jouw steun is onmisbaar geweest tijdens 
mijn gehele promotietraject. Tijn, jouw 
onuitputtelijke vrolijkheid heeft me erg veel 
energie gegeven tijdens de laatste loodjes!
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Wouter Geert Touw werd geboren op 19 
augustus 1988 te Breda. In 2006 voltooide hij 
zijn Gymnasiumopleiding aan het Stedelijk 
Gymnasium in Breda cum laude en begon hij 
zijn studie Moleculaire Levenswetenschappen 
aan de Radboud Universiteit Nijmegen. 
In 2012 studeerde Wouter summa cum 
laude af, na zich gespecialiseerd te hebben 
in bioinformatica en structurele biologie 
gedurende stages onder begeleiding van Prof. 
Dr. Gert Vriend (Centre for Molecular and 
Biomolecular Informatics, Radboudumc 
Nijmegen), Prof. Dr. Geerten Vuister (Protein 
Biophysics, Radboud Universiteit) en Prof. 
Dr. Irmgard Sinning (Biochemie-Zentrum der 
Universität Heidelberg). In november 2012 
startte Wouter zijn promotieonderzoek in de 
Protein Structure Bioinformatics groep van het 
CMBI met Prof. Dr. Gert Vriend als promotor 
en Dr. Robbie Joosten (Nederlands Kanker 
Instituut, Amsterdam) als copromotor. 
Sinds april 2016 is Wouter werkzaam als 
post-doctoraal onderzoeker op de afdeling 
biochemie in de groep van Dr. Tassos Perrakis 
van het NKI.

